KR102729973B1 - 인플루엔자 헤마글루티닌에 대한 인간 항체 - Google Patents
인플루엔자 헤마글루티닌에 대한 인간 항체 Download PDFInfo
- Publication number
- KR102729973B1 KR102729973B1 KR1020177020050A KR20177020050A KR102729973B1 KR 102729973 B1 KR102729973 B1 KR 102729973B1 KR 1020177020050 A KR1020177020050 A KR 1020177020050A KR 20177020050 A KR20177020050 A KR 20177020050A KR 102729973 B1 KR102729973 B1 KR 102729973B1
- Authority
- KR
- South Korea
- Prior art keywords
- antibody
- influenza
- antigen
- antibodies
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010022000 influenza Diseases 0.000 title claims abstract description 286
- 101710154606 Hemagglutinin Proteins 0.000 title claims abstract description 193
- 101710093908 Outer capsid protein VP4 Proteins 0.000 title claims abstract description 193
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 title claims abstract description 193
- 101710176177 Protein A56 Proteins 0.000 title claims abstract description 193
- 239000000185 hemagglutinin Substances 0.000 title claims abstract description 188
- 238000009739 binding Methods 0.000 claims abstract description 213
- 230000027455 binding Effects 0.000 claims abstract description 212
- 239000000427 antigen Substances 0.000 claims abstract description 169
- 108091007433 antigens Proteins 0.000 claims abstract description 169
- 102000036639 antigens Human genes 0.000 claims abstract description 169
- 239000012634 fragment Substances 0.000 claims abstract description 148
- 241000712461 unidentified influenza virus Species 0.000 claims abstract description 80
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 42
- 239000003443 antiviral agent Substances 0.000 claims abstract description 16
- 229960005486 vaccine Drugs 0.000 claims abstract description 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 92
- 241000699670 Mus sp. Species 0.000 claims description 76
- 208000015181 infectious disease Diseases 0.000 claims description 57
- 150000007523 nucleic acids Chemical class 0.000 claims description 56
- 229960003752 oseltamivir Drugs 0.000 claims description 49
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 claims description 49
- 230000004083 survival effect Effects 0.000 claims description 45
- 102000039446 nucleic acids Human genes 0.000 claims description 39
- 108020004707 nucleic acids Proteins 0.000 claims description 39
- 239000003814 drug Substances 0.000 claims description 36
- 239000000203 mixture Substances 0.000 claims description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 31
- 208000037797 influenza A Diseases 0.000 claims description 30
- 230000009385 viral infection Effects 0.000 claims description 30
- 241000700605 Viruses Species 0.000 claims description 28
- 241000124008 Mammalia Species 0.000 claims description 23
- 201000010099 disease Diseases 0.000 claims description 21
- 238000010494 dissociation reaction Methods 0.000 claims description 20
- 230000005593 dissociations Effects 0.000 claims description 19
- 230000001965 increasing effect Effects 0.000 claims description 19
- 208000024891 symptom Diseases 0.000 claims description 19
- 229940124597 therapeutic agent Drugs 0.000 claims description 18
- 238000006386 neutralization reaction Methods 0.000 claims description 17
- 108091033319 polynucleotide Proteins 0.000 claims description 16
- 102000040430 polynucleotide Human genes 0.000 claims description 16
- 239000002157 polynucleotide Substances 0.000 claims description 16
- 241000712431 Influenza A virus Species 0.000 claims description 15
- 238000001990 intravenous administration Methods 0.000 claims description 13
- 230000009089 cytolysis Effects 0.000 claims description 11
- 230000000295 complement effect Effects 0.000 claims description 10
- 241000282693 Cercopithecidae Species 0.000 claims description 7
- 239000003085 diluting agent Substances 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 6
- 238000005305 interferometry Methods 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 206010061598 Immunodeficiency Diseases 0.000 claims description 5
- 206010011224 Cough Diseases 0.000 claims description 4
- 208000000059 Dyspnea Diseases 0.000 claims description 4
- 206010013975 Dyspnoeas Diseases 0.000 claims description 4
- 206010035664 Pneumonia Diseases 0.000 claims description 4
- 206010037660 Pyrexia Diseases 0.000 claims description 4
- 238000010171 animal model Methods 0.000 claims description 4
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 4
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 4
- 206010006451 bronchitis Diseases 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 239000013604 expression vector Substances 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 208000013220 shortness of breath Diseases 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 239000003246 corticosteroid Substances 0.000 claims description 3
- 206010012601 diabetes mellitus Diseases 0.000 claims description 3
- 208000019622 heart disease Diseases 0.000 claims description 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims description 3
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims description 3
- 208000000112 Myalgia Diseases 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 239000012528 membrane Substances 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 238000009116 palliative therapy Methods 0.000 claims 1
- 206010039083 rhinitis Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 55
- 102000004169 proteins and genes Human genes 0.000 abstract description 34
- 108090000623 proteins and genes Proteins 0.000 abstract description 34
- 230000000694 effects Effects 0.000 abstract description 17
- 230000003472 neutralizing effect Effects 0.000 abstract description 17
- 230000007501 viral attachment Effects 0.000 abstract description 7
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 230000007502 viral entry Effects 0.000 abstract 1
- 108020004414 DNA Proteins 0.000 description 269
- 210000004027 cell Anatomy 0.000 description 50
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 49
- 235000001014 amino acid Nutrition 0.000 description 48
- 108090000765 processed proteins & peptides Proteins 0.000 description 44
- 150000001413 amino acids Chemical class 0.000 description 42
- 229940024606 amino acid Drugs 0.000 description 41
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 40
- 101100505161 Caenorhabditis elegans mel-32 gene Proteins 0.000 description 38
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 37
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 36
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 35
- 108010008355 arginyl-glutamine Proteins 0.000 description 35
- MBLJBGZWLHTJBH-SZMVWBNQSA-N Trp-Val-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 MBLJBGZWLHTJBH-SZMVWBNQSA-N 0.000 description 34
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 33
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 33
- FEHQLKKBVJHSEC-SZMVWBNQSA-N Leu-Glu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 FEHQLKKBVJHSEC-SZMVWBNQSA-N 0.000 description 32
- 108010003137 tyrosyltyrosine Proteins 0.000 description 32
- 238000003556 assay Methods 0.000 description 31
- OYTPNWYZORARHL-XHNCKOQMSA-N Gln-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N OYTPNWYZORARHL-XHNCKOQMSA-N 0.000 description 30
- WNZOCXUOGVYYBJ-CDMKHQONSA-N Gly-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CN)O WNZOCXUOGVYYBJ-CDMKHQONSA-N 0.000 description 30
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 30
- 235000018102 proteins Nutrition 0.000 description 30
- 108010044292 tryptophyltyrosine Proteins 0.000 description 30
- UQJNXZSSGQIPIQ-FBCQKBJTSA-N Gly-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)CN UQJNXZSSGQIPIQ-FBCQKBJTSA-N 0.000 description 29
- 108010089804 glycyl-threonine Proteins 0.000 description 27
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 26
- 101100315624 Caenorhabditis elegans tyr-1 gene Proteins 0.000 description 25
- SPSSJSICDYYTQN-HJGDQZAQSA-N Met-Thr-Gln Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O SPSSJSICDYYTQN-HJGDQZAQSA-N 0.000 description 25
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 25
- 241000699666 Mus <mouse, genus> Species 0.000 description 24
- KLYYKKGCPOGDPE-OEAJRASXSA-N Phe-Thr-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O KLYYKKGCPOGDPE-OEAJRASXSA-N 0.000 description 24
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 24
- AOHKLEBWKMKITA-IHRRRGAJSA-N Arg-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N AOHKLEBWKMKITA-IHRRRGAJSA-N 0.000 description 23
- 108010037850 glycylvaline Proteins 0.000 description 23
- 230000035772 mutation Effects 0.000 description 23
- AZWNCEBQZXELEZ-FXQIFTODSA-N Ser-Pro-Ser Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O AZWNCEBQZXELEZ-FXQIFTODSA-N 0.000 description 22
- QUILOGWWLXMSAT-IHRRRGAJSA-N Tyr-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QUILOGWWLXMSAT-IHRRRGAJSA-N 0.000 description 22
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 22
- OWFGFHQMSBTKLX-UFYCRDLUSA-N Val-Tyr-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N OWFGFHQMSBTKLX-UFYCRDLUSA-N 0.000 description 22
- 108010015792 glycyllysine Proteins 0.000 description 22
- 102000004196 processed proteins & peptides Human genes 0.000 description 22
- 230000001225 therapeutic effect Effects 0.000 description 22
- XYBJLTKSGFBLCS-QXEWZRGKSA-N Asp-Arg-Val Chemical compound NC(N)=NCCC[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@@H](N)CC(O)=O XYBJLTKSGFBLCS-QXEWZRGKSA-N 0.000 description 21
- SZQCDCKIGWQAQN-FXQIFTODSA-N Cys-Arg-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O SZQCDCKIGWQAQN-FXQIFTODSA-N 0.000 description 21
- OSCLNNWLKKIQJM-WDSKDSINSA-N Gln-Ser-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O OSCLNNWLKKIQJM-WDSKDSINSA-N 0.000 description 21
- CQGSYZCULZMEDE-UHFFFAOYSA-N Leu-Gln-Pro Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)N1CCCC1C(O)=O CQGSYZCULZMEDE-UHFFFAOYSA-N 0.000 description 21
- IXHKPDJKKCUKHS-GARJFASQSA-N Lys-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N IXHKPDJKKCUKHS-GARJFASQSA-N 0.000 description 21
- FQPDRTDDEZXCEC-SVSWQMSJSA-N Thr-Ile-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O FQPDRTDDEZXCEC-SVSWQMSJSA-N 0.000 description 21
- 210000004602 germ cell Anatomy 0.000 description 21
- 229920001184 polypeptide Polymers 0.000 description 21
- UWKNTTJNVSYXPC-CIUDSAMLSA-N Lys-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN UWKNTTJNVSYXPC-CIUDSAMLSA-N 0.000 description 20
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 20
- GXUWHVZYDAHFSV-FLBSBUHZSA-N Thr-Ile-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GXUWHVZYDAHFSV-FLBSBUHZSA-N 0.000 description 20
- 108010054812 diprotin A Proteins 0.000 description 20
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- ARHJJAAWNWOACN-FXQIFTODSA-N Ala-Ser-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O ARHJJAAWNWOACN-FXQIFTODSA-N 0.000 description 19
- PAQUJCSYVIBPLC-AVGNSLFASA-N Glu-Asp-Phe Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 PAQUJCSYVIBPLC-AVGNSLFASA-N 0.000 description 19
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 19
- JXFLPKSDLDEOQK-JHEQGTHGSA-N Gln-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CCC(N)=O JXFLPKSDLDEOQK-JHEQGTHGSA-N 0.000 description 18
- ZFBBMCKQSNJZSN-AUTRQRHGSA-N Gln-Val-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZFBBMCKQSNJZSN-AUTRQRHGSA-N 0.000 description 18
- AIMGJYMCTAABEN-GVXVVHGQSA-N Leu-Val-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O AIMGJYMCTAABEN-GVXVVHGQSA-N 0.000 description 18
- YMTLKLXDFCSCNX-BYPYZUCNSA-N Ser-Gly-Gly Chemical compound OC[C@H](N)C(=O)NCC(=O)NCC(O)=O YMTLKLXDFCSCNX-BYPYZUCNSA-N 0.000 description 18
- BIBYEFRASCNLAA-CDMKHQONSA-N Thr-Phe-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=CC=C1 BIBYEFRASCNLAA-CDMKHQONSA-N 0.000 description 18
- XKUKSGPZAADMRA-UHFFFAOYSA-N glycyl-glycyl-glycine Natural products NCC(=O)NCC(=O)NCC(O)=O XKUKSGPZAADMRA-UHFFFAOYSA-N 0.000 description 18
- 238000001727 in vivo Methods 0.000 description 18
- 238000006467 substitution reaction Methods 0.000 description 18
- CREYEAPXISDKSB-FQPOAREZSA-N Ala-Thr-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CREYEAPXISDKSB-FQPOAREZSA-N 0.000 description 17
- TYYLDKGBCJGJGW-UHFFFAOYSA-N L-tryptophan-L-tyrosine Natural products C=1NC2=CC=CC=C2C=1CC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 TYYLDKGBCJGJGW-UHFFFAOYSA-N 0.000 description 17
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 17
- MVJRBCJCRYGCKV-GVXVVHGQSA-N Leu-Val-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O MVJRBCJCRYGCKV-GVXVVHGQSA-N 0.000 description 17
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 17
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 17
- 238000011282 treatment Methods 0.000 description 17
- YQPFCZVKMUVZIN-AUTRQRHGSA-N Glu-Val-Gln Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O YQPFCZVKMUVZIN-AUTRQRHGSA-N 0.000 description 16
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 16
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 16
- MCIXMYKSPQUMJG-SRVKXCTJSA-N Phe-Ser-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O MCIXMYKSPQUMJG-SRVKXCTJSA-N 0.000 description 16
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 16
- FMDHKPRACUXATF-ACZMJKKPSA-N Ser-Gln-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O FMDHKPRACUXATF-ACZMJKKPSA-N 0.000 description 16
- YUJLIIRMIAGMCQ-CIUDSAMLSA-N Ser-Leu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YUJLIIRMIAGMCQ-CIUDSAMLSA-N 0.000 description 16
- JQTYTBPCSOAZHI-FXQIFTODSA-N Val-Ser-Cys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N JQTYTBPCSOAZHI-FXQIFTODSA-N 0.000 description 16
- 108010038633 aspartylglutamate Proteins 0.000 description 16
- 108010067216 glycyl-glycyl-glycine Proteins 0.000 description 16
- 108010010147 glycylglutamine Proteins 0.000 description 16
- ISJWBVIYRBAXEB-CIUDSAMLSA-N Arg-Ser-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O ISJWBVIYRBAXEB-CIUDSAMLSA-N 0.000 description 15
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 15
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 15
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 15
- QEDMOZUJTGEIBF-FXQIFTODSA-N Ser-Arg-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O QEDMOZUJTGEIBF-FXQIFTODSA-N 0.000 description 15
- LGIMRDKGABDMBN-DCAQKATOSA-N Ser-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N LGIMRDKGABDMBN-DCAQKATOSA-N 0.000 description 15
- QOIKZODVIPOPDD-AVGNSLFASA-N Tyr-Cys-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOIKZODVIPOPDD-AVGNSLFASA-N 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 15
- 238000002474 experimental method Methods 0.000 description 15
- 230000003612 virological effect Effects 0.000 description 15
- AWAXZRDKUHOPBO-GUBZILKMSA-N Ala-Gln-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O AWAXZRDKUHOPBO-GUBZILKMSA-N 0.000 description 14
- LSMDIAAALJJLRO-XQXXSGGOSA-N Ala-Thr-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O LSMDIAAALJJLRO-XQXXSGGOSA-N 0.000 description 14
- YFHATWYGAAXQCF-JYJNAYRXSA-N Arg-Pro-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YFHATWYGAAXQCF-JYJNAYRXSA-N 0.000 description 14
- NKVZTQVGUNLLQW-JBDRJPRFSA-N Ile-Ala-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)O)N NKVZTQVGUNLLQW-JBDRJPRFSA-N 0.000 description 14
- SITWEMZOJNKJCH-UHFFFAOYSA-N L-alanine-L-arginine Natural products CC(N)C(=O)NC(C(O)=O)CCCNC(N)=N SITWEMZOJNKJCH-UHFFFAOYSA-N 0.000 description 14
- 241000880493 Leptailurus serval Species 0.000 description 14
- AXZGZMGRBDQTEY-SRVKXCTJSA-N Leu-Gln-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O AXZGZMGRBDQTEY-SRVKXCTJSA-N 0.000 description 14
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 14
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 14
- YMIZSYUAZJSOFL-SRVKXCTJSA-N Phe-Ser-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O YMIZSYUAZJSOFL-SRVKXCTJSA-N 0.000 description 14
- UQFYNFTYDHUIMI-WHFBIAKZSA-N Ser-Gly-Ala Chemical compound OC(=O)[C@H](C)NC(=O)CNC(=O)[C@@H](N)CO UQFYNFTYDHUIMI-WHFBIAKZSA-N 0.000 description 14
- 229940079593 drug Drugs 0.000 description 14
- 239000007924 injection Substances 0.000 description 14
- 238000002347 injection Methods 0.000 description 14
- 108010038320 lysylphenylalanine Proteins 0.000 description 14
- 108010012581 phenylalanylglutamate Proteins 0.000 description 14
- 108010038745 tryptophylglycine Proteins 0.000 description 14
- MKJBPDLENBUHQU-CIUDSAMLSA-N Asn-Ser-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O MKJBPDLENBUHQU-CIUDSAMLSA-N 0.000 description 13
- FQCILXROGNOZON-YUMQZZPRSA-N Gln-Pro-Gly Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O FQCILXROGNOZON-YUMQZZPRSA-N 0.000 description 13
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 13
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 13
- SJDQOYTYNGZZJX-SRVKXCTJSA-N Met-Glu-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O SJDQOYTYNGZZJX-SRVKXCTJSA-N 0.000 description 13
- MNYNCKZAEIAONY-XGEHTFHBSA-N Thr-Val-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O MNYNCKZAEIAONY-XGEHTFHBSA-N 0.000 description 13
- VCXWRWYFJLXITF-AUTRQRHGSA-N Tyr-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 VCXWRWYFJLXITF-AUTRQRHGSA-N 0.000 description 13
- 230000004540 complement-dependent cytotoxicity Effects 0.000 description 13
- 239000002552 dosage form Substances 0.000 description 13
- 230000004048 modification Effects 0.000 description 13
- 238000012986 modification Methods 0.000 description 13
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 12
- QNFRBNZGVVKBNJ-PEFMBERDSA-N Asp-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)O)N QNFRBNZGVVKBNJ-PEFMBERDSA-N 0.000 description 12
- SXFPZRRVWSUYII-KBIXCLLPSA-N Gln-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N SXFPZRRVWSUYII-KBIXCLLPSA-N 0.000 description 12
- JWNZHMSRZXXGTM-XKBZYTNZSA-N Glu-Ser-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JWNZHMSRZXXGTM-XKBZYTNZSA-N 0.000 description 12
- XMPXVJIDADUOQB-RCOVLWMOSA-N Gly-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C([O-])=O)NC(=O)CNC(=O)C[NH3+] XMPXVJIDADUOQB-RCOVLWMOSA-N 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- YRJOLUDFVAUXLI-GSSVUCPTSA-N Thr-Thr-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(O)=O YRJOLUDFVAUXLI-GSSVUCPTSA-N 0.000 description 12
- WUFHZIRMAZZWRS-OSUNSFLBSA-N Val-Thr-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](C(C)C)N WUFHZIRMAZZWRS-OSUNSFLBSA-N 0.000 description 12
- 108010008685 alanyl-glutamyl-aspartic acid Proteins 0.000 description 12
- JBGSZRYCXBPWGX-BQBZGAKWSA-N Ala-Arg-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N JBGSZRYCXBPWGX-BQBZGAKWSA-N 0.000 description 11
- UGXYFDQFLVCDFC-CIUDSAMLSA-N Asn-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O UGXYFDQFLVCDFC-CIUDSAMLSA-N 0.000 description 11
- JBDLMLZNDRLDIX-HJGDQZAQSA-N Asn-Thr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O JBDLMLZNDRLDIX-HJGDQZAQSA-N 0.000 description 11
- KSOBNUBCYHGUKH-UWVGGRQHSA-N Gly-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN KSOBNUBCYHGUKH-UWVGGRQHSA-N 0.000 description 11
- UAELWXJFLZBKQS-WHOFXGATSA-N Ile-Phe-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(O)=O UAELWXJFLZBKQS-WHOFXGATSA-N 0.000 description 11
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 11
- WYOBRXPIZVKNMF-IRXDYDNUSA-N Tyr-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CC=C(O)C=C1 WYOBRXPIZVKNMF-IRXDYDNUSA-N 0.000 description 11
- HTONZBWRYUKUKC-RCWTZXSCSA-N Val-Thr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O HTONZBWRYUKUKC-RCWTZXSCSA-N 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- 230000000890 antigenic effect Effects 0.000 description 11
- 230000002163 immunogen Effects 0.000 description 11
- 238000000338 in vitro Methods 0.000 description 11
- 210000002966 serum Anatomy 0.000 description 11
- JNTMAZFVYNDPLB-PEDHHIEDSA-N (2S,3S)-2-[[[(2S)-1-[(2S,3S)-2-amino-3-methyl-1-oxopentyl]-2-pyrrolidinyl]-oxomethyl]amino]-3-methylpentanoic acid Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JNTMAZFVYNDPLB-PEDHHIEDSA-N 0.000 description 10
- SNDBKTFJWVEVPO-WHFBIAKZSA-N Asp-Gly-Ser Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SNDBKTFJWVEVPO-WHFBIAKZSA-N 0.000 description 10
- 102100021277 Beta-secretase 2 Human genes 0.000 description 10
- 101710150190 Beta-secretase 2 Proteins 0.000 description 10
- 101100512078 Caenorhabditis elegans lys-1 gene Proteins 0.000 description 10
- RBWKVOSARCFSQQ-FXQIFTODSA-N Gln-Gln-Ser Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O RBWKVOSARCFSQQ-FXQIFTODSA-N 0.000 description 10
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 10
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 10
- QPVFUAUFEBPIPT-CDMKHQONSA-N Phe-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QPVFUAUFEBPIPT-CDMKHQONSA-N 0.000 description 10
- SVGAWGVHFIYAEE-JSGCOSHPSA-N Trp-Gly-Gln Chemical compound C1=CC=C2C(C[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O)=CNC2=C1 SVGAWGVHFIYAEE-JSGCOSHPSA-N 0.000 description 10
- 108010068265 aspartyltyrosine Proteins 0.000 description 10
- 208000035475 disorder Diseases 0.000 description 10
- 229910052739 hydrogen Inorganic materials 0.000 description 10
- 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 10
- KYQNAIMCTRZLNP-QSFUFRPTSA-N Asp-Ile-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O KYQNAIMCTRZLNP-QSFUFRPTSA-N 0.000 description 9
- UWLHDGMRWXHFFY-HPCHECBXSA-N Ile-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N1CCC[C@@H]1C(=O)O)N UWLHDGMRWXHFFY-HPCHECBXSA-N 0.000 description 9
- USTCFDAQCLDPBD-XIRDDKMYSA-N Leu-Asn-Trp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N USTCFDAQCLDPBD-XIRDDKMYSA-N 0.000 description 9
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 9
- 108010006232 Neuraminidase Proteins 0.000 description 9
- 102000005348 Neuraminidase Human genes 0.000 description 9
- 102100035824 Unconventional myosin-Ig Human genes 0.000 description 9
- 108010078144 glutaminyl-glycine Proteins 0.000 description 9
- 108010050848 glycylleucine Proteins 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- XQJAFSDFQZPYCU-UWJYBYFXSA-N Ala-Asn-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N XQJAFSDFQZPYCU-UWJYBYFXSA-N 0.000 description 8
- VNYMOTCMNHJGTG-JBDRJPRFSA-N Ala-Ile-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O VNYMOTCMNHJGTG-JBDRJPRFSA-N 0.000 description 8
- RVGMVLVBDRQVKB-UWVGGRQHSA-N Gly-Met-His Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN RVGMVLVBDRQVKB-UWVGGRQHSA-N 0.000 description 8
- DBUNZBWUWCIELX-JHEQGTHGSA-N Gly-Thr-Glu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O DBUNZBWUWCIELX-JHEQGTHGSA-N 0.000 description 8
- TVTZEOHWHUVYCG-KYNKHSRBSA-N Gly-Thr-Thr Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O TVTZEOHWHUVYCG-KYNKHSRBSA-N 0.000 description 8
- NZGTYCMLUGYMCV-XUXIUFHCSA-N Ile-Lys-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N NZGTYCMLUGYMCV-XUXIUFHCSA-N 0.000 description 8
- HXWALXSAVBLTPK-NUTKFTJISA-N Leu-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N HXWALXSAVBLTPK-NUTKFTJISA-N 0.000 description 8
- 108091028043 Nucleic acid sequence Proteins 0.000 description 8
- QKWYXRPICJEQAJ-KJEVXHAQSA-N Pro-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2)O QKWYXRPICJEQAJ-KJEVXHAQSA-N 0.000 description 8
- 125000000539 amino acid group Chemical group 0.000 description 8
- 230000000903 blocking effect Effects 0.000 description 8
- 230000037396 body weight Effects 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 230000002265 prevention Effects 0.000 description 8
- 230000000069 prophylactic effect Effects 0.000 description 8
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 7
- 101100476210 Caenorhabditis elegans rnt-1 gene Proteins 0.000 description 7
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 7
- GHAXJVNBAKGWEJ-AVGNSLFASA-N Gln-Ser-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O GHAXJVNBAKGWEJ-AVGNSLFASA-N 0.000 description 7
- QLNKFGTZOBVMCS-JBACZVJFSA-N Glu-Tyr-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QLNKFGTZOBVMCS-JBACZVJFSA-N 0.000 description 7
- QESXLSQLQHHTIX-RHYQMDGZSA-N Leu-Val-Thr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QESXLSQLQHHTIX-RHYQMDGZSA-N 0.000 description 7
- XWCYBVBLJRWOFR-WDSKDSINSA-N Ser-Gln-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O XWCYBVBLJRWOFR-WDSKDSINSA-N 0.000 description 7
- OLKICIBQRVSQMA-SRVKXCTJSA-N Ser-Ser-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OLKICIBQRVSQMA-SRVKXCTJSA-N 0.000 description 7
- YOOAQCZYZHGUAZ-KATARQTJSA-N Thr-Leu-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YOOAQCZYZHGUAZ-KATARQTJSA-N 0.000 description 7
- 208000036142 Viral infection Diseases 0.000 description 7
- 238000010521 absorption reaction Methods 0.000 description 7
- 210000003719 b-lymphocyte Anatomy 0.000 description 7
- 230000004071 biological effect Effects 0.000 description 7
- 210000004899 c-terminal region Anatomy 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 210000004408 hybridoma Anatomy 0.000 description 7
- 239000000523 sample Substances 0.000 description 7
- 238000007920 subcutaneous administration Methods 0.000 description 7
- MFAMTAVAFBPXDC-LPEHRKFASA-N Arg-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O MFAMTAVAFBPXDC-LPEHRKFASA-N 0.000 description 6
- JSHWXQIZOCVWIA-ZKWXMUAHSA-N Asp-Ser-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O JSHWXQIZOCVWIA-ZKWXMUAHSA-N 0.000 description 6
- 101100112922 Candida albicans CDR3 gene Proteins 0.000 description 6
- 238000002965 ELISA Methods 0.000 description 6
- XTZDZAXYPDISRR-MNXVOIDGSA-N Glu-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XTZDZAXYPDISRR-MNXVOIDGSA-N 0.000 description 6
- 108060003951 Immunoglobulin Proteins 0.000 description 6
- TVEOVCYCYGKVPP-HSCHXYMDSA-N Leu-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(C)C)N TVEOVCYCYGKVPP-HSCHXYMDSA-N 0.000 description 6
- 101150006914 TRP1 gene Proteins 0.000 description 6
- YLRLHDFMMWDYTK-KKUMJFAQSA-N Tyr-Cys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 YLRLHDFMMWDYTK-KKUMJFAQSA-N 0.000 description 6
- LUMQYLVYUIRHHU-YJRXYDGGSA-N Tyr-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LUMQYLVYUIRHHU-YJRXYDGGSA-N 0.000 description 6
- 108010011559 alanylphenylalanine Proteins 0.000 description 6
- 229940042406 direct acting antivirals neuraminidase inhibitors Drugs 0.000 description 6
- 230000004927 fusion Effects 0.000 description 6
- 102000018358 immunoglobulin Human genes 0.000 description 6
- 239000002105 nanoparticle Substances 0.000 description 6
- 108010051242 phenylalanylserine Proteins 0.000 description 6
- -1 phosphoryl groups Chemical group 0.000 description 6
- 108010029020 prolylglycine Proteins 0.000 description 6
- 102000005962 receptors Human genes 0.000 description 6
- 108020003175 receptors Proteins 0.000 description 6
- 239000002911 sialidase inhibitor Substances 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 108010061238 threonyl-glycine Proteins 0.000 description 6
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 5
- XEGZSHSPQNDNRH-JRQIVUDYSA-N Asn-Tyr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XEGZSHSPQNDNRH-JRQIVUDYSA-N 0.000 description 5
- HOBNTSHITVVNBN-ZPFDUUQYSA-N Asp-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CC(=O)O)N HOBNTSHITVVNBN-ZPFDUUQYSA-N 0.000 description 5
- HTSSXFASOUSJQG-IHPCNDPISA-N Asp-Tyr-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O HTSSXFASOUSJQG-IHPCNDPISA-N 0.000 description 5
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 5
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 5
- MIIVFRCYJABHTQ-ONGXEEELSA-N Gly-Leu-Val Chemical compound [H]NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O MIIVFRCYJABHTQ-ONGXEEELSA-N 0.000 description 5
- WXLYNEHOGRYNFU-URLPEUOOSA-N Ile-Thr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N WXLYNEHOGRYNFU-URLPEUOOSA-N 0.000 description 5
- NXRNRBOKDBIVKQ-CXTHYWKRSA-N Ile-Tyr-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N NXRNRBOKDBIVKQ-CXTHYWKRSA-N 0.000 description 5
- LZDNBBYBDGBADK-UHFFFAOYSA-N L-valyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C(C)C)C(O)=O)=CNC2=C1 LZDNBBYBDGBADK-UHFFFAOYSA-N 0.000 description 5
- BOFAFKVZQUMTID-AVGNSLFASA-N Leu-Gln-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N BOFAFKVZQUMTID-AVGNSLFASA-N 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 108010066427 N-valyltryptophan Proteins 0.000 description 5
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 5
- VGNYHOBZJKWRGI-CIUDSAMLSA-N Ser-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO VGNYHOBZJKWRGI-CIUDSAMLSA-N 0.000 description 5
- XQJCEKXQUJQNNK-ZLUOBGJFSA-N Ser-Ser-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O XQJCEKXQUJQNNK-ZLUOBGJFSA-N 0.000 description 5
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 5
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 5
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 5
- KZTLZZQTJMCGIP-ZJDVBMNYSA-N Thr-Val-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KZTLZZQTJMCGIP-ZJDVBMNYSA-N 0.000 description 5
- 239000012911 assay medium Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 229910052805 deuterium Inorganic materials 0.000 description 5
- 230000009977 dual effect Effects 0.000 description 5
- 229940127121 immunoconjugate Drugs 0.000 description 5
- 229960003971 influenza vaccine Drugs 0.000 description 5
- 239000002773 nucleotide Substances 0.000 description 5
- 125000003729 nucleotide group Chemical group 0.000 description 5
- 238000003305 oral gavage Methods 0.000 description 5
- PGZUMBJQJWIWGJ-ONAKXNSWSA-N oseltamivir phosphate Chemical compound OP(O)(O)=O.CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 PGZUMBJQJWIWGJ-ONAKXNSWSA-N 0.000 description 5
- 238000000159 protein binding assay Methods 0.000 description 5
- 108010048818 seryl-histidine Proteins 0.000 description 5
- 108010026333 seryl-proline Proteins 0.000 description 5
- 229940061367 tamiflu Drugs 0.000 description 5
- 208000030507 AIDS Diseases 0.000 description 4
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 4
- SVBXIUDNTRTKHE-CIUDSAMLSA-N Ala-Arg-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O SVBXIUDNTRTKHE-CIUDSAMLSA-N 0.000 description 4
- SDZRIBWEVVRDQI-CIUDSAMLSA-N Ala-Lys-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(O)=O SDZRIBWEVVRDQI-CIUDSAMLSA-N 0.000 description 4
- SUHLZMHFRALVSY-YUMQZZPRSA-N Ala-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)NCC(O)=O SUHLZMHFRALVSY-YUMQZZPRSA-N 0.000 description 4
- ZJIFRAPZHAGLGR-MELADBBJSA-N Asn-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZJIFRAPZHAGLGR-MELADBBJSA-N 0.000 description 4
- MYTHOBCLNIOFBL-SRVKXCTJSA-N Asn-Ser-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MYTHOBCLNIOFBL-SRVKXCTJSA-N 0.000 description 4
- DXHINQUXBZNUCF-MELADBBJSA-N Asn-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O DXHINQUXBZNUCF-MELADBBJSA-N 0.000 description 4
- MRQQMVZUHXUPEV-IHRRRGAJSA-N Asp-Arg-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MRQQMVZUHXUPEV-IHRRRGAJSA-N 0.000 description 4
- ALMIMUZAWTUNIO-BZSNNMDCSA-N Asp-Tyr-Tyr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ALMIMUZAWTUNIO-BZSNNMDCSA-N 0.000 description 4
- LOJYQMFIIJVETK-WDSKDSINSA-N Gln-Gln Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(O)=O LOJYQMFIIJVETK-WDSKDSINSA-N 0.000 description 4
- RDPOETHPAQEGDP-ACZMJKKPSA-N Glu-Asp-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O RDPOETHPAQEGDP-ACZMJKKPSA-N 0.000 description 4
- LJPIRKICOISLKN-WHFBIAKZSA-N Gly-Ala-Ser Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O LJPIRKICOISLKN-WHFBIAKZSA-N 0.000 description 4
- NGBGZCUWFVVJKC-IRXDYDNUSA-N Gly-Tyr-Tyr Chemical compound C([C@H](NC(=O)CN)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 NGBGZCUWFVVJKC-IRXDYDNUSA-N 0.000 description 4
- 108090000288 Glycoproteins Proteins 0.000 description 4
- 102000003886 Glycoproteins Human genes 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- BOTVMTSMOUSDRW-GMOBBJLQSA-N Ile-Arg-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(N)=O)C(O)=O BOTVMTSMOUSDRW-GMOBBJLQSA-N 0.000 description 4
- JNLSTRPWUXOORL-MMWGEVLESA-N Ile-Ser-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N JNLSTRPWUXOORL-MMWGEVLESA-N 0.000 description 4
- MITYXXNZSZLHGG-OBAATPRFSA-N Ile-Trp-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)N MITYXXNZSZLHGG-OBAATPRFSA-N 0.000 description 4
- JRJLGNFWYFSJHB-HOCLYGCPSA-N Leu-Gly-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O JRJLGNFWYFSJHB-HOCLYGCPSA-N 0.000 description 4
- YNNPKXBBRZVIRX-IHRRRGAJSA-N Lys-Arg-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O YNNPKXBBRZVIRX-IHRRRGAJSA-N 0.000 description 4
- IIHMNTBFPMRJCN-RCWTZXSCSA-N Met-Val-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IIHMNTBFPMRJCN-RCWTZXSCSA-N 0.000 description 4
- ZENDEDYRYVHBEG-SRVKXCTJSA-N Phe-Asp-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 ZENDEDYRYVHBEG-SRVKXCTJSA-N 0.000 description 4
- IUVYJBMTHARMIP-PCBIJLKTSA-N Phe-Asp-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IUVYJBMTHARMIP-PCBIJLKTSA-N 0.000 description 4
- IAOZOFPONWDXNT-IXOXFDKPSA-N Phe-Ser-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O IAOZOFPONWDXNT-IXOXFDKPSA-N 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 4
- ULVMNZOKDBHKKI-ACZMJKKPSA-N Ser-Gln-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ULVMNZOKDBHKKI-ACZMJKKPSA-N 0.000 description 4
- XXXAXOWMBOKTRN-XPUUQOCRSA-N Ser-Gly-Val Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O XXXAXOWMBOKTRN-XPUUQOCRSA-N 0.000 description 4
- DKGRNFUXVTYRAS-UBHSHLNASA-N Ser-Ser-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O DKGRNFUXVTYRAS-UBHSHLNASA-N 0.000 description 4
- KIEIJCFVGZCUAS-MELADBBJSA-N Ser-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N)C(=O)O KIEIJCFVGZCUAS-MELADBBJSA-N 0.000 description 4
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 4
- JVTHIXKSVYEWNI-JRQIVUDYSA-N Thr-Asn-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JVTHIXKSVYEWNI-JRQIVUDYSA-N 0.000 description 4
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 4
- TYGHOWWWMTWVKM-HJOGWXRNSA-N Tyr-Tyr-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=C(O)C=C1 TYGHOWWWMTWVKM-HJOGWXRNSA-N 0.000 description 4
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 4
- 102000025171 antigen binding proteins Human genes 0.000 description 4
- 108091000831 antigen binding proteins Proteins 0.000 description 4
- 238000002820 assay format Methods 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 230000013595 glycosylation Effects 0.000 description 4
- 238000006206 glycosylation reaction Methods 0.000 description 4
- 108010047748 hemorphin 4 Proteins 0.000 description 4
- 230000003053 immunization Effects 0.000 description 4
- 238000002649 immunization Methods 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000010172 mouse model Methods 0.000 description 4
- 201000000050 myeloid neoplasm Diseases 0.000 description 4
- 108010084525 phenylalanyl-phenylalanyl-glycine Proteins 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 108010079317 prolyl-tyrosine Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 108010033670 threonyl-aspartyl-tyrosine Proteins 0.000 description 4
- ARAIBEBZBOPLMB-UFGQHTETSA-N zanamivir Chemical compound CC(=O)N[C@@H]1[C@@H](N=C(N)N)C=C(C(O)=O)O[C@H]1[C@H](O)[C@H](O)CO ARAIBEBZBOPLMB-UFGQHTETSA-N 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 3
- MUGAESARFRGOTQ-IGNZVWTISA-N Ala-Tyr-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N MUGAESARFRGOTQ-IGNZVWTISA-N 0.000 description 3
- WESHVRNMNFMVBE-FXQIFTODSA-N Arg-Asn-Asp Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)CN=C(N)N WESHVRNMNFMVBE-FXQIFTODSA-N 0.000 description 3
- SLKLLQWZQHXYSV-CIUDSAMLSA-N Asn-Ala-Lys Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(O)=O SLKLLQWZQHXYSV-CIUDSAMLSA-N 0.000 description 3
- BVLIJXXSXBUGEC-SRVKXCTJSA-N Asn-Asn-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O BVLIJXXSXBUGEC-SRVKXCTJSA-N 0.000 description 3
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 3
- 238000011725 BALB/c mouse Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- CRRFJBGUGNNOCS-PEFMBERDSA-N Gln-Asp-Ile Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CRRFJBGUGNNOCS-PEFMBERDSA-N 0.000 description 3
- DQPOBSRQNWOBNA-GUBZILKMSA-N Gln-His-Asn Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(N)=O)C(O)=O DQPOBSRQNWOBNA-GUBZILKMSA-N 0.000 description 3
- DQLVHRFFBQOWFL-JYJNAYRXSA-N Gln-Lys-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)O DQLVHRFFBQOWFL-JYJNAYRXSA-N 0.000 description 3
- OTQSTOXRUBVWAP-NRPADANISA-N Gln-Ser-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OTQSTOXRUBVWAP-NRPADANISA-N 0.000 description 3
- LCNXZQROPKFGQK-WHFBIAKZSA-N Gly-Asp-Ser Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O LCNXZQROPKFGQK-WHFBIAKZSA-N 0.000 description 3
- SCWYHUQOOFRVHP-MBLNEYKQSA-N Gly-Ile-Thr Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SCWYHUQOOFRVHP-MBLNEYKQSA-N 0.000 description 3
- OJNZVYSGVYLQIN-BQBZGAKWSA-N Gly-Met-Asp Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(O)=O OJNZVYSGVYLQIN-BQBZGAKWSA-N 0.000 description 3
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 3
- ZZWUYQXMIFTIIY-WEDXCCLWSA-N Gly-Thr-Leu Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O ZZWUYQXMIFTIIY-WEDXCCLWSA-N 0.000 description 3
- XHVONGZZVUUORG-WEDXCCLWSA-N Gly-Thr-Lys Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)N[C@H](C(O)=O)CCCCN XHVONGZZVUUORG-WEDXCCLWSA-N 0.000 description 3
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- JODPUDMBQBIWCK-GHCJXIJMSA-N Ile-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O JODPUDMBQBIWCK-GHCJXIJMSA-N 0.000 description 3
- ZFWISYLMLXFBSX-KKPKCPPISA-N Ile-Trp-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N ZFWISYLMLXFBSX-KKPKCPPISA-N 0.000 description 3
- 102000006496 Immunoglobulin Heavy Chains Human genes 0.000 description 3
- 108010019476 Immunoglobulin Heavy Chains Proteins 0.000 description 3
- 108010050904 Interferons Proteins 0.000 description 3
- 102000014150 Interferons Human genes 0.000 description 3
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 3
- YIRIDPUGZKHMHT-ACRUOGEOSA-N Leu-Tyr-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YIRIDPUGZKHMHT-ACRUOGEOSA-N 0.000 description 3
- NNKLKUUGESXCBS-KBPBESRZSA-N Lys-Gly-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NNKLKUUGESXCBS-KBPBESRZSA-N 0.000 description 3
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 3
- 108010079364 N-glycylalanine Proteins 0.000 description 3
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- HTTYNOXBBOWZTB-SRVKXCTJSA-N Phe-Asn-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N HTTYNOXBBOWZTB-SRVKXCTJSA-N 0.000 description 3
- CSYVXYQDIVCQNU-QWRGUYRKSA-N Phe-Asp-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O CSYVXYQDIVCQNU-QWRGUYRKSA-N 0.000 description 3
- XDMMOISUAHXXFD-SRVKXCTJSA-N Phe-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O XDMMOISUAHXXFD-SRVKXCTJSA-N 0.000 description 3
- VCYJKOLZYPYGJV-AVGNSLFASA-N Pro-Arg-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VCYJKOLZYPYGJV-AVGNSLFASA-N 0.000 description 3
- VTFXTWDFPTWNJY-RHYQMDGZSA-N Pro-Leu-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O VTFXTWDFPTWNJY-RHYQMDGZSA-N 0.000 description 3
- DWPXHLIBFQLKLK-CYDGBPFRSA-N Pro-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 DWPXHLIBFQLKLK-CYDGBPFRSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- WDXYVIIVDIDOSX-DCAQKATOSA-N Ser-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CCCN=C(N)N WDXYVIIVDIDOSX-DCAQKATOSA-N 0.000 description 3
- HBOABDXGTMMDSE-GUBZILKMSA-N Ser-Arg-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O HBOABDXGTMMDSE-GUBZILKMSA-N 0.000 description 3
- FIDMVVBUOCMMJG-CIUDSAMLSA-N Ser-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO FIDMVVBUOCMMJG-CIUDSAMLSA-N 0.000 description 3
- IOVHBRCQOGWAQH-ZKWXMUAHSA-N Ser-Gly-Ile Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O IOVHBRCQOGWAQH-ZKWXMUAHSA-N 0.000 description 3
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 3
- GZGFSPWOMUKKCV-NAKRPEOUSA-N Ser-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO GZGFSPWOMUKKCV-NAKRPEOUSA-N 0.000 description 3
- PAXANSWUSVPFNK-IUKAMOBKSA-N Thr-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N PAXANSWUSVPFNK-IUKAMOBKSA-N 0.000 description 3
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 3
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 3
- JAGGEZACYAAMIL-CQDKDKBSSA-N Tyr-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=C(C=C1)O)N JAGGEZACYAAMIL-CQDKDKBSSA-N 0.000 description 3
- RMRFSFXLFWWAJZ-HJOGWXRNSA-N Tyr-Tyr-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 RMRFSFXLFWWAJZ-HJOGWXRNSA-N 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 229960003805 amantadine Drugs 0.000 description 3
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 3
- 229960005475 antiinfective agent Drugs 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 108010009111 arginyl-glycyl-glutamic acid Proteins 0.000 description 3
- 108010077245 asparaginyl-proline Proteins 0.000 description 3
- 108010047857 aspartylglycine Proteins 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000002648 combination therapy Methods 0.000 description 3
- 239000000562 conjugate Substances 0.000 description 3
- 230000021615 conjugation Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 210000001163 endosome Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 3
- 108010081551 glycylphenylalanine Proteins 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 108010018006 histidylserine Proteins 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000003018 immunoassay Methods 0.000 description 3
- 238000001802 infusion Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 108010034529 leucyl-lysine Proteins 0.000 description 3
- 210000004698 lymphocyte Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 108010020755 prolyl-glycyl-glycine Proteins 0.000 description 3
- 230000002797 proteolythic effect Effects 0.000 description 3
- 238000003127 radioimmunoassay Methods 0.000 description 3
- 230000008707 rearrangement Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 229960000888 rimantadine Drugs 0.000 description 3
- 102220117530 rs112626848 Human genes 0.000 description 3
- 102220238658 rs1468529365 Human genes 0.000 description 3
- 102220268018 rs201210997 Human genes 0.000 description 3
- 238000009738 saturating Methods 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000011830 transgenic mouse model Methods 0.000 description 3
- 238000011269 treatment regimen Methods 0.000 description 3
- 108010020532 tyrosyl-proline Proteins 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- KVWLTGNCJYDJET-LSJOCFKGSA-N Ala-Arg-His Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N KVWLTGNCJYDJET-LSJOCFKGSA-N 0.000 description 2
- UCIYCBSJBQGDGM-LPEHRKFASA-N Ala-Arg-Pro Chemical compound C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N UCIYCBSJBQGDGM-LPEHRKFASA-N 0.000 description 2
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 2
- DWINFPQUSSHSFS-UVBJJODRSA-N Ala-Arg-Trp Chemical compound N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O DWINFPQUSSHSFS-UVBJJODRSA-N 0.000 description 2
- LXAARTARZJJCMB-CIQUZCHMSA-N Ala-Ile-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O LXAARTARZJJCMB-CIQUZCHMSA-N 0.000 description 2
- LDLSENBXQNDTPB-DCAQKATOSA-N Ala-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LDLSENBXQNDTPB-DCAQKATOSA-N 0.000 description 2
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 2
- AWNAEZICPNGAJK-FXQIFTODSA-N Ala-Met-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(O)=O AWNAEZICPNGAJK-FXQIFTODSA-N 0.000 description 2
- MSWSRLGNLKHDEI-ACZMJKKPSA-N Ala-Ser-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O MSWSRLGNLKHDEI-ACZMJKKPSA-N 0.000 description 2
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 2
- NCQMBSJGJMYKCK-ZLUOBGJFSA-N Ala-Ser-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O NCQMBSJGJMYKCK-ZLUOBGJFSA-N 0.000 description 2
- VRTOMXFZHGWHIJ-KZVJFYERSA-N Ala-Thr-Arg Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O VRTOMXFZHGWHIJ-KZVJFYERSA-N 0.000 description 2
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 2
- ZDILXFDENZVOTL-BPNCWPANSA-N Ala-Val-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZDILXFDENZVOTL-BPNCWPANSA-N 0.000 description 2
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 2
- JGDGLDNAQJJGJI-AVGNSLFASA-N Arg-Arg-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)N JGDGLDNAQJJGJI-AVGNSLFASA-N 0.000 description 2
- UISQLSIBJKEJSS-GUBZILKMSA-N Arg-Arg-Ser Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(O)=O UISQLSIBJKEJSS-GUBZILKMSA-N 0.000 description 2
- NUBPTCMEOCKWDO-DCAQKATOSA-N Arg-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N NUBPTCMEOCKWDO-DCAQKATOSA-N 0.000 description 2
- KWTVWJPNHAOREN-IHRRRGAJSA-N Arg-Asn-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O KWTVWJPNHAOREN-IHRRRGAJSA-N 0.000 description 2
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- DAPLJWATMAXPPZ-CIUDSAMLSA-N Asn-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(N)=O DAPLJWATMAXPPZ-CIUDSAMLSA-N 0.000 description 2
- NVGWESORMHFISY-SRVKXCTJSA-N Asn-Asn-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O NVGWESORMHFISY-SRVKXCTJSA-N 0.000 description 2
- GYOHQKJEQQJBOY-QEJZJMRPSA-N Asn-Glu-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N GYOHQKJEQQJBOY-QEJZJMRPSA-N 0.000 description 2
- UDSVWSUXKYXSTR-QWRGUYRKSA-N Asn-Gly-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UDSVWSUXKYXSTR-QWRGUYRKSA-N 0.000 description 2
- XVBDDUPJVQXDSI-PEFMBERDSA-N Asn-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVBDDUPJVQXDSI-PEFMBERDSA-N 0.000 description 2
- SEKBHZJLARBNPB-GHCJXIJMSA-N Asn-Ile-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O SEKBHZJLARBNPB-GHCJXIJMSA-N 0.000 description 2
- MDDXKBHIMYYJLW-FXQIFTODSA-N Asn-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N MDDXKBHIMYYJLW-FXQIFTODSA-N 0.000 description 2
- LSJQOMAZIKQMTJ-SRVKXCTJSA-N Asn-Phe-Asp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LSJQOMAZIKQMTJ-SRVKXCTJSA-N 0.000 description 2
- HPBNLFLSSQDFQW-WHFBIAKZSA-N Asn-Ser-Gly Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O HPBNLFLSSQDFQW-WHFBIAKZSA-N 0.000 description 2
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 2
- BCADFFUQHIMQAA-KKHAAJSZSA-N Asn-Thr-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BCADFFUQHIMQAA-KKHAAJSZSA-N 0.000 description 2
- QTKYFZCMSQLYHI-UBHSHLNASA-N Asn-Trp-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O QTKYFZCMSQLYHI-UBHSHLNASA-N 0.000 description 2
- TZQWZQSMHDVLQL-QEJZJMRPSA-N Asn-Trp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N TZQWZQSMHDVLQL-QEJZJMRPSA-N 0.000 description 2
- DAYDURRBMDCCFL-AAEUAGOBSA-N Asn-Trp-Gly Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N DAYDURRBMDCCFL-AAEUAGOBSA-N 0.000 description 2
- SKQTXVZTCGSRJS-SRVKXCTJSA-N Asn-Tyr-Asp Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O SKQTXVZTCGSRJS-SRVKXCTJSA-N 0.000 description 2
- YSYTWUMRHSFODC-QWRGUYRKSA-N Asn-Tyr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O YSYTWUMRHSFODC-QWRGUYRKSA-N 0.000 description 2
- NECWUSYTYSIFNC-DLOVCJGASA-N Asp-Ala-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 NECWUSYTYSIFNC-DLOVCJGASA-N 0.000 description 2
- NJIKKGUVGUBICV-ZLUOBGJFSA-N Asp-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(O)=O NJIKKGUVGUBICV-ZLUOBGJFSA-N 0.000 description 2
- HOQGTAIGQSDCHR-SRVKXCTJSA-N Asp-Asn-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HOQGTAIGQSDCHR-SRVKXCTJSA-N 0.000 description 2
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 2
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 2
- CYCKJEFVFNRWEZ-UGYAYLCHSA-N Asp-Ile-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O CYCKJEFVFNRWEZ-UGYAYLCHSA-N 0.000 description 2
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 2
- USNJAPJZSGTTPX-XVSYOHENSA-N Asp-Phe-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O USNJAPJZSGTTPX-XVSYOHENSA-N 0.000 description 2
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 108090001008 Avidin Proteins 0.000 description 2
- 241000282465 Canis Species 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- OZHXXYOHPLLLMI-CIUDSAMLSA-N Cys-Lys-Ala Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O OZHXXYOHPLLLMI-CIUDSAMLSA-N 0.000 description 2
- YFKWIIRWHGKSQQ-WFBYXXMGSA-N Cys-Trp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CS)N YFKWIIRWHGKSQQ-WFBYXXMGSA-N 0.000 description 2
- CLEFUAZULXANBU-MELADBBJSA-N Cys-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CS)N)C(=O)O CLEFUAZULXANBU-MELADBBJSA-N 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- QRLVDLBMBULFAL-UHFFFAOYSA-N Digitonin Natural products CC1CCC2(OC1)OC3C(O)C4C5CCC6CC(OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OCC(O)C(O)C9OC%10OC(CO)C(O)C(OC%11OC(CO)C(O)C(O)C%11O)C%10O)C8O)C(O)C7O)C(O)CC6(C)C5CCC4(C)C3C2C QRLVDLBMBULFAL-UHFFFAOYSA-N 0.000 description 2
- WUAYFMZULZDSLB-ACZMJKKPSA-N Gln-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O WUAYFMZULZDSLB-ACZMJKKPSA-N 0.000 description 2
- MCAVASRGVBVPMX-FXQIFTODSA-N Gln-Glu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MCAVASRGVBVPMX-FXQIFTODSA-N 0.000 description 2
- LTXLIIZACMCQTO-GUBZILKMSA-N Gln-His-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N LTXLIIZACMCQTO-GUBZILKMSA-N 0.000 description 2
- YPFFHGRJCUBXPX-NHCYSSNCSA-N Gln-Pro-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O)C(O)=O YPFFHGRJCUBXPX-NHCYSSNCSA-N 0.000 description 2
- LPIKVBWNNVFHCQ-GUBZILKMSA-N Gln-Ser-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LPIKVBWNNVFHCQ-GUBZILKMSA-N 0.000 description 2
- WPJDPEOQUIXXOY-AVGNSLFASA-N Gln-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O WPJDPEOQUIXXOY-AVGNSLFASA-N 0.000 description 2
- SGVGIVDZLSHSEN-RYUDHWBXSA-N Gln-Tyr-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O SGVGIVDZLSHSEN-RYUDHWBXSA-N 0.000 description 2
- QZQYITIKPAUDGN-GVXVVHGQSA-N Gln-Val-His Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCC(=O)N)N QZQYITIKPAUDGN-GVXVVHGQSA-N 0.000 description 2
- VYOILACOFPPNQH-UMNHJUIQSA-N Gln-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N VYOILACOFPPNQH-UMNHJUIQSA-N 0.000 description 2
- RUFHOVYUYSNDNY-ACZMJKKPSA-N Glu-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O RUFHOVYUYSNDNY-ACZMJKKPSA-N 0.000 description 2
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 2
- FYBSCGZLICNOBA-XQXXSGGOSA-N Glu-Ala-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O FYBSCGZLICNOBA-XQXXSGGOSA-N 0.000 description 2
- AVZHGSCDKIQZPQ-CIUDSAMLSA-N Glu-Arg-Ala Chemical compound C[C@H](NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCC(O)=O)C(O)=O AVZHGSCDKIQZPQ-CIUDSAMLSA-N 0.000 description 2
- CYHBMLHCQXXCCT-AVGNSLFASA-N Glu-Asp-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CYHBMLHCQXXCCT-AVGNSLFASA-N 0.000 description 2
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 2
- VHPVBPCCWVDGJL-IRIUXVKKSA-N Glu-Thr-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VHPVBPCCWVDGJL-IRIUXVKKSA-N 0.000 description 2
- MLILEEIVMRUYBX-NHCYSSNCSA-N Glu-Val-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O MLILEEIVMRUYBX-NHCYSSNCSA-N 0.000 description 2
- XCLCVBYNGXEVDU-WHFBIAKZSA-N Gly-Asn-Ser Chemical compound NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O XCLCVBYNGXEVDU-WHFBIAKZSA-N 0.000 description 2
- FMNHBTKMRFVGRO-FOHZUACHSA-N Gly-Asn-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CN FMNHBTKMRFVGRO-FOHZUACHSA-N 0.000 description 2
- XQHSBNVACKQWAV-WHFBIAKZSA-N Gly-Asp-Asn Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XQHSBNVACKQWAV-WHFBIAKZSA-N 0.000 description 2
- QGZSAHIZRQHCEQ-QWRGUYRKSA-N Gly-Asp-Tyr Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QGZSAHIZRQHCEQ-QWRGUYRKSA-N 0.000 description 2
- CQZDZKRHFWJXDF-WDSKDSINSA-N Gly-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CN CQZDZKRHFWJXDF-WDSKDSINSA-N 0.000 description 2
- OLPPXYMMIARYAL-QMMMGPOBSA-N Gly-Gly-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)CNC(=O)CN OLPPXYMMIARYAL-QMMMGPOBSA-N 0.000 description 2
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 2
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 2
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 2
- HAXARWKYFIIHKD-ZKWXMUAHSA-N Gly-Ile-Ser Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O HAXARWKYFIIHKD-ZKWXMUAHSA-N 0.000 description 2
- ICUTTWWCDIIIEE-BQBZGAKWSA-N Gly-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN ICUTTWWCDIIIEE-BQBZGAKWSA-N 0.000 description 2
- IALQAMYQJBZNSK-WHFBIAKZSA-N Gly-Ser-Asn Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O IALQAMYQJBZNSK-WHFBIAKZSA-N 0.000 description 2
- FKYQEVBRZSFAMJ-QWRGUYRKSA-N Gly-Ser-Tyr Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FKYQEVBRZSFAMJ-QWRGUYRKSA-N 0.000 description 2
- GULGDABMYTYMJZ-STQMWFEESA-N Gly-Trp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(O)=O)C(O)=O GULGDABMYTYMJZ-STQMWFEESA-N 0.000 description 2
- IROABALAWGJQGM-OALUTQOASA-N Gly-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)CN IROABALAWGJQGM-OALUTQOASA-N 0.000 description 2
- YJDALMUYJIENAG-QWRGUYRKSA-N Gly-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN)O YJDALMUYJIENAG-QWRGUYRKSA-N 0.000 description 2
- DNAZKGFYFRGZIH-QWRGUYRKSA-N Gly-Tyr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=C(O)C=C1 DNAZKGFYFRGZIH-QWRGUYRKSA-N 0.000 description 2
- GBYYQVBXFVDJPJ-WLTAIBSBSA-N Gly-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)CN)O GBYYQVBXFVDJPJ-WLTAIBSBSA-N 0.000 description 2
- SBVMXEZQJVUARN-XPUUQOCRSA-N Gly-Val-Ser Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O SBVMXEZQJVUARN-XPUUQOCRSA-N 0.000 description 2
- AFMOTCMSEBITOE-YEPSODPASA-N Gly-Val-Thr Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O AFMOTCMSEBITOE-YEPSODPASA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- LPBWRHRHEIYAIP-KKUMJFAQSA-N His-Tyr-Asp Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O LPBWRHRHEIYAIP-KKUMJFAQSA-N 0.000 description 2
- PZUZIHRPOVVHOT-KBPBESRZSA-N His-Tyr-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)NCC(O)=O)C1=CN=CN1 PZUZIHRPOVVHOT-KBPBESRZSA-N 0.000 description 2
- 102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 2
- 101710177940 IgG receptor FcRn large subunit p51 Proteins 0.000 description 2
- UAVQIQOOBXFKRC-BYULHYEWSA-N Ile-Asn-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O UAVQIQOOBXFKRC-BYULHYEWSA-N 0.000 description 2
- HVWXAQVMRBKKFE-UGYAYLCHSA-N Ile-Asp-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N HVWXAQVMRBKKFE-UGYAYLCHSA-N 0.000 description 2
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 2
- WYUHAXJAMDTOAU-IAVJCBSLSA-N Ile-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N WYUHAXJAMDTOAU-IAVJCBSLSA-N 0.000 description 2
- JHNJNTMTZHEDLJ-NAKRPEOUSA-N Ile-Ser-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O JHNJNTMTZHEDLJ-NAKRPEOUSA-N 0.000 description 2
- RQJUKVXWAKJDBW-SVSWQMSJSA-N Ile-Ser-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N RQJUKVXWAKJDBW-SVSWQMSJSA-N 0.000 description 2
- PMAOIIWHZHAPBT-HJPIBITLSA-N Ile-Tyr-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CS)C(=O)O)N PMAOIIWHZHAPBT-HJPIBITLSA-N 0.000 description 2
- PRTZQMBYUZFSFA-XEGUGMAKSA-N Ile-Tyr-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)NCC(=O)O)N PRTZQMBYUZFSFA-XEGUGMAKSA-N 0.000 description 2
- 108010054477 Immunoglobulin Fab Fragments Proteins 0.000 description 2
- 102000001706 Immunoglobulin Fab Fragments Human genes 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 2
- 101710189008 Immunoglobulin kappa light chain Proteins 0.000 description 2
- 102100029567 Immunoglobulin kappa light chain Human genes 0.000 description 2
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 2
- JQSXWJXBASFONF-KKUMJFAQSA-N Leu-Asp-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JQSXWJXBASFONF-KKUMJFAQSA-N 0.000 description 2
- QCSFMCFHVGTLFF-NHCYSSNCSA-N Leu-Asp-Val Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O QCSFMCFHVGTLFF-NHCYSSNCSA-N 0.000 description 2
- DLCXCECTCPKKCD-GUBZILKMSA-N Leu-Gln-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O DLCXCECTCPKKCD-GUBZILKMSA-N 0.000 description 2
- CCQLQKZTXZBXTN-NHCYSSNCSA-N Leu-Gly-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O CCQLQKZTXZBXTN-NHCYSSNCSA-N 0.000 description 2
- VGPCJSXPPOQPBK-YUMQZZPRSA-N Leu-Gly-Ser Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O VGPCJSXPPOQPBK-YUMQZZPRSA-N 0.000 description 2
- NRFGTHFONZYFNY-MGHWNKPDSA-N Leu-Ile-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NRFGTHFONZYFNY-MGHWNKPDSA-N 0.000 description 2
- SBANPBVRHYIMRR-GARJFASQSA-N Leu-Ser-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N SBANPBVRHYIMRR-GARJFASQSA-N 0.000 description 2
- SBANPBVRHYIMRR-UHFFFAOYSA-N Leu-Ser-Pro Natural products CC(C)CC(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O SBANPBVRHYIMRR-UHFFFAOYSA-N 0.000 description 2
- LCNASHSOFMRYFO-WDCWCFNPSA-N Leu-Thr-Gln Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCC(N)=O LCNASHSOFMRYFO-WDCWCFNPSA-N 0.000 description 2
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 2
- LJBVRCDPWOJOEK-PPCPHDFISA-N Leu-Thr-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LJBVRCDPWOJOEK-PPCPHDFISA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- QIJVAFLRMVBHMU-KKUMJFAQSA-N Lys-Asp-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QIJVAFLRMVBHMU-KKUMJFAQSA-N 0.000 description 2
- PRSBSVAVOQOAMI-BJDJZHNGSA-N Lys-Ile-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCCCN PRSBSVAVOQOAMI-BJDJZHNGSA-N 0.000 description 2
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 2
- FPQMQEOVSKMVMA-ACRUOGEOSA-N Lys-Tyr-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)NC(=O)[C@H](CCCCN)N)O FPQMQEOVSKMVMA-ACRUOGEOSA-N 0.000 description 2
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 2
- QWTGQXGNNMIUCW-BPUTZDHNSA-N Met-Asn-Trp Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O QWTGQXGNNMIUCW-BPUTZDHNSA-N 0.000 description 2
- OSOLWRWQADPDIQ-DCAQKATOSA-N Met-Asp-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O OSOLWRWQADPDIQ-DCAQKATOSA-N 0.000 description 2
- WUGMRIBZSVSJNP-UHFFFAOYSA-N N-L-alanyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)C(N)C)C(O)=O)=CNC2=C1 WUGMRIBZSVSJNP-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- LSXGADJXBDFXQU-DLOVCJGASA-N Phe-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 LSXGADJXBDFXQU-DLOVCJGASA-N 0.000 description 2
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 2
- CDNPIRSCAFMMBE-SRVKXCTJSA-N Phe-Asn-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CDNPIRSCAFMMBE-SRVKXCTJSA-N 0.000 description 2
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 2
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 2
- LXUJDHOKVUYHRC-KKUMJFAQSA-N Phe-Cys-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N LXUJDHOKVUYHRC-KKUMJFAQSA-N 0.000 description 2
- IILUKIJNFMUBNF-IHRRRGAJSA-N Phe-Gln-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O IILUKIJNFMUBNF-IHRRRGAJSA-N 0.000 description 2
- ABQFNJAFONNUTH-FHWLQOOXSA-N Phe-Gln-Tyr Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N ABQFNJAFONNUTH-FHWLQOOXSA-N 0.000 description 2
- YYKZDTVQHTUKDW-RYUDHWBXSA-N Phe-Gly-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N YYKZDTVQHTUKDW-RYUDHWBXSA-N 0.000 description 2
- CWFGECHCRMGPPT-MXAVVETBSA-N Phe-Ile-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O CWFGECHCRMGPPT-MXAVVETBSA-N 0.000 description 2
- BYAIIACBWBOJCU-URLPEUOOSA-N Phe-Ile-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BYAIIACBWBOJCU-URLPEUOOSA-N 0.000 description 2
- YCCUXNNKXDGMAM-KKUMJFAQSA-N Phe-Leu-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YCCUXNNKXDGMAM-KKUMJFAQSA-N 0.000 description 2
- FQUUYTNBMIBOHS-IHRRRGAJSA-N Phe-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N FQUUYTNBMIBOHS-IHRRRGAJSA-N 0.000 description 2
- IWZRODDWOSIXPZ-IRXDYDNUSA-N Phe-Phe-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(O)=O)C1=CC=CC=C1 IWZRODDWOSIXPZ-IRXDYDNUSA-N 0.000 description 2
- JXQVYPWVGUOIDV-MXAVVETBSA-N Phe-Ser-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JXQVYPWVGUOIDV-MXAVVETBSA-N 0.000 description 2
- MVIJMIZJPHQGEN-IHRRRGAJSA-N Phe-Ser-Val Chemical compound CC(C)[C@@H](C([O-])=O)NC(=O)[C@H](CO)NC(=O)[C@@H]([NH3+])CC1=CC=CC=C1 MVIJMIZJPHQGEN-IHRRRGAJSA-N 0.000 description 2
- JHSRGEODDALISP-XVSYOHENSA-N Phe-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O JHSRGEODDALISP-XVSYOHENSA-N 0.000 description 2
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 2
- GNRMAQSIROFNMI-IXOXFDKPSA-N Phe-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O GNRMAQSIROFNMI-IXOXFDKPSA-N 0.000 description 2
- WDOCBGZHAQQIBL-IHPCNDPISA-N Phe-Trp-Ser Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 WDOCBGZHAQQIBL-IHPCNDPISA-N 0.000 description 2
- GCFNFKNPCMBHNT-IRXDYDNUSA-N Phe-Tyr-Gly Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)NCC(=O)O)N GCFNFKNPCMBHNT-IRXDYDNUSA-N 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 2
- JMVQDLDPDBXAAX-YUMQZZPRSA-N Pro-Gly-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 JMVQDLDPDBXAAX-YUMQZZPRSA-N 0.000 description 2
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 2
- KLSOMAFWRISSNI-OSUNSFLBSA-N Pro-Ile-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 KLSOMAFWRISSNI-OSUNSFLBSA-N 0.000 description 2
- QDDJNKWPTJHROJ-UFYCRDLUSA-N Pro-Tyr-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 QDDJNKWPTJHROJ-UFYCRDLUSA-N 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 2
- 102000004389 Ribonucleoproteins Human genes 0.000 description 2
- 108010081734 Ribonucleoproteins Proteins 0.000 description 2
- WTWGOQRNRFHFQD-JBDRJPRFSA-N Ser-Ala-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WTWGOQRNRFHFQD-JBDRJPRFSA-N 0.000 description 2
- IDCKUIWEIZYVSO-WFBYXXMGSA-N Ser-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CO)C)C(O)=O)=CNC2=C1 IDCKUIWEIZYVSO-WFBYXXMGSA-N 0.000 description 2
- RDFQNDHEHVSONI-ZLUOBGJFSA-N Ser-Asn-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O RDFQNDHEHVSONI-ZLUOBGJFSA-N 0.000 description 2
- ICHZYBVODUVUKN-SRVKXCTJSA-N Ser-Asn-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ICHZYBVODUVUKN-SRVKXCTJSA-N 0.000 description 2
- KDGARKCAKHBEDB-NKWVEPMBSA-N Ser-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CO)N)C(=O)O KDGARKCAKHBEDB-NKWVEPMBSA-N 0.000 description 2
- OQPNSDWGAMFJNU-QWRGUYRKSA-N Ser-Gly-Tyr Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 OQPNSDWGAMFJNU-QWRGUYRKSA-N 0.000 description 2
- FYUIFUJFNCLUIX-XVYDVKMFSA-N Ser-His-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(O)=O FYUIFUJFNCLUIX-XVYDVKMFSA-N 0.000 description 2
- UIPXCLNLUUAMJU-JBDRJPRFSA-N Ser-Ile-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UIPXCLNLUUAMJU-JBDRJPRFSA-N 0.000 description 2
- ADJDNJCSPNFFPI-FXQIFTODSA-N Ser-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO ADJDNJCSPNFFPI-FXQIFTODSA-N 0.000 description 2
- RHAPJNVNWDBFQI-BQBZGAKWSA-N Ser-Pro-Gly Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O RHAPJNVNWDBFQI-BQBZGAKWSA-N 0.000 description 2
- XGQKSRGHEZNWIS-IHRRRGAJSA-N Ser-Pro-Tyr Chemical compound N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O XGQKSRGHEZNWIS-IHRRRGAJSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- ILZAUMFXKSIUEF-SRVKXCTJSA-N Ser-Ser-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ILZAUMFXKSIUEF-SRVKXCTJSA-N 0.000 description 2
- CUXJENOFJXOSOZ-BIIVOSGPSA-N Ser-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CO)N)C(=O)O CUXJENOFJXOSOZ-BIIVOSGPSA-N 0.000 description 2
- JURQXQBJKUHGJS-UHFFFAOYSA-N Ser-Ser-Ser-Ser Chemical compound OCC(N)C(=O)NC(CO)C(=O)NC(CO)C(=O)NC(CO)C(O)=O JURQXQBJKUHGJS-UHFFFAOYSA-N 0.000 description 2
- NADLKBTYNKUJEP-KATARQTJSA-N Ser-Thr-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O NADLKBTYNKUJEP-KATARQTJSA-N 0.000 description 2
- NERYDXBVARJIQS-JYBASQMISA-N Ser-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N)O NERYDXBVARJIQS-JYBASQMISA-N 0.000 description 2
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 2
- 210000001744 T-lymphocyte Anatomy 0.000 description 2
- WFUAUEQXPVNAEF-ZJDVBMNYSA-N Thr-Arg-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CCCN=C(N)N WFUAUEQXPVNAEF-ZJDVBMNYSA-N 0.000 description 2
- KRPKYGOFYUNIGM-XVSYOHENSA-N Thr-Asp-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O KRPKYGOFYUNIGM-XVSYOHENSA-N 0.000 description 2
- DCLBXIWHLVEPMQ-JRQIVUDYSA-N Thr-Asp-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 DCLBXIWHLVEPMQ-JRQIVUDYSA-N 0.000 description 2
- XXNLGZRRSKPSGF-HTUGSXCWSA-N Thr-Gln-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O XXNLGZRRSKPSGF-HTUGSXCWSA-N 0.000 description 2
- HOVLHEKTGVIKAP-WDCWCFNPSA-N Thr-Leu-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O HOVLHEKTGVIKAP-WDCWCFNPSA-N 0.000 description 2
- MECLEFZMPPOEAC-VOAKCMCISA-N Thr-Leu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)O)N)O MECLEFZMPPOEAC-VOAKCMCISA-N 0.000 description 2
- MXDOAJQRJBMGMO-FJXKBIBVSA-N Thr-Pro-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O MXDOAJQRJBMGMO-FJXKBIBVSA-N 0.000 description 2
- BBPCSGKKPJUYRB-UVOCVTCTSA-N Thr-Thr-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O BBPCSGKKPJUYRB-UVOCVTCTSA-N 0.000 description 2
- YOPQYBJJNSIQGZ-JNPHEJMOSA-N Thr-Tyr-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)[C@H](O)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=C(O)C=C1 YOPQYBJJNSIQGZ-JNPHEJMOSA-N 0.000 description 2
- 102100031989 Transmembrane protease serine 2 Human genes 0.000 description 2
- 101710081844 Transmembrane protease serine 2 Proteins 0.000 description 2
- KZTLJLFVOIMRAQ-IHPCNDPISA-N Trp-Asn-Tyr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KZTLJLFVOIMRAQ-IHPCNDPISA-N 0.000 description 2
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 description 2
- DDHFMBDACJYSKW-AQZXSJQPSA-N Trp-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N)O DDHFMBDACJYSKW-AQZXSJQPSA-N 0.000 description 2
- JKLJVFCPCWMNMZ-UMPQAUOISA-N Trp-Thr-Met Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCSC)C(O)=O)[C@@H](C)O)=CNC2=C1 JKLJVFCPCWMNMZ-UMPQAUOISA-N 0.000 description 2
- FHHYVSCGOMPLLO-IHPCNDPISA-N Trp-Tyr-Asp Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 FHHYVSCGOMPLLO-IHPCNDPISA-N 0.000 description 2
- PKZIWSHDJYIPRH-JBACZVJFSA-N Trp-Tyr-Gln Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O PKZIWSHDJYIPRH-JBACZVJFSA-N 0.000 description 2
- AYHSJESDFKREAR-KKUMJFAQSA-N Tyr-Asn-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AYHSJESDFKREAR-KKUMJFAQSA-N 0.000 description 2
- JWHOIHCOHMZSAR-QWRGUYRKSA-N Tyr-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 JWHOIHCOHMZSAR-QWRGUYRKSA-N 0.000 description 2
- NLMXVDDEQFKQQU-CFMVVWHZSA-N Tyr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NLMXVDDEQFKQQU-CFMVVWHZSA-N 0.000 description 2
- ZAGPDPNPWYPEIR-SRVKXCTJSA-N Tyr-Cys-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O ZAGPDPNPWYPEIR-SRVKXCTJSA-N 0.000 description 2
- FJKXUIJOMUWCDD-FHWLQOOXSA-N Tyr-Gln-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N)O FJKXUIJOMUWCDD-FHWLQOOXSA-N 0.000 description 2
- HVHJYXDXRIWELT-RYUDHWBXSA-N Tyr-Glu-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O HVHJYXDXRIWELT-RYUDHWBXSA-N 0.000 description 2
- CNLKDWSAORJEMW-KWQFWETISA-N Tyr-Gly-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](C)C(O)=O CNLKDWSAORJEMW-KWQFWETISA-N 0.000 description 2
- GULIUBBXCYPDJU-CQDKDKBSSA-N Tyr-Leu-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CC1=CC=C(O)C=C1 GULIUBBXCYPDJU-CQDKDKBSSA-N 0.000 description 2
- UMSZZGTXGKHTFJ-SRVKXCTJSA-N Tyr-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 UMSZZGTXGKHTFJ-SRVKXCTJSA-N 0.000 description 2
- OJCISMMNNUNNJA-BZSNNMDCSA-N Tyr-Tyr-Asp Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(O)=O)C(O)=O)C1=CC=C(O)C=C1 OJCISMMNNUNNJA-BZSNNMDCSA-N 0.000 description 2
- RGJZPXFZIUUQDN-BPNCWPANSA-N Tyr-Val-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O RGJZPXFZIUUQDN-BPNCWPANSA-N 0.000 description 2
- NWEGIYMHTZXVBP-JSGCOSHPSA-N Tyr-Val-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O NWEGIYMHTZXVBP-JSGCOSHPSA-N 0.000 description 2
- ASQFIHTXXMFENG-XPUUQOCRSA-N Val-Ala-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O ASQFIHTXXMFENG-XPUUQOCRSA-N 0.000 description 2
- IQQYYFPCWKWUHW-YDHLFZDLSA-N Val-Asn-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N IQQYYFPCWKWUHW-YDHLFZDLSA-N 0.000 description 2
- CJDZKZFMAXGUOJ-IHRRRGAJSA-N Val-Cys-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N CJDZKZFMAXGUOJ-IHRRRGAJSA-N 0.000 description 2
- VCAWFLIWYNMHQP-UKJIMTQDSA-N Val-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N VCAWFLIWYNMHQP-UKJIMTQDSA-N 0.000 description 2
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 2
- QHSSPPHOHJSTML-HOCLYGCPSA-N Val-Trp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N QHSSPPHOHJSTML-HOCLYGCPSA-N 0.000 description 2
- PGBMPFKFKXYROZ-UFYCRDLUSA-N Val-Tyr-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)O)N PGBMPFKFKXYROZ-UFYCRDLUSA-N 0.000 description 2
- 108010081404 acein-2 Proteins 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 238000011360 adjunctive therapy Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 108010024078 alanyl-glycyl-serine Proteins 0.000 description 2
- 108010087924 alanylproline Proteins 0.000 description 2
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000002924 anti-infective effect Effects 0.000 description 2
- 230000010056 antibody-dependent cellular cytotoxicity Effects 0.000 description 2
- 229940125715 antihistaminic agent Drugs 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000004599 antimicrobial Substances 0.000 description 2
- 239000012736 aqueous medium Substances 0.000 description 2
- 229940009098 aspartate Drugs 0.000 description 2
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 2
- 108010092854 aspartyllysine Proteins 0.000 description 2
- 229940090047 auto-injector Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 229960001334 corticosteroids Drugs 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 description 2
- 210000000805 cytoplasm Anatomy 0.000 description 2
- 239000000850 decongestant Substances 0.000 description 2
- 229940124581 decongestants Drugs 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- UVYVLBIGDKGWPX-KUAJCENISA-N digitonin Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)C[C@@H](O)[C@H](O[C@H]5[C@@H]([C@@H](O)[C@@H](O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)CO7)O)[C@H](O)[C@@H](CO)O6)O[C@H]6[C@@H]([C@@H](O[C@H]7[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O7)O)[C@@H](O)[C@@H](CO)O6)O)[C@@H](CO)O5)O)C[C@@H]4CC[C@H]3[C@@H]2[C@@H]1O)C)[C@@H]1C)[C@]11CC[C@@H](C)CO1 UVYVLBIGDKGWPX-KUAJCENISA-N 0.000 description 2
- UVYVLBIGDKGWPX-UHFFFAOYSA-N digitonine Natural products CC1C(C2(CCC3C4(C)CC(O)C(OC5C(C(O)C(OC6C(C(OC7C(C(O)C(O)CO7)O)C(O)C(CO)O6)OC6C(C(OC7C(C(O)C(O)C(CO)O7)O)C(O)C(CO)O6)O)C(CO)O5)O)CC4CCC3C2C2O)C)C2OC11CCC(C)CO1 UVYVLBIGDKGWPX-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 208000027685 extreme exhaustion Diseases 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
- 108010080575 glutamyl-aspartyl-alanine Proteins 0.000 description 2
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 2
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 2
- 108010072405 glycyl-aspartyl-glycine Proteins 0.000 description 2
- 108010078326 glycyl-glycyl-valine Proteins 0.000 description 2
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 2
- 108010045126 glycyl-tyrosyl-glycine Proteins 0.000 description 2
- 108010077515 glycylproline Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 108010028295 histidylhistidine Proteins 0.000 description 2
- 108010025306 histidylleucine Proteins 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 238000002650 immunosuppressive therapy Methods 0.000 description 2
- 238000009169 immunotherapy Methods 0.000 description 2
- 238000000099 in vitro assay Methods 0.000 description 2
- 208000033065 inborn errors of immunity Diseases 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- 208000027866 inflammatory disease Diseases 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 229940079322 interferon Drugs 0.000 description 2
- 229940047124 interferons Drugs 0.000 description 2
- 238000007912 intraperitoneal administration Methods 0.000 description 2
- 229940126181 ion channel inhibitor Drugs 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 108010000761 leucylarginine Proteins 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 108010017391 lysylvaline Proteins 0.000 description 2
- 238000004949 mass spectrometry Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000036963 noncompetitive effect Effects 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- ORMNNUPLFAPCFD-DVLYDCSHSA-M phenethicillin potassium Chemical compound [K+].N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C([O-])=O)=O)C(=O)C(C)OC1=CC=CC=C1 ORMNNUPLFAPCFD-DVLYDCSHSA-M 0.000 description 2
- 108010070409 phenylalanyl-glycyl-glycine Proteins 0.000 description 2
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 2
- 230000004962 physiological condition Effects 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108010077112 prolyl-proline Proteins 0.000 description 2
- 108010020432 prolyl-prolylisoleucine Proteins 0.000 description 2
- 108010015796 prolylisoleucine Proteins 0.000 description 2
- 108010090894 prolylleucine Proteins 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002685 pulmonary effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002285 radioactive effect Effects 0.000 description 2
- 238000001959 radiotherapy Methods 0.000 description 2
- 238000003259 recombinant expression Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229940061374 relenza Drugs 0.000 description 2
- 229960000329 ribavirin Drugs 0.000 description 2
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 2
- 102200148758 rs116840795 Human genes 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000011287 therapeutic dose Methods 0.000 description 2
- 229960000172 trivalent influenza vaccine Drugs 0.000 description 2
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 2
- 108010035534 tyrosyl-leucyl-alanine Proteins 0.000 description 2
- 108010051110 tyrosyl-lysine Proteins 0.000 description 2
- 108010071635 tyrosyl-prolyl-arginine Proteins 0.000 description 2
- 108010077037 tyrosyl-tyrosyl-phenylalanine Proteins 0.000 description 2
- 238000002255 vaccination Methods 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 229960001028 zanamivir Drugs 0.000 description 2
- BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
- ZQJHYRVSKHGGJY-YPKJBDGSSA-N (2s,3r)-2-[[(2s)-2-[[(2s)-1-[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3-phenylpropanoyl]amino]-3-hydroxybutanoic acid Chemical compound C([C@@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ZQJHYRVSKHGGJY-YPKJBDGSSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 241000023308 Acca Species 0.000 description 1
- 206010069754 Acquired gene mutation Diseases 0.000 description 1
- 229940124963 Afluria Drugs 0.000 description 1
- FXKNPWNXPQZLES-ZLUOBGJFSA-N Ala-Asn-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O FXKNPWNXPQZLES-ZLUOBGJFSA-N 0.000 description 1
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 1
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 1
- CXQODNIBUNQWAS-CIUDSAMLSA-N Ala-Gln-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CXQODNIBUNQWAS-CIUDSAMLSA-N 0.000 description 1
- ZODMADSIQZZBSQ-FXQIFTODSA-N Ala-Gln-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZODMADSIQZZBSQ-FXQIFTODSA-N 0.000 description 1
- GSHKMNKPMLXSQW-KBIXCLLPSA-N Ala-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C)N GSHKMNKPMLXSQW-KBIXCLLPSA-N 0.000 description 1
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 1
- QQACQIHVWCVBBR-GVARAGBVSA-N Ala-Ile-Tyr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QQACQIHVWCVBBR-GVARAGBVSA-N 0.000 description 1
- VCSABYLVNWQYQE-UHFFFAOYSA-N Ala-Lys-Lys Natural products NCCCCC(NC(=O)C(N)C)C(=O)NC(CCCCN)C(O)=O VCSABYLVNWQYQE-UHFFFAOYSA-N 0.000 description 1
- MAEQBGQTDWDSJQ-LSJOCFKGSA-N Ala-Met-His Chemical compound C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N MAEQBGQTDWDSJQ-LSJOCFKGSA-N 0.000 description 1
- FVNAUOZKIPAYNA-BPNCWPANSA-N Ala-Met-Tyr Chemical compound CSCC[C@H](NC(=O)[C@H](C)N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FVNAUOZKIPAYNA-BPNCWPANSA-N 0.000 description 1
- DHBKYZYFEXXUAK-ONGXEEELSA-N Ala-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 DHBKYZYFEXXUAK-ONGXEEELSA-N 0.000 description 1
- RUXQNKVQSKOOBS-JURCDPSOSA-N Ala-Phe-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RUXQNKVQSKOOBS-JURCDPSOSA-N 0.000 description 1
- DCVYRWFAMZFSDA-ZLUOBGJFSA-N Ala-Ser-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O DCVYRWFAMZFSDA-ZLUOBGJFSA-N 0.000 description 1
- SYIFFFHSXBNPMC-UWJYBYFXSA-N Ala-Ser-Tyr Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N SYIFFFHSXBNPMC-UWJYBYFXSA-N 0.000 description 1
- JJHBEVZAZXZREW-LFSVMHDDSA-N Ala-Thr-Phe Chemical compound C[C@@H](O)[C@H](NC(=O)[C@H](C)N)C(=O)N[C@@H](Cc1ccccc1)C(O)=O JJHBEVZAZXZREW-LFSVMHDDSA-N 0.000 description 1
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- OMSKGWFGWCQFBD-KZVJFYERSA-N Ala-Val-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OMSKGWFGWCQFBD-KZVJFYERSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 108010032595 Antibody Binding Sites Proteins 0.000 description 1
- MCYJBCKCAPERSE-FXQIFTODSA-N Arg-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N MCYJBCKCAPERSE-FXQIFTODSA-N 0.000 description 1
- USNSOPDIZILSJP-FXQIFTODSA-N Arg-Asn-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O USNSOPDIZILSJP-FXQIFTODSA-N 0.000 description 1
- DXQIQUIQYAGRCC-CIUDSAMLSA-N Arg-Asp-Gln Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N)CN=C(N)N DXQIQUIQYAGRCC-CIUDSAMLSA-N 0.000 description 1
- BEXGZLUHRXTZCC-CIUDSAMLSA-N Arg-Gln-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N BEXGZLUHRXTZCC-CIUDSAMLSA-N 0.000 description 1
- AUFHLLPVPSMEOG-YUMQZZPRSA-N Arg-Gly-Glu Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AUFHLLPVPSMEOG-YUMQZZPRSA-N 0.000 description 1
- CYXCAHZVPFREJD-LURJTMIESA-N Arg-Gly-Gly Chemical compound NC(=N)NCCC[C@H](N)C(=O)NCC(=O)NCC(O)=O CYXCAHZVPFREJD-LURJTMIESA-N 0.000 description 1
- OTZMRMHZCMZOJZ-SRVKXCTJSA-N Arg-Leu-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O OTZMRMHZCMZOJZ-SRVKXCTJSA-N 0.000 description 1
- PRLPSDIHSRITSF-UNQGMJICSA-N Arg-Phe-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PRLPSDIHSRITSF-UNQGMJICSA-N 0.000 description 1
- HGKHPCFTRQDHCU-IUCAKERBSA-N Arg-Pro-Gly Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O HGKHPCFTRQDHCU-IUCAKERBSA-N 0.000 description 1
- AMIQZQAAYGYKOP-FXQIFTODSA-N Arg-Ser-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O AMIQZQAAYGYKOP-FXQIFTODSA-N 0.000 description 1
- ADPACBMPYWJJCE-FXQIFTODSA-N Arg-Ser-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O ADPACBMPYWJJCE-FXQIFTODSA-N 0.000 description 1
- AUZAXCPWMDBWEE-HJGDQZAQSA-N Arg-Thr-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O AUZAXCPWMDBWEE-HJGDQZAQSA-N 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- VDCIPFYVCICPEC-FXQIFTODSA-N Asn-Arg-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O VDCIPFYVCICPEC-FXQIFTODSA-N 0.000 description 1
- MFFOYNGMOYFPBD-DCAQKATOSA-N Asn-Arg-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MFFOYNGMOYFPBD-DCAQKATOSA-N 0.000 description 1
- HUZGPXBILPMCHM-IHRRRGAJSA-N Asn-Arg-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HUZGPXBILPMCHM-IHRRRGAJSA-N 0.000 description 1
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 1
- NKLRWRRVYGQNIH-GHCJXIJMSA-N Asn-Ile-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O NKLRWRRVYGQNIH-GHCJXIJMSA-N 0.000 description 1
- AWXDRZJQCVHCIT-DCAQKATOSA-N Asn-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC(N)=O AWXDRZJQCVHCIT-DCAQKATOSA-N 0.000 description 1
- REQUGIWGOGSOEZ-ZLUOBGJFSA-N Asn-Ser-Asn Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)C(=O)N REQUGIWGOGSOEZ-ZLUOBGJFSA-N 0.000 description 1
- GZXOUBTUAUAVHD-ACZMJKKPSA-N Asn-Ser-Glu Chemical compound NC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O GZXOUBTUAUAVHD-ACZMJKKPSA-N 0.000 description 1
- KZYSHAMXEBPJBD-JRQIVUDYSA-N Asn-Thr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KZYSHAMXEBPJBD-JRQIVUDYSA-N 0.000 description 1
- JPPLRQVZMZFOSX-UWJYBYFXSA-N Asn-Tyr-Ala Chemical compound NC(=O)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=C(O)C=C1 JPPLRQVZMZFOSX-UWJYBYFXSA-N 0.000 description 1
- RTFXPCYMDYBZNQ-SRVKXCTJSA-N Asn-Tyr-Asn Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O RTFXPCYMDYBZNQ-SRVKXCTJSA-N 0.000 description 1
- DATSKXOXPUAOLK-KKUMJFAQSA-N Asn-Tyr-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O DATSKXOXPUAOLK-KKUMJFAQSA-N 0.000 description 1
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 1
- ZLGKHJHFYSRUBH-FXQIFTODSA-N Asp-Arg-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O ZLGKHJHFYSRUBH-FXQIFTODSA-N 0.000 description 1
- YNQIDCRRTWGHJD-ZLUOBGJFSA-N Asp-Asn-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CC(O)=O YNQIDCRRTWGHJD-ZLUOBGJFSA-N 0.000 description 1
- OMMIEVATLAGRCK-BYPYZUCNSA-N Asp-Gly-Gly Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)NCC(O)=O OMMIEVATLAGRCK-BYPYZUCNSA-N 0.000 description 1
- KLYPOCBLKMPBIQ-GHCJXIJMSA-N Asp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N KLYPOCBLKMPBIQ-GHCJXIJMSA-N 0.000 description 1
- UZNSWMFLKVKJLI-VHWLVUOQSA-N Asp-Ile-Trp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O UZNSWMFLKVKJLI-VHWLVUOQSA-N 0.000 description 1
- KOWYNSKRPUWSFG-IHPCNDPISA-N Asp-Phe-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)[C@H](CC(=O)O)N KOWYNSKRPUWSFG-IHPCNDPISA-N 0.000 description 1
- WMLFFCRUSPNENW-ZLUOBGJFSA-N Asp-Ser-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O WMLFFCRUSPNENW-ZLUOBGJFSA-N 0.000 description 1
- CUQDCPXNZPDYFQ-ZLUOBGJFSA-N Asp-Ser-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O CUQDCPXNZPDYFQ-ZLUOBGJFSA-N 0.000 description 1
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 1
- GHAHOJDCBRXAKC-IHPCNDPISA-N Asp-Trp-Tyr Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CC=C(C=C3)O)C(=O)O)NC(=O)[C@H](CC(=O)O)N GHAHOJDCBRXAKC-IHPCNDPISA-N 0.000 description 1
- NALWOULWGHTVDA-UWVGGRQHSA-N Asp-Tyr Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NALWOULWGHTVDA-UWVGGRQHSA-N 0.000 description 1
- GYNUXDMCDILYIQ-QRTARXTBSA-N Asp-Val-Trp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)O)N GYNUXDMCDILYIQ-QRTARXTBSA-N 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 241001155433 Centrarchus macropterus Species 0.000 description 1
- 241000272161 Charadriiformes Species 0.000 description 1
- 206010008469 Chest discomfort Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 108020004705 Codon Proteins 0.000 description 1
- 241000699802 Cricetulus griseus Species 0.000 description 1
- PRXCTTWKGJAPMT-ZLUOBGJFSA-N Cys-Ala-Ser Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O PRXCTTWKGJAPMT-ZLUOBGJFSA-N 0.000 description 1
- GEEXORWTBTUOHC-FXQIFTODSA-N Cys-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N)CN=C(N)N GEEXORWTBTUOHC-FXQIFTODSA-N 0.000 description 1
- BYALSSDCQYHKMY-XGEHTFHBSA-N Cys-Arg-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N)O BYALSSDCQYHKMY-XGEHTFHBSA-N 0.000 description 1
- ZLHPWFSAUJEEAN-KBIXCLLPSA-N Cys-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CS)N ZLHPWFSAUJEEAN-KBIXCLLPSA-N 0.000 description 1
- NIXHTNJAGGFBAW-CIUDSAMLSA-N Cys-Lys-Ser Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CS)N NIXHTNJAGGFBAW-CIUDSAMLSA-N 0.000 description 1
- PGBLJHDDKCVSTC-CIUDSAMLSA-N Cys-Met-Gln Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CS)C(=O)N[C@@H](CCC(N)=O)C(O)=O PGBLJHDDKCVSTC-CIUDSAMLSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101710189104 Fibritin Proteins 0.000 description 1
- 229940124893 Fluvirin Drugs 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- BTSPOOHJBYJRKO-CIUDSAMLSA-N Gln-Asp-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O BTSPOOHJBYJRKO-CIUDSAMLSA-N 0.000 description 1
- JKPGHIQCHIIRMS-AVGNSLFASA-N Gln-Asp-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N JKPGHIQCHIIRMS-AVGNSLFASA-N 0.000 description 1
- OFPWCBGRYAOLMU-AVGNSLFASA-N Gln-Asp-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O OFPWCBGRYAOLMU-AVGNSLFASA-N 0.000 description 1
- LPYPANUXJGFMGV-FXQIFTODSA-N Gln-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LPYPANUXJGFMGV-FXQIFTODSA-N 0.000 description 1
- NKCZYEDZTKOFBG-GUBZILKMSA-N Gln-Gln-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O NKCZYEDZTKOFBG-GUBZILKMSA-N 0.000 description 1
- KVXVVDFOZNYYKZ-DCAQKATOSA-N Gln-Gln-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O KVXVVDFOZNYYKZ-DCAQKATOSA-N 0.000 description 1
- LVNILKSSFHCSJZ-IHRRRGAJSA-N Gln-Gln-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LVNILKSSFHCSJZ-IHRRRGAJSA-N 0.000 description 1
- CLPQUWHBWXFJOX-BQBZGAKWSA-N Gln-Gly-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O CLPQUWHBWXFJOX-BQBZGAKWSA-N 0.000 description 1
- OOLCSQQPSLIETN-JYJNAYRXSA-N Gln-His-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CCC(=O)N)N)O OOLCSQQPSLIETN-JYJNAYRXSA-N 0.000 description 1
- VZRAXPGTUNDIDK-GUBZILKMSA-N Gln-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N VZRAXPGTUNDIDK-GUBZILKMSA-N 0.000 description 1
- XZLLTYBONVKGLO-SDDRHHMPSA-N Gln-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)N)N)C(=O)O XZLLTYBONVKGLO-SDDRHHMPSA-N 0.000 description 1
- CELXWPDNIGWCJN-WDCWCFNPSA-N Gln-Lys-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O CELXWPDNIGWCJN-WDCWCFNPSA-N 0.000 description 1
- LVRKAFPPFJRIOF-GARJFASQSA-N Gln-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N LVRKAFPPFJRIOF-GARJFASQSA-N 0.000 description 1
- AQPZYBSRDRZBAG-AVGNSLFASA-N Gln-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N AQPZYBSRDRZBAG-AVGNSLFASA-N 0.000 description 1
- UESYBOXFJWJVSB-AVGNSLFASA-N Gln-Phe-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O UESYBOXFJWJVSB-AVGNSLFASA-N 0.000 description 1
- FNAJNWPDTIXYJN-CIUDSAMLSA-N Gln-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCC(N)=O FNAJNWPDTIXYJN-CIUDSAMLSA-N 0.000 description 1
- WLRYGVYQFXRJDA-DCAQKATOSA-N Gln-Pro-Pro Chemical compound NC(=O)CC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 WLRYGVYQFXRJDA-DCAQKATOSA-N 0.000 description 1
- KPNWAJMEMRCLAL-GUBZILKMSA-N Gln-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N KPNWAJMEMRCLAL-GUBZILKMSA-N 0.000 description 1
- SYZZMPFLOLSMHL-XHNCKOQMSA-N Gln-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)[C@H](CCC(=O)N)N)C(=O)O SYZZMPFLOLSMHL-XHNCKOQMSA-N 0.000 description 1
- UBRQJXFDVZNYJP-AVGNSLFASA-N Gln-Tyr-Ser Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UBRQJXFDVZNYJP-AVGNSLFASA-N 0.000 description 1
- CKRUHITYRFNUKW-WDSKDSINSA-N Glu-Asn-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O CKRUHITYRFNUKW-WDSKDSINSA-N 0.000 description 1
- PXXGVUVQWQGGIG-YUMQZZPRSA-N Glu-Gly-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N PXXGVUVQWQGGIG-YUMQZZPRSA-N 0.000 description 1
- INGJLBQKTRJLFO-UKJIMTQDSA-N Glu-Ile-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(O)=O INGJLBQKTRJLFO-UKJIMTQDSA-N 0.000 description 1
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 1
- NPMSEUWUMOSEFM-CIUDSAMLSA-N Glu-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N NPMSEUWUMOSEFM-CIUDSAMLSA-N 0.000 description 1
- QJVZSVUYZFYLFQ-CIUDSAMLSA-N Glu-Pro-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O QJVZSVUYZFYLFQ-CIUDSAMLSA-N 0.000 description 1
- SWDNPSMMEWRNOH-HJGDQZAQSA-N Glu-Pro-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O SWDNPSMMEWRNOH-HJGDQZAQSA-N 0.000 description 1
- RFTVTKBHDXCEEX-WDSKDSINSA-N Glu-Ser-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)NCC(O)=O RFTVTKBHDXCEEX-WDSKDSINSA-N 0.000 description 1
- DMYACXMQUABZIQ-NRPADANISA-N Glu-Ser-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O DMYACXMQUABZIQ-NRPADANISA-N 0.000 description 1
- GPSHCSTUYOQPAI-JHEQGTHGSA-N Glu-Thr-Gly Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O GPSHCSTUYOQPAI-JHEQGTHGSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- UGVQELHRNUDMAA-BYPYZUCNSA-N Gly-Ala-Gly Chemical compound [NH3+]CC(=O)N[C@@H](C)C(=O)NCC([O-])=O UGVQELHRNUDMAA-BYPYZUCNSA-N 0.000 description 1
- XUDLUKYPXQDCRX-BQBZGAKWSA-N Gly-Arg-Asn Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O XUDLUKYPXQDCRX-BQBZGAKWSA-N 0.000 description 1
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 1
- UFPXDFOYHVEIPI-BYPYZUCNSA-N Gly-Gly-Asp Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O UFPXDFOYHVEIPI-BYPYZUCNSA-N 0.000 description 1
- XPJBQTCXPJNIFE-ZETCQYMHSA-N Gly-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)CN XPJBQTCXPJNIFE-ZETCQYMHSA-N 0.000 description 1
- KAJAOGBVWCYGHZ-JTQLQIEISA-N Gly-Gly-Phe Chemical compound [NH3+]CC(=O)NCC(=O)N[C@H](C([O-])=O)CC1=CC=CC=C1 KAJAOGBVWCYGHZ-JTQLQIEISA-N 0.000 description 1
- AAHSHTLISQUZJL-QSFUFRPTSA-N Gly-Ile-Ile Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O AAHSHTLISQUZJL-QSFUFRPTSA-N 0.000 description 1
- FGPLUIQCSKGLTI-WDSKDSINSA-N Gly-Ser-Glu Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O FGPLUIQCSKGLTI-WDSKDSINSA-N 0.000 description 1
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 1
- ABPRMMYHROQBLY-NKWVEPMBSA-N Gly-Ser-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CO)NC(=O)CN)C(=O)O ABPRMMYHROQBLY-NKWVEPMBSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- RJVZMGQMJOQIAX-GJZGRUSLSA-N Gly-Trp-Met Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(O)=O RJVZMGQMJOQIAX-GJZGRUSLSA-N 0.000 description 1
- KOYUSMBPJOVSOO-XEGUGMAKSA-N Gly-Tyr-Ile Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KOYUSMBPJOVSOO-XEGUGMAKSA-N 0.000 description 1
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- HVLSXIKZNLPZJJ-TXZCQADKSA-N HA peptide Chemical compound C([C@@H](C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 HVLSXIKZNLPZJJ-TXZCQADKSA-N 0.000 description 1
- MDOBWSFNSNPENN-PMVVWTBXSA-N His-Thr-Gly Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O MDOBWSFNSNPENN-PMVVWTBXSA-N 0.000 description 1
- SWBUZLFWGJETAO-KKUMJFAQSA-N His-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N)O SWBUZLFWGJETAO-KKUMJFAQSA-N 0.000 description 1
- 101000935587 Homo sapiens Flavin reductase (NADPH) Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- QICVAHODWHIWIS-HTFCKZLJSA-N Ile-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N QICVAHODWHIWIS-HTFCKZLJSA-N 0.000 description 1
- HDOYNXLPTRQLAD-JBDRJPRFSA-N Ile-Ala-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)N HDOYNXLPTRQLAD-JBDRJPRFSA-N 0.000 description 1
- LVQDUPQUJZWKSU-PYJNHQTQSA-N Ile-Arg-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N LVQDUPQUJZWKSU-PYJNHQTQSA-N 0.000 description 1
- HDODQNPMSHDXJT-GHCJXIJMSA-N Ile-Asn-Ser Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O HDODQNPMSHDXJT-GHCJXIJMSA-N 0.000 description 1
- LEDRIAHEWDJRMF-CFMVVWHZSA-N Ile-Asn-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LEDRIAHEWDJRMF-CFMVVWHZSA-N 0.000 description 1
- BGZIJZJBXRVBGJ-SXTJYALSSA-N Ile-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N BGZIJZJBXRVBGJ-SXTJYALSSA-N 0.000 description 1
- ZDNORQNHCJUVOV-KBIXCLLPSA-N Ile-Gln-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O ZDNORQNHCJUVOV-KBIXCLLPSA-N 0.000 description 1
- DFFTXLCCDFYRKD-MBLNEYKQSA-N Ile-Gly-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)O)N DFFTXLCCDFYRKD-MBLNEYKQSA-N 0.000 description 1
- UAQSZXGJGLHMNV-XEGUGMAKSA-N Ile-Gly-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)N UAQSZXGJGLHMNV-XEGUGMAKSA-N 0.000 description 1
- WIZPFZKOFZXDQG-HTFCKZLJSA-N Ile-Ile-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O WIZPFZKOFZXDQG-HTFCKZLJSA-N 0.000 description 1
- YNMQUIVKEFRCPH-QSFUFRPTSA-N Ile-Ile-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O)N YNMQUIVKEFRCPH-QSFUFRPTSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- PNTWNAXGBOZMBO-MNXVOIDGSA-N Ile-Lys-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PNTWNAXGBOZMBO-MNXVOIDGSA-N 0.000 description 1
- HQEPKOFULQTSFV-JURCDPSOSA-N Ile-Phe-Ala Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)O)N HQEPKOFULQTSFV-JURCDPSOSA-N 0.000 description 1
- CIJLNXXMDUOFPH-HJWJTTGWSA-N Ile-Pro-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 CIJLNXXMDUOFPH-HJWJTTGWSA-N 0.000 description 1
- JZNVOBUNTWNZPW-GHCJXIJMSA-N Ile-Ser-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)O)N JZNVOBUNTWNZPW-GHCJXIJMSA-N 0.000 description 1
- FBGXMKUWQFPHFB-JBDRJPRFSA-N Ile-Ser-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N FBGXMKUWQFPHFB-JBDRJPRFSA-N 0.000 description 1
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 1
- JDCQDJVYUXNCGF-SPOWBLRKSA-N Ile-Ser-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)N JDCQDJVYUXNCGF-SPOWBLRKSA-N 0.000 description 1
- SAEWJTCJQVZQNZ-IUKAMOBKSA-N Ile-Thr-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N SAEWJTCJQVZQNZ-IUKAMOBKSA-N 0.000 description 1
- WKSHBPRUIRGWRZ-KCTSRDHCSA-N Ile-Trp-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)NCC(=O)O)N WKSHBPRUIRGWRZ-KCTSRDHCSA-N 0.000 description 1
- RTSQPLLOYSGMKM-DSYPUSFNSA-N Ile-Trp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(C)C)C(=O)O)N RTSQPLLOYSGMKM-DSYPUSFNSA-N 0.000 description 1
- JSLIXOUMAOUGBN-JUKXBJQTSA-N Ile-Tyr-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N JSLIXOUMAOUGBN-JUKXBJQTSA-N 0.000 description 1
- NSPNUMNLZNOPAQ-SJWGOKEGSA-N Ile-Tyr-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N NSPNUMNLZNOPAQ-SJWGOKEGSA-N 0.000 description 1
- 108010058683 Immobilized Proteins Proteins 0.000 description 1
- 102000013463 Immunoglobulin Light Chains Human genes 0.000 description 1
- 108010065825 Immunoglobulin Light Chains Proteins 0.000 description 1
- 229940124873 Influenza virus vaccine Drugs 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- 102100040018 Interferon alpha-2 Human genes 0.000 description 1
- 108010079944 Interferon-alpha2b Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical group C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- QNRRHYPPQFELSF-CNYIRLTGSA-N Laninamivir Chemical compound OC[C@@H](O)[C@@H](OC)[C@@H]1OC(C(O)=O)=C[C@H](N=C(N)N)[C@H]1NC(C)=O QNRRHYPPQFELSF-CNYIRLTGSA-N 0.000 description 1
- 241000272168 Laridae Species 0.000 description 1
- ULXYQAJWJGLCNR-YUMQZZPRSA-N Leu-Asp-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O ULXYQAJWJGLCNR-YUMQZZPRSA-N 0.000 description 1
- VQPPIMUZCZCOIL-GUBZILKMSA-N Leu-Gln-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O VQPPIMUZCZCOIL-GUBZILKMSA-N 0.000 description 1
- ZYLJULGXQDNXDK-GUBZILKMSA-N Leu-Gln-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ZYLJULGXQDNXDK-GUBZILKMSA-N 0.000 description 1
- KAFOIVJDVSZUMD-UHFFFAOYSA-N Leu-Gln-Gln Natural products CC(C)CC(N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(O)=O KAFOIVJDVSZUMD-UHFFFAOYSA-N 0.000 description 1
- FQZPTCNSNPWHLJ-AVGNSLFASA-N Leu-Gln-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(O)=O FQZPTCNSNPWHLJ-AVGNSLFASA-N 0.000 description 1
- YSKSXVKQLLBVEX-SZMVWBNQSA-N Leu-Gln-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)C(O)=O)=CNC2=C1 YSKSXVKQLLBVEX-SZMVWBNQSA-N 0.000 description 1
- KUEVMUXNILMJTK-JYJNAYRXSA-N Leu-Gln-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KUEVMUXNILMJTK-JYJNAYRXSA-N 0.000 description 1
- QDSKNVXKLPQNOJ-GVXVVHGQSA-N Leu-Gln-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O QDSKNVXKLPQNOJ-GVXVVHGQSA-N 0.000 description 1
- RVVBWTWPNFDYBE-SRVKXCTJSA-N Leu-Glu-Arg Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O RVVBWTWPNFDYBE-SRVKXCTJSA-N 0.000 description 1
- HPBCTWSUJOGJSH-MNXVOIDGSA-N Leu-Glu-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HPBCTWSUJOGJSH-MNXVOIDGSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- PRZVBIAOPFGAQF-SRVKXCTJSA-N Leu-Glu-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O PRZVBIAOPFGAQF-SRVKXCTJSA-N 0.000 description 1
- HYMLKESRWLZDBR-WEDXCCLWSA-N Leu-Gly-Thr Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O HYMLKESRWLZDBR-WEDXCCLWSA-N 0.000 description 1
- OYQUOLRTJHWVSQ-SRVKXCTJSA-N Leu-His-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O OYQUOLRTJHWVSQ-SRVKXCTJSA-N 0.000 description 1
- OMHLATXVNQSALM-FQUUOJAGSA-N Leu-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(C)C)N OMHLATXVNQSALM-FQUUOJAGSA-N 0.000 description 1
- KYIIALJHAOIAHF-KKUMJFAQSA-N Leu-Leu-His Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 KYIIALJHAOIAHF-KKUMJFAQSA-N 0.000 description 1
- ZAVCJRJOQKIOJW-KKUMJFAQSA-N Leu-Phe-Asp Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=CC=C1 ZAVCJRJOQKIOJW-KKUMJFAQSA-N 0.000 description 1
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 1
- LINKCQUOMUDLKN-KATARQTJSA-N Leu-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC(C)C)N)O LINKCQUOMUDLKN-KATARQTJSA-N 0.000 description 1
- RIHIGSWBLHSGLV-CQDKDKBSSA-N Leu-Tyr-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C)C(O)=O RIHIGSWBLHSGLV-CQDKDKBSSA-N 0.000 description 1
- OZTZJMUZVAVJGY-BZSNNMDCSA-N Leu-Tyr-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N OZTZJMUZVAVJGY-BZSNNMDCSA-N 0.000 description 1
- LMDVGHQPPPLYAR-IHRRRGAJSA-N Leu-Val-His Chemical compound N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O LMDVGHQPPPLYAR-IHRRRGAJSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- PXHCFKXNSBJSTQ-KKUMJFAQSA-N Lys-Asn-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N)O PXHCFKXNSBJSTQ-KKUMJFAQSA-N 0.000 description 1
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 1
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 1
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 1
- OIYWBDBHEGAVST-BZSNNMDCSA-N Lys-His-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OIYWBDBHEGAVST-BZSNNMDCSA-N 0.000 description 1
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 1
- YDDDRTIPNTWGIG-SRVKXCTJSA-N Lys-Lys-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O YDDDRTIPNTWGIG-SRVKXCTJSA-N 0.000 description 1
- LUAJJLPHUXPQLH-KKUMJFAQSA-N Lys-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCCCN)N LUAJJLPHUXPQLH-KKUMJFAQSA-N 0.000 description 1
- HYSVGEAWTGPMOA-IHRRRGAJSA-N Lys-Pro-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O HYSVGEAWTGPMOA-IHRRRGAJSA-N 0.000 description 1
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
- GHKXHCMRAUYLBS-CIUDSAMLSA-N Lys-Ser-Asn Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O GHKXHCMRAUYLBS-CIUDSAMLSA-N 0.000 description 1
- SBQDRNOLGSYHQA-YUMQZZPRSA-N Lys-Ser-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SBQDRNOLGSYHQA-YUMQZZPRSA-N 0.000 description 1
- JOSAKOKSPXROGQ-BJDJZHNGSA-N Lys-Ser-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O JOSAKOKSPXROGQ-BJDJZHNGSA-N 0.000 description 1
- IOQWIOPSKJOEKI-SRVKXCTJSA-N Lys-Ser-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O IOQWIOPSKJOEKI-SRVKXCTJSA-N 0.000 description 1
- MIFFFXHMAHFACR-KATARQTJSA-N Lys-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCCN MIFFFXHMAHFACR-KATARQTJSA-N 0.000 description 1
- PELXPRPDQRFBGQ-KKUMJFAQSA-N Lys-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N)O PELXPRPDQRFBGQ-KKUMJFAQSA-N 0.000 description 1
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000282567 Macaca fascicularis Species 0.000 description 1
- 101710199769 Matrix protein 2 Proteins 0.000 description 1
- 108010090054 Membrane Glycoproteins Proteins 0.000 description 1
- 102000012750 Membrane Glycoproteins Human genes 0.000 description 1
- CAODKDAPYGUMLK-FXQIFTODSA-N Met-Asn-Ser Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O CAODKDAPYGUMLK-FXQIFTODSA-N 0.000 description 1
- YLLWCSDBVGZLOW-CIUDSAMLSA-N Met-Gln-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O YLLWCSDBVGZLOW-CIUDSAMLSA-N 0.000 description 1
- PHURAEXVWLDIGT-LPEHRKFASA-N Met-Ser-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N PHURAEXVWLDIGT-LPEHRKFASA-N 0.000 description 1
- GHQFLTYXGUETFD-UFYCRDLUSA-N Met-Tyr-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O)N GHQFLTYXGUETFD-UFYCRDLUSA-N 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 241000699667 Mus spretus Species 0.000 description 1
- 108010021466 Mutant Proteins Proteins 0.000 description 1
- 102000008300 Mutant Proteins Human genes 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- 206010028735 Nasal congestion Diseases 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- BKWJQWJPZMUWEG-LFSVMHDDSA-N Phe-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 BKWJQWJPZMUWEG-LFSVMHDDSA-N 0.000 description 1
- SEPNOAFMZLLCEW-UBHSHLNASA-N Phe-Ala-Val Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)O SEPNOAFMZLLCEW-UBHSHLNASA-N 0.000 description 1
- LZDIENNKWVXJMX-JYJNAYRXSA-N Phe-Arg-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H](N)CC1=CC=CC=C1 LZDIENNKWVXJMX-JYJNAYRXSA-N 0.000 description 1
- FSPGBMWPNMRWDB-AVGNSLFASA-N Phe-Cys-Gln Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N FSPGBMWPNMRWDB-AVGNSLFASA-N 0.000 description 1
- NPLGQVKZFGJWAI-QWHCGFSZSA-N Phe-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O NPLGQVKZFGJWAI-QWHCGFSZSA-N 0.000 description 1
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 1
- ZVJGAXNBBKPYOE-HKUYNNGSSA-N Phe-Trp-Gly Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(O)=O)C1=CC=CC=C1 ZVJGAXNBBKPYOE-HKUYNNGSSA-N 0.000 description 1
- KIQUCMUULDXTAZ-HJOGWXRNSA-N Phe-Tyr-Tyr Chemical compound N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O KIQUCMUULDXTAZ-HJOGWXRNSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZSKJPKFTPQCPIH-RCWTZXSCSA-N Pro-Arg-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZSKJPKFTPQCPIH-RCWTZXSCSA-N 0.000 description 1
- OYEUSRAZOGIDBY-JYJNAYRXSA-N Pro-Arg-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OYEUSRAZOGIDBY-JYJNAYRXSA-N 0.000 description 1
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 1
- BODDREDDDRZUCF-QTKMDUPCSA-N Pro-His-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@@H]2CCCN2)O BODDREDDDRZUCF-QTKMDUPCSA-N 0.000 description 1
- UREQLMJCKFLLHM-NAKRPEOUSA-N Pro-Ile-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(O)=O UREQLMJCKFLLHM-NAKRPEOUSA-N 0.000 description 1
- LNICFEXCAHIJOR-DCAQKATOSA-N Pro-Ser-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O LNICFEXCAHIJOR-DCAQKATOSA-N 0.000 description 1
- UGDMQJSXSSZUKL-IHRRRGAJSA-N Pro-Ser-Tyr Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O UGDMQJSXSSZUKL-IHRRRGAJSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- NCDNCNXCDXHOMX-UHFFFAOYSA-N Ritonavir Natural products C=1C=CC=CC=1CC(NC(=O)OCC=1SC=NC=1)C(O)CC(CC=1C=CC=CC=1)NC(=O)C(C(C)C)NC(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-UHFFFAOYSA-N 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- YQHZVYJAGWMHES-ZLUOBGJFSA-N Ser-Ala-Ser Chemical compound OC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YQHZVYJAGWMHES-ZLUOBGJFSA-N 0.000 description 1
- QGMLKFGTGXWAHF-IHRRRGAJSA-N Ser-Arg-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGMLKFGTGXWAHF-IHRRRGAJSA-N 0.000 description 1
- FTVRVZNYIYWJGB-ACZMJKKPSA-N Ser-Asp-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FTVRVZNYIYWJGB-ACZMJKKPSA-N 0.000 description 1
- NJSPTZXVPZDRCU-UBHSHLNASA-N Ser-Asp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N NJSPTZXVPZDRCU-UBHSHLNASA-N 0.000 description 1
- AEGUWTFAQQWVLC-BQBZGAKWSA-N Ser-Gly-Arg Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O AEGUWTFAQQWVLC-BQBZGAKWSA-N 0.000 description 1
- BPMRXBZYPGYPJN-WHFBIAKZSA-N Ser-Gly-Asn Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O BPMRXBZYPGYPJN-WHFBIAKZSA-N 0.000 description 1
- MUARUIBTKQJKFY-WHFBIAKZSA-N Ser-Gly-Asp Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MUARUIBTKQJKFY-WHFBIAKZSA-N 0.000 description 1
- IXCHOHLPHNGFTJ-YUMQZZPRSA-N Ser-Gly-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N IXCHOHLPHNGFTJ-YUMQZZPRSA-N 0.000 description 1
- HMRAQFJFTOLDKW-GUBZILKMSA-N Ser-His-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(O)=O HMRAQFJFTOLDKW-GUBZILKMSA-N 0.000 description 1
- WEQAYODCJHZSJZ-KKUMJFAQSA-N Ser-His-Tyr Chemical compound C([C@H](NC(=O)[C@H](CO)N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CN=CN1 WEQAYODCJHZSJZ-KKUMJFAQSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- VMLONWHIORGALA-SRVKXCTJSA-N Ser-Leu-Leu Chemical compound CC(C)C[C@@H](C([O-])=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]([NH3+])CO VMLONWHIORGALA-SRVKXCTJSA-N 0.000 description 1
- UBRMZSHOOIVJPW-SRVKXCTJSA-N Ser-Leu-Lys Chemical compound OC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(O)=O UBRMZSHOOIVJPW-SRVKXCTJSA-N 0.000 description 1
- KCGIREHVWRXNDH-GARJFASQSA-N Ser-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N KCGIREHVWRXNDH-GARJFASQSA-N 0.000 description 1
- JWOBLHJRDADHLN-KKUMJFAQSA-N Ser-Leu-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JWOBLHJRDADHLN-KKUMJFAQSA-N 0.000 description 1
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 1
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 1
- JLKWJWPDXPKKHI-FXQIFTODSA-N Ser-Pro-Asn Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CO)N)C(=O)N[C@@H](CC(=O)N)C(=O)O JLKWJWPDXPKKHI-FXQIFTODSA-N 0.000 description 1
- FKYWFUYPVKLJLP-DCAQKATOSA-N Ser-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CO FKYWFUYPVKLJLP-DCAQKATOSA-N 0.000 description 1
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 1
- WUXCHQZLUHBSDJ-LKXGYXEUSA-N Ser-Thr-Asp Chemical compound OC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WUXCHQZLUHBSDJ-LKXGYXEUSA-N 0.000 description 1
- OJFFAQFRCVPHNN-JYBASQMISA-N Ser-Thr-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O OJFFAQFRCVPHNN-JYBASQMISA-N 0.000 description 1
- ZKOKTQPHFMRSJP-YJRXYDGGSA-N Ser-Thr-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKOKTQPHFMRSJP-YJRXYDGGSA-N 0.000 description 1
- BDMWLJLPPUCLNV-XGEHTFHBSA-N Ser-Thr-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O BDMWLJLPPUCLNV-XGEHTFHBSA-N 0.000 description 1
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 1
- FVFUOQIYDPAIJR-XIRDDKMYSA-N Ser-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CO)N FVFUOQIYDPAIJR-XIRDDKMYSA-N 0.000 description 1
- UBTNVMGPMYDYIU-HJPIBITLSA-N Ser-Tyr-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UBTNVMGPMYDYIU-HJPIBITLSA-N 0.000 description 1
- HKHCTNFKZXAMIF-KKUMJFAQSA-N Ser-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CC=C(O)C=C1 HKHCTNFKZXAMIF-KKUMJFAQSA-N 0.000 description 1
- VVKVHAOOUGNDPJ-SRVKXCTJSA-N Ser-Tyr-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O VVKVHAOOUGNDPJ-SRVKXCTJSA-N 0.000 description 1
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 1
- UNURFMVMXLENAZ-KJEVXHAQSA-N Thr-Arg-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UNURFMVMXLENAZ-KJEVXHAQSA-N 0.000 description 1
- JBHMLZSKIXMVFS-XVSYOHENSA-N Thr-Asn-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JBHMLZSKIXMVFS-XVSYOHENSA-N 0.000 description 1
- YDWLCDQXLCILCZ-BWAGICSOSA-N Thr-His-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YDWLCDQXLCILCZ-BWAGICSOSA-N 0.000 description 1
- IHAPJUHCZXBPHR-WZLNRYEVSA-N Thr-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N IHAPJUHCZXBPHR-WZLNRYEVSA-N 0.000 description 1
- IMDMLDSVUSMAEJ-HJGDQZAQSA-N Thr-Leu-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IMDMLDSVUSMAEJ-HJGDQZAQSA-N 0.000 description 1
- KKPOGALELPLJTL-MEYUZBJRSA-N Thr-Lys-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 KKPOGALELPLJTL-MEYUZBJRSA-N 0.000 description 1
- DXPURPNJDFCKKO-RHYQMDGZSA-N Thr-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O DXPURPNJDFCKKO-RHYQMDGZSA-N 0.000 description 1
- YJVJPJPHHFOVMG-VEVYYDQMSA-N Thr-Met-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N)O YJVJPJPHHFOVMG-VEVYYDQMSA-N 0.000 description 1
- GUHLYMZJVXUIPO-RCWTZXSCSA-N Thr-Met-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O GUHLYMZJVXUIPO-RCWTZXSCSA-N 0.000 description 1
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 1
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 1
- IVDFVBVIVLJJHR-LKXGYXEUSA-N Thr-Ser-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IVDFVBVIVLJJHR-LKXGYXEUSA-N 0.000 description 1
- AHERARIZBPOMNU-KATARQTJSA-N Thr-Ser-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O AHERARIZBPOMNU-KATARQTJSA-N 0.000 description 1
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
- NDZYTIMDOZMECO-SHGPDSBTSA-N Thr-Thr-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O NDZYTIMDOZMECO-SHGPDSBTSA-N 0.000 description 1
- JAWUQFCGNVEDRN-MEYUZBJRSA-N Thr-Tyr-Leu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N)O JAWUQFCGNVEDRN-MEYUZBJRSA-N 0.000 description 1
- CYCGARJWIQWPQM-YJRXYDGGSA-N Thr-Tyr-Ser Chemical compound C[C@@H](O)[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CO)C([O-])=O)CC1=CC=C(O)C=C1 CYCGARJWIQWPQM-YJRXYDGGSA-N 0.000 description 1
- AKHDFZHUPGVFEJ-YEPSODPASA-N Thr-Val-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AKHDFZHUPGVFEJ-YEPSODPASA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GQHAIUPYZPTADF-FDARSICLSA-N Trp-Ile-Arg Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)=CNC2=C1 GQHAIUPYZPTADF-FDARSICLSA-N 0.000 description 1
- KIMOCKLJBXHFIN-YLVFBTJISA-N Trp-Ile-Gly Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O)=CNC2=C1 KIMOCKLJBXHFIN-YLVFBTJISA-N 0.000 description 1
- RCMHSGRBJCMFLR-BPUTZDHNSA-N Trp-Met-Asn Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(O)=O)=CNC2=C1 RCMHSGRBJCMFLR-BPUTZDHNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- BURPTJBFWIOHEY-UWJYBYFXSA-N Tyr-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BURPTJBFWIOHEY-UWJYBYFXSA-N 0.000 description 1
- NOXKHHXSHQFSGJ-FQPOAREZSA-N Tyr-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NOXKHHXSHQFSGJ-FQPOAREZSA-N 0.000 description 1
- SCCKSNREWHMKOJ-SRVKXCTJSA-N Tyr-Asn-Ser Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O SCCKSNREWHMKOJ-SRVKXCTJSA-N 0.000 description 1
- NSTPFWRAIDTNGH-BZSNNMDCSA-N Tyr-Asn-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O NSTPFWRAIDTNGH-BZSNNMDCSA-N 0.000 description 1
- SMLCYZYQFRTLCO-UWJYBYFXSA-N Tyr-Cys-Ala Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O SMLCYZYQFRTLCO-UWJYBYFXSA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- JHORGUYURUBVOM-KKUMJFAQSA-N Tyr-His-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O JHORGUYURUBVOM-KKUMJFAQSA-N 0.000 description 1
- QARCDOCCDOLJSF-HJPIBITLSA-N Tyr-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QARCDOCCDOLJSF-HJPIBITLSA-N 0.000 description 1
- NKUGCYDFQKFVOJ-JYJNAYRXSA-N Tyr-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NKUGCYDFQKFVOJ-JYJNAYRXSA-N 0.000 description 1
- SZEIFUXUTBBQFQ-STQMWFEESA-N Tyr-Pro-Gly Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SZEIFUXUTBBQFQ-STQMWFEESA-N 0.000 description 1
- KWKJGBHDYJOVCR-SRVKXCTJSA-N Tyr-Ser-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N)O KWKJGBHDYJOVCR-SRVKXCTJSA-N 0.000 description 1
- MDXLPNRXCFOBTL-BZSNNMDCSA-N Tyr-Ser-Tyr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O MDXLPNRXCFOBTL-BZSNNMDCSA-N 0.000 description 1
- XUIOBCQESNDTDE-FQPOAREZSA-N Tyr-Thr-Ala Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](C)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N)O XUIOBCQESNDTDE-FQPOAREZSA-N 0.000 description 1
- LDKDSFQSEUOCOO-RPTUDFQQSA-N Tyr-Thr-Phe Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LDKDSFQSEUOCOO-RPTUDFQQSA-N 0.000 description 1
- QRCBQDPRKMYTMB-IHPCNDPISA-N Tyr-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N QRCBQDPRKMYTMB-IHPCNDPISA-N 0.000 description 1
- MWUYSCVVPVITMW-IGNZVWTISA-N Tyr-Tyr-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=C(O)C=C1 MWUYSCVVPVITMW-IGNZVWTISA-N 0.000 description 1
- ANHVRCNNGJMJNG-BZSNNMDCSA-N Tyr-Tyr-Cys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N[C@@H](CS)C(=O)O)N)O ANHVRCNNGJMJNG-BZSNNMDCSA-N 0.000 description 1
- CVUDMNSZAIZFAE-UHFFFAOYSA-N Val-Arg-Pro Natural products NC(N)=NCCCC(NC(=O)C(N)C(C)C)C(=O)N1CCCC1C(O)=O CVUDMNSZAIZFAE-UHFFFAOYSA-N 0.000 description 1
- VMRFIKXKOFNMHW-GUBZILKMSA-N Val-Arg-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N VMRFIKXKOFNMHW-GUBZILKMSA-N 0.000 description 1
- YODDULVCGFQRFZ-ZKWXMUAHSA-N Val-Asp-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O YODDULVCGFQRFZ-ZKWXMUAHSA-N 0.000 description 1
- OVLIFGQSBSNGHY-KKHAAJSZSA-N Val-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N)O OVLIFGQSBSNGHY-KKHAAJSZSA-N 0.000 description 1
- HQYVQDRYODWONX-DCAQKATOSA-N Val-His-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CO)C(=O)O)N HQYVQDRYODWONX-DCAQKATOSA-N 0.000 description 1
- WNZSAUMKZQXHNC-UKJIMTQDSA-N Val-Ile-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N WNZSAUMKZQXHNC-UKJIMTQDSA-N 0.000 description 1
- KNYHAWKHFQRYOX-PYJNHQTQSA-N Val-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N KNYHAWKHFQRYOX-PYJNHQTQSA-N 0.000 description 1
- JZWZACGUZVCQPS-RNJOBUHISA-N Val-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N JZWZACGUZVCQPS-RNJOBUHISA-N 0.000 description 1
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 1
- APQIVBCUIUDSMB-OSUNSFLBSA-N Val-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](C(C)C)N APQIVBCUIUDSMB-OSUNSFLBSA-N 0.000 description 1
- DIOSYUIWOQCXNR-ONGXEEELSA-N Val-Lys-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O DIOSYUIWOQCXNR-ONGXEEELSA-N 0.000 description 1
- AIWLHFZYOUUJGB-UFYCRDLUSA-N Val-Phe-Tyr Chemical compound C([C@H](NC(=O)[C@@H](N)C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 AIWLHFZYOUUJGB-UFYCRDLUSA-N 0.000 description 1
- USLVEJAHTBLSIL-CYDGBPFRSA-N Val-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C USLVEJAHTBLSIL-CYDGBPFRSA-N 0.000 description 1
- PGQUDQYHWICSAB-NAKRPEOUSA-N Val-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N PGQUDQYHWICSAB-NAKRPEOUSA-N 0.000 description 1
- DLLRRUDLMSJTMB-GUBZILKMSA-N Val-Ser-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)O)N DLLRRUDLMSJTMB-GUBZILKMSA-N 0.000 description 1
- LCHZBEUVGAVMKS-RHYQMDGZSA-N Val-Thr-Leu Chemical compound CC(C)C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)[C@@H](C)O)C(O)=O LCHZBEUVGAVMKS-RHYQMDGZSA-N 0.000 description 1
- USXYVSTVPHELAF-RCWTZXSCSA-N Val-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](C(C)C)N)O USXYVSTVPHELAF-RCWTZXSCSA-N 0.000 description 1
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 1
- DVLWZWNAQUBZBC-ZNSHCXBVSA-N Val-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C(C)C)N)O DVLWZWNAQUBZBC-ZNSHCXBVSA-N 0.000 description 1
- YLBNZCJFSVJDRJ-KJEVXHAQSA-N Val-Thr-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](Cc1ccc(O)cc1)C(O)=O YLBNZCJFSVJDRJ-KJEVXHAQSA-N 0.000 description 1
- JSOXWWFKRJKTMT-WOPDTQHZSA-N Val-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N JSOXWWFKRJKTMT-WOPDTQHZSA-N 0.000 description 1
- OIRDTQYFTABQOQ-UHTZMRCNSA-N Vidarabine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1O OIRDTQYFTABQOQ-UHTZMRCNSA-N 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000556 agonist Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 238000012867 alanine scanning Methods 0.000 description 1
- 108010044940 alanylglutamine Proteins 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 230000001668 ameliorated effect Effects 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 239000003708 ampul Substances 0.000 description 1
- 239000012491 analyte Substances 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 230000009830 antibody antigen interaction Effects 0.000 description 1
- 239000000611 antibody drug conjugate Substances 0.000 description 1
- 230000005875 antibody response Effects 0.000 description 1
- 229940049595 antibody-drug conjugate Drugs 0.000 description 1
- 230000007503 antigenic stimulation Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 108010062796 arginyllysine Proteins 0.000 description 1
- 108010060035 arginylproline Proteins 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 230000002238 attenuated effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 238000002306 biochemical method Methods 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 102220349284 c.287A>T Human genes 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000011260 co-administration Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000012875 competitive assay Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000009827 complement-dependent cellular cytotoxicity Effects 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000011340 continuous therapy Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012866 crystallographic experiment Methods 0.000 description 1
- 108010081447 cytochrophin-4 Proteins 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000026502 entry into host cell Effects 0.000 description 1
- 229940015979 epipen Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229960005102 foscarnet Drugs 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 108010026364 glycyl-glycyl-leucine Proteins 0.000 description 1
- 108010033719 glycyl-histidyl-glycine Proteins 0.000 description 1
- 108010079413 glycyl-prolyl-glutamic acid Proteins 0.000 description 1
- 108010008671 glycyl-tryptophyl-methionine Proteins 0.000 description 1
- 108010048994 glycyl-tyrosyl-alanine Proteins 0.000 description 1
- YMAWOPBAYDPSLA-UHFFFAOYSA-N glycylglycine Chemical compound [NH3+]CC(=O)NCC([O-])=O YMAWOPBAYDPSLA-UHFFFAOYSA-N 0.000 description 1
- 108010084389 glycyltryptophan Proteins 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 108010040030 histidinoalanine Proteins 0.000 description 1
- 229940062714 humalog mix Drugs 0.000 description 1
- 229960004716 idoxuridine Drugs 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000008073 immune recognition Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000005462 in vivo assay Methods 0.000 description 1
- CBVCZFGXHXORBI-PXQQMZJSSA-N indinavir Chemical compound C([C@H](N(CC1)C[C@@H](O)C[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H]2C3=CC=CC=C3C[C@H]2O)C(=O)NC(C)(C)C)N1CC1=CC=CN=C1 CBVCZFGXHXORBI-PXQQMZJSSA-N 0.000 description 1
- 229960001936 indinavir Drugs 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 108700010900 influenza virus proteins Proteins 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 238000012923 label-free technique Methods 0.000 description 1
- 229950004244 laninamivir Drugs 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 210000004962 mammalian cell Anatomy 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 210000004898 n-terminal fragment Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000013610 patient sample Substances 0.000 description 1
- 229940090048 pen injector Drugs 0.000 description 1
- 230000007030 peptide scission Effects 0.000 description 1
- XRQDFNLINLXZLB-CKIKVBCHSA-N peramivir Chemical compound CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(O)=O)C[C@H]1NC(N)=N XRQDFNLINLXZLB-CKIKVBCHSA-N 0.000 description 1
- 229960001084 peramivir Drugs 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010082795 phenylalanyl-arginyl-arginine Proteins 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000010837 receptor-mediated endocytosis Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 229960000311 ritonavir Drugs 0.000 description 1
- NCDNCNXCDXHOMX-XGKFQTDJSA-N ritonavir Chemical compound N([C@@H](C(C)C)C(=O)N[C@H](C[C@H](O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1SC=NC=1)CC=1C=CC=CC=1)C(=O)N(C)CC1=CSC(C(C)C)=N1 NCDNCNXCDXHOMX-XGKFQTDJSA-N 0.000 description 1
- 102220210869 rs1057524586 Human genes 0.000 description 1
- 102220220520 rs1060503090 Human genes 0.000 description 1
- 102220206698 rs142514490 Human genes 0.000 description 1
- 102220325921 rs1555376589 Human genes 0.000 description 1
- 102220142694 rs192332456 Human genes 0.000 description 1
- 102200164344 rs63751661 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229960001852 saquinavir Drugs 0.000 description 1
- QWAXKHKRTORLEM-UGJKXSETSA-N saquinavir Chemical compound C([C@@H]([C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)C=1N=C2C=CC=CC2=CC=1)C1=CC=CC=C1 QWAXKHKRTORLEM-UGJKXSETSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 230000037439 somatic mutation Effects 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 210000004988 splenocyte Anatomy 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- 108010072986 threonyl-seryl-lysine Proteins 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- 238000012250 transgenic expression Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 229960003962 trifluridine Drugs 0.000 description 1
- VSQQQLOSPVPRAZ-RRKCRQDMSA-N trifluridine Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C(F)(F)F)=C1 VSQQQLOSPVPRAZ-RRKCRQDMSA-N 0.000 description 1
- 238000005829 trimerization reaction Methods 0.000 description 1
- 108010080629 tryptophan-leucine Proteins 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 108010073969 valyllysine Proteins 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 229960003636 vidarabine Drugs 0.000 description 1
- 230000008478 viral entry into host cell Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- HBOMLICNUCNMMY-XLPZGREQSA-N zidovudine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 HBOMLICNUCNMMY-XLPZGREQSA-N 0.000 description 1
- 229960002555 zidovudine Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1018—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
도 2. 마우스에서 중증 인플루엔자를 치료하기 위해 감염 후 72시간에 H1H11729P의 1회 용량이 오셀타미비르와 조합될 때 추가적인 효험이 관찰됨을 도시한다. 마우스는 10 x MLD50의 A/Puerto Rico/08/1934 (H1N1)으로 비강 내 (IN) 감염 후 72시간에 5일 동안 7 (사각형, 점선) 또는 15 mg/kg의 H1H11729P (원, 점선), 대조군 IgG (삼각형), 25 mg/kg BID 오셀타미비르 (다이아몬드, 점선)의 1회 유효량 미만의 (sub-efficacious) 용량 또는 5일 동안 7 (사각형, 실선) 또는 15 mg/kg H1H11729P (원, 실선)의 1회 용량과 오셀타미비르 요법의 조합을 받았다. 세 번의 독립적인 시험 (군 당 N=15)의 결과가 도시된다.
도 3. H1H11729P로 지칭되는 항체에 대한 HCVR, HCDR1, HCDR2, HCDR3, LCVR, LCDR1, LCDR2 및 LCDR3 아미노산 서열을 도시한다.
도 4. H1H11829N2로 지칭되는 항체에 대한 HCVR, HCDR1, HCDR2, HCDR3, LCVR, LCDR1, LCDR2 및 LCDR3 아미노산 서열을 도시한다.
| 서열 번호: | ||||||||
| 항체 명칭 | HCVR | HCDR1 | HCDR2 | HCDR3 | LCVR | LCDR1 | LCDR2 | LCDR3 |
| H1H11723P | 2 | 4 | 6 | 8 | 10 | 12 | 14 | 16 |
| H1H11729P | 18 | 20 | 22 | 24 | 26 | 28 | 30 | 32 |
| H1H11820N | 34 | 36 | 38 | 40 | 42 | 44 | 46 | 48 |
| H1H11829N | 50 | 52 | 54 | 56 | 58 | 60 | 62 | 64 |
| H1H11829N2 | 50 | 52 | 54 | 56 | 66 | 68 | 70 | 72 |
| H2aM11829N | 50 | 52 | 54 | 56 | 58 | 60 | 62 | 64 |
| H2M11830N | 74 | 76 | 78 | 80 | 82 | 84 | 86 | 88 |
| H1H11830N2 | 74 | 76 | 78 | 80 | 66 | 68 | 70 | 72 |
| H1H11903N | 90 | 92 | 94 | 96 | 98 | 100 | 102 | 104 |
| H1H14571N | 106 | 108 | 110 | 112 | 114 | 116 | 118 | 120 |
| H2a14571N | 106 | 108 | 110 | 112 | 114 | 116 | 118 | 120 |
| H1H11704P | 122 | 124 | 126 | 128 | 130 | 132 | 134 | 136 |
| H1H11711P | 138 | 140 | 142 | 144 | 146 | 148 | 150 | 152 |
| H1H11714P | 154 | 156 | 158 | 160 | 162 | 164 | 166 | 168 |
| H1H11717P | 170 | 172 | 174 | 176 | 178 | 180 | 182 | 184 |
| H1H11724P | 186 | 188 | 190 | 192 | 194 | 196 | 198 | 200 |
| H1H11727P | 202 | 204 | 206 | 208 | 210 | 212 | 214 | 216 |
| H1H11730P2 | 218 | 220 | 222 | 224 | 226 | 228 | 230 | 232 |
| H1H11731P2 | 234 | 236 | 238 | 240 | 66 | 68 | 70 | 72 |
| H1H11734P2 | 242 | 244 | 246 | 248 | 66 | 68 | 70 | 72 |
| H1H11736P2 | 250 | 252 | 254 | 256 | 66 | 68 | 70 | 72 |
| H1H11742P2 | 258 | 260 | 262 | 264 | 66 | 68 | 70 | 72 |
| H1H11744P2 | 266 | 268 | 270 | 272 | 66 | 68 | 70 | 72 |
| H1H11745P2 | 274 | 276 | 278 | 280 | 66 | 68 | 70 | 72 |
| H1H11747P2 | 282 | 284 | 286 | 288 | 66 | 68 | 70 | 72 |
| H1H11748P2 | 290 | 292 | 294 | 296 | 66 | 68 | 70 | 72 |
| 서열 번호: | ||||||||
| 항체 명칭 | HCVR | HCDR1 | HCDR2 | HCDR3 | LCVR | LCDR1 | LCDR2 | LCDR3 |
| H1H11723P | 1 | 3 | 5 | 7 | 9 | 11 | 13 | 15 |
| H1H11729P | 17 | 19 | 21 | 23 | 25 | 27 | 29 | 31 |
| H1H11820N | 33 | 35 | 37 | 39 | 41 | 43 | 45 | 47 |
| H1H11829N | 49 | 51 | 53 | 55 | 57 | 59 | 61 | 63 |
| H1H11829N2 | 49 | 51 | 53 | 55 | 65 | 67 | 69 | 71 |
| H2aM11829N | 49 | 51 | 53 | 55 | 57 | 59 | 61 | 63 |
| H2M11830N | 73 | 75 | 77 | 79 | 81 | 83 | 85 | 87 |
| H1H11830N2 | 73 | 75 | 77 | 79 | 65 | 67 | 69 | 71 |
| H1H11903N | 89 | 91 | 93 | 95 | 97 | 99 | 101 | 103 |
| H1H14571N | 105 | 107 | 109 | 111 | 113 | 115 | 117 | 119 |
| H2a14571N | 105 | 107 | 109 | 111 | 113 | 115 | 117 | 119 |
| H1H11704P | 121 | 123 | 125 | 127 | 129 | 131 | 133 | 135 |
| H1H11711P | 137 | 139 | 141 | 143 | 145 | 147 | 149 | 151 |
| H1H11714P | 153 | 155 | 157 | 159 | 161 | 163 | 165 | 167 |
| H1H11717P | 169 | 171 | 173 | 175 | 177 | 179 | 181 | 183 |
| H1H11724P | 185 | 187 | 189 | 191 | 193 | 195 | 197 | 199 |
| H1H11727P | 201 | 203 | 205 | 207 | 209 | 211 | 213 | 215 |
| H1H11730P | 217 | 219 | 221 | 223 | 225 | 227 | 229 | 231 |
| H1H11731P2 | 233 | 235 | 237 | 239 | 65 | 67 | 69 | 71 |
| H1H11734P2 | 241 | 243 | 245 | 247 | 65 | 67 | 69 | 71 |
| H1H11736P2 | 249 | 251 | 253 | 255 | 65 | 67 | 69 | 71 |
| H1H11742P2 | 257 | 259 | 261 | 263 | 65 | 67 | 69 | 71 |
| H1H11744P2 | 265 | 267 | 269 | 271 | 65 | 67 | 69 | 71 |
| H1H11745P2 | 273 | 275 | 277 | 279 | 65 | 67 | 69 | 71 |
| H1H11747P2 | 281 | 283 | 285 | 287 | 65 | 67 | 69 | 71 |
| H1H11748P2 | 289 | 291 | 293 | 295 | 65 | 67 | 69 | 71 |
| 캡쳐된 mAb |
주사된 분석물 | 캡쳐된 mAb의 양 (nm) | 결합된 300nM HA (nm) | k a (1/Ms) |
k d (1/s) |
KD (M) |
t½ (분) |
| H2aM11829N | A/California/07/2009 (H1N1) | 0.53 ±0.01 | 0.62 | 1.20E+05 | 1.00E-05* | 8.35E-11 | 1155* |
| A/Puerto Rico/08/34 (H1N1) | 0.53 ±0.01 | 0.59 | 1.09E+05 | 1.16E-05 | 1.06E-10 | 999 | |
| A/Vietnam/1203/2004 (H5N1) | 0.52 ±0.01 | 0.50 | 3.81E+04 | 1.99E-05 | 5.23E-10 | 580 | |
| H1H11729P | A/California/07/2009 (H1N1) | 0.65 ±0.01 | 0.84 | 7.35E+04 | 1.00E-05* | 1.36E-10 | 1155* |
| A/Puerto Rico/08/34 (H1N1) | 0.67 ±0.01 | 0.72 | 8.26E+04 | 1.00E-05* | 1.21E-10 | 1155* | |
| A/Vietnam/1203/2004 (H5N1) | 0.66 ±0.01 | 0.62 | 1.99E+04 | 3.10E-05 | 1.56E-09 | 373 | |
| H2aM14571N | A/California/07/2009 (H1N1) | 0.51 ±0.01 | 0.58 | 1.05E+05 | 1.18E-05 | 1.12E-10 | 978 |
| A/Puerto Rico/08/34 (H1N1) | 0.5 ±0.02 |
0.46 | 6.80E+04 | 2.44E-05 | 3.59E-10 | 474 | |
| A/Vietnam/1203/2004 (H5N1) | 0.51 ±0.01 | 0.31 | 1.14E+04 | 1.00E-05* | 8.77E-10 | 1155* |
| AHC Octet 바이오센서를 사용하여 캡쳐된 제1 mAb (mAb-1) | mAb-1과 경쟁하는 것으로 나타난 mAb-2 항체 |
| H2aM11829N | H2aM14571N |
| H1H11729P | |
| H2aM14571N | H2aM11829N |
| H1H11729P | |
| H1H11729P | H2aM11829N |
| H2aM14571N |
| PID | IC50 (nM) | ||||||
| H1_ PR34 |
H1_ WS33 |
H1_ IVR148 |
H1_ CA09 |
H9_ RG26 |
H13_ MD77 |
H16_ DE09 |
|
| H2aM11829N | 3.29 | 1.68 | 48.0 | 3.50 | 10.2 | 2.11 | 7.39 |
| H1H11729P | 2.82 | 2.47 | 129.5 | 4.54 | 14.9 | 33.8 | 21.6 |
| 항체 번호 | IC90(nM) | IC90(nM) | ||
| H5N1 A/Vietnam/1203/2004 | H1N1 A/California/07/2009 | |||
| 시험 1 | 시험 2 | 시험 1 | ||
| H1H11829N2 | 83.3 | 41.7 | 41.7 | |
| H1H11729P | 41.7 | 10.4 | 83.3 | |
| AbPID | EC50(nM) | ||
| 시험 1 | 시험 2 | 시험 3 | |
| H1H11829N2 | 65.94 | 38.75 | 20.94 |
| H1H11729P | 50.83 | 38.49 | 40.44 |
| hIgG1 무관한 mAb | > 333 | > 333 | > 333 |
| PID | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) |
| 식염수 (미감염) | 5 | 100 (5/5) |
| H2aM11829N | 5 | 100 (5/5) |
| H1H11729P | 5 | 100 (5/5) |
| H2a14571N | ND | ND |
| hIgG1 아이소타입 대조군 | 5 | 0 (0/5) |
| mIgG2a 아이소타입 대조군 | 5 | 0 (0/5) |
| PID | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) |
| 식염수 (미감염) | 5 | 100 (5/5) |
| H2aM11829N | 5 | 100 (5/5) |
| H1H11729P | 5 | 100 (5/5) |
| H2a14571N | 5 | 100 (5/5) |
| 공격 바이러스: H1N1 A/Puerto Rico/08/1934 |
공격 바이러스: H1N1 A/California/04/2009 |
|||||
| PID | mAb의 용량 (mg/kg) | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) | mAb의 용량 (mg/kg) | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) |
| 담체 단백질이 들어있는 식염수 (미감염) | N/A | 5 | 100 (5/5) | N/A | 5 | 100 (5/5) |
| H1H11829N2 | 1 | 5 | 100 (5/5) | 2 | 5 | 100 (5/5) |
| 0.5 | 60 (3/5) | 0.5 | 100 (5/5) | |||
| 0.1 | 0 (0/5) | 0.2 | 100 (5/5) | |||
| 0.05 | 20 (1/5) | 0.05 | ND | |||
| H1H11729P | 1 | 5 | 100 (5/5) | 2 | 5 | 100 (5/5) |
| 0.5 | 100 (5/5) | 0.5 | 100 (5/5) | |||
| 0.1 | 40 (2/5) | 0.2 | 100 (5/5) | |||
| 0.05 | 0 (0/5) | 0.05 | 60 (3/5) | |||
| 공격 바이러스: H1N1 A/Puerto Rico/08/1934 (15 mg/kg mAb) |
공격 바이러스: H1N1 A/California/04/2009 (30 mg/kg mAb) |
|||||
| PID | 감염 후 일 | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) | 감염 후 일 | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) |
| H1H11829N2 | 3 | 5 | 40 (2/5) | 1 | 5 | 100 (5/5) |
| 4 | ND | 2 | 0 (0/5) | |||
| 5 | ND | 3 | 20 (1/5) | |||
| H1H11729P | 3 | 5 | 60 (3/5) | 1 | 5 | 100 (5/5) |
| 4 | 0 (0/5) | 2 | 0 (0/5) | |||
| 5 | 0 (0/5) | 3 | 20 (1/5) | |||
| 아미노산 서열 번호 | ||||||||
| 항체 명칭 | HCVR | HCDR1 | HCDR2 | HCDR3 | LCVR | LCDR1 | LCDR2 | LCDR3 |
| H1H17952B | 298 | 300 | 302 | 304 | 306 | 308 | 310 | 312 |
| H1H17953B | 314 | 316 | 318 | 320 | 322 | 324 | 326 | 328 |
| H1H17954B | 330 | 332 | 334 | 336 | 338 | 340 | 342 | 344 |
| H1H17955B | 346 | 348 | 350 | 352 | 354 | 356 | 358 | 360 |
| H1H17956B | 362 | 364 | 366 | 368 | 370 | 372 | 374 | 376 |
| H1H17957B | 378 | 380 | 382 | 384 | 386 | 388 | 390 | 392 |
| H1H17958B | 394 | 396 | 398 | 400 | 402 | 404 | 406 | 408 |
| H1H17959B | 410 | 412 | 414 | 416 | 418 | 420 | 422 | 424 |
| H1H17960B | 426 | 428 | 430 | 432 | 434 | 436 | 438 | 440 |
| H1H17961B | 442 | 444 | 446 | 448 | 450 | 452 | 454 | 456 |
| H1H17962B | 458 | 460 | 462 | 464 | 466 | 468 | 470 | 472 |
| H1H17963B | 474 | 476 | 478 | 480 | 482 | 484 | 486 | 488 |
| H1H17964B | 490 | 492 | 494 | 496 | 498 | 500 | 502 | 504 |
| H1H17965B | 506 | 508 | 510 | 512 | 514 | 516 | 518 | 520 |
| H1H17966B | 522 | 524 | 526 | 528 | 530 | 532 | 534 | 536 |
| H1H17967B | 538 | 540 | 542 | 544 | 546 | 548 | 550 | 552 |
| H1H17968B | 554 | 556 | 558 | 560 | 562 | 564 | 566 | 568 |
| H1H17969B | 570 | 572 | 574 | 576 | 578 | 580 | 582 | 584 |
| H1H17970B | 586 | 588 | 590 | 592 | 594 | 596 | 598 | 600 |
| H1H17971B | 602 | 604 | 606 | 608 | 610 | 612 | 614 | 616 |
| H1H17972B | 618 | 620 | 622 | 624 | 626 | 628 | 630 | 632 |
| H1H17973B | 634 | 636 | 638 | 640 | 642 | 644 | 646 | 648 |
| H1H17974B | 650 | 652 | 654 | 656 | 658 | 660 | 662 | 664 |
| H1H17975B | 666 | 668 | 670 | 672 | 674 | 676 | 678 | 680 |
| H1H17976B | 682 | 684 | 686 | 688 | 690 | 692 | 694 | 696 |
| H1H17977B | 698 | 700 | 702 | 704 | 706 | 708 | 710 | 712 |
| H1H17978B | 714 | 716 | 718 | 720 | 722 | 724 | 726 | 728 |
| H1H17979B | 730 | 732 | 734 | 736 | 738 | 740 | 742 | 744 |
| H1H17980B | 746 | 748 | 750 | 752 | 754 | 756 | 758 | 760 |
| H1H17981B | 762 | 764 | 766 | 768 | 770 | 772 | 774 | 776 |
| H1H17982B | 778 | 780 | 782 | 784 | 786 | 788 | 790 | 792 |
| H1H17983B | 794 | 796 | 798 | 800 | 802 | 804 | 806 | 808 |
| H1H17984B | 810 | 812 | 814 | 816 | 818 | 820 | 822 | 824 |
| H1H17985B | 826 | 828 | 830 | 832 | 834 | 836 | 838 | 840 |
| H1H17986B | 842 | 844 | 846 | 848 | 850 | 852 | 854 | 856 |
| H1H17987B | 858 | 860 | 862 | 864 | 866 | 868 | 870 | 872 |
| H1H17988B | 874 | 876 | 878 | 880 | 882 | 884 | 886 | 888 |
| H1H17989B | 890 | 892 | 894 | 896 | 898 | 900 | 902 | 904 |
| H1H17990B | 906 | 908 | 910 | 912 | 914 | 916 | 918 | 920 |
| H1H17991B | 922 | 924 | 926 | 928 | 930 | 932 | 934 | 936 |
| H1H17992B | 938 | 940 | 942 | 944 | 946 | 948 | 950 | 952 |
| H1H17993B | 954 | 956 | 958 | 960 | 962 | 964 | 966 | 968 |
| H1H17994B | 970 | 972 | 974 | 976 | 978 | 980 | 982 | 984 |
| H1H17995B | 986 | 988 | 990 | 992 | 994 | 996 | 998 | 1000 |
| H1H17996B | 1002 | 1004 | 1006 | 1008 | 1010 | 1012 | 1014 | 1016 |
| H1H17997B | 1018 | 1020 | 1022 | 1024 | 1026 | 1028 | 1030 | 1032 |
| H1H17998B | 1034 | 1036 | 1038 | 1040 | 1042 | 1044 | 1046 | 1048 |
| H1H17999B | 1050 | 1052 | 1054 | 1056 | 1058 | 1060 | 1062 | 1064 |
| H1H18000B | 1066 | 1068 | 1070 | 1072 | 1074 | 1076 | 1078 | 1080 |
| H1H18001B | 1082 | 1084 | 1086 | 1088 | 1090 | 1092 | 1094 | 1096 |
| H1H18002B | 1098 | 1100 | 1102 | 1104 | 1106 | 1108 | 1110 | 1112 |
| H1H18003B | 1114 | 1116 | 1118 | 1120 | 1122 | 1124 | 1126 | 1128 |
| H1H18004B | 1130 | 1132 | 1134 | 1136 | 1138 | 1140 | 1142 | 1144 |
| H1H18005B | 1146 | 1148 | 1150 | 1152 | 1154 | 1156 | 1158 | 1160 |
| H1H18006B | 1162 | 1164 | 1166 | 1168 | 1170 | 1172 | 1174 | 1176 |
| H1H18007B | 1178 | 1180 | 1182 | 1184 | 1186 | 1188 | 1190 | 1192 |
| H1H18008B | 1194 | 1196 | 1198 | 1200 | 1202 | 1204 | 1206 | 1208 |
| H1H18009B | 1210 | 1212 | 1214 | 1216 | 1218 | 1220 | 1222 | 1224 |
| H1H18010B | 1226 | 1228 | 1230 | 1232 | 1234 | 1236 | 1238 | 1240 |
| H1H18011B | 1242 | 1244 | 1246 | 1248 | 1250 | 1252 | 1254 | 1256 |
| H1H18012B | 1258 | 1260 | 1262 | 1264 | 1266 | 1268 | 1270 | 1272 |
| H1H18013B | 1274 | 1276 | 1278 | 1280 | 1282 | 1284 | 1286 | 1288 |
| H1H18014B | 1290 | 1292 | 1294 | 1296 | 1298 | 1300 | 1302 | 1304 |
| H1H18015B | 1306 | 1308 | 1310 | 1312 | 1314 | 1316 | 1318 | 1320 |
| H1H18016B | 1322 | 1324 | 1326 | 1328 | 1330 | 1332 | 1334 | 1336 |
| H1H18017B | 1338 | 1340 | 1342 | 1344 | 1346 | 1348 | 1350 | 1352 |
| H1H18018B | 1354 | 1356 | 1358 | 1360 | 1362 | 1364 | 1366 | 1368 |
| H1H18019B | 1370 | 1372 | 1374 | 1376 | 1378 | 1380 | 1382 | 1384 |
| H1H18020B | 1386 | 1388 | 1390 | 1392 | 1394 | 1396 | 1398 | 1400 |
| H1H18021B | 1402 | 1404 | 1406 | 1408 | 1410 | 1412 | 1414 | 1416 |
| H1H18022B | 1418 | 1420 | 1422 | 1424 | 1426 | 1428 | 1430 | 1432 |
| H1H18023B | 1434 | 1436 | 1438 | 1440 | 1442 | 1444 | 1446 | 1448 |
| H1H18024B | 1450 | 1452 | 1454 | 1456 | 1458 | 1460 | 1462 | 1464 |
| H1H18025B | 1466 | 1468 | 1470 | 1472 | 1474 | 1476 | 1478 | 1480 |
| H1H18026B | 1482 | 1484 | 1486 | 1488 | 1490 | 1492 | 1494 | 1496 |
| H1H18027B | 1498 | 1500 | 1502 | 1504 | 1506 | 1508 | 1510 | 1512 |
| H1H18028B | 1514 | 1516 | 1518 | 1520 | 1522 | 1524 | 1526 | 1528 |
| H1H18029B | 1530 | 1532 | 1534 | 1536 | 1538 | 1540 | 1542 | 1544 |
| H1H18030B | 1546 | 1548 | 1550 | 1552 | 1554 | 1556 | 1558 | 1560 |
| H1H18031B | 1562 | 1564 | 1566 | 1568 | 1570 | 1572 | 1574 | 1576 |
| H1H18032B | 1578 | 1580 | 1582 | 1584 | 1586 | 1588 | 1590 | 1592 |
| H1H18033B | 1594 | 1596 | 1598 | 1600 | 1602 | 1604 | 1606 | 1608 |
| H1H18034B | 1610 | 1612 | 1614 | 1616 | 1618 | 1620 | 1622 | 1624 |
| H1H18035B | 1626 | 1628 | 1630 | 1632 | 1634 | 1636 | 1638 | 1640 |
| H1H18037B | 1642 | 1644 | 1646 | 1648 | 1650 | 1652 | 1654 | 1656 |
| H1H18038B | 1658 | 1660 | 1662 | 1664 | 1666 | 1668 | 1670 | 1672 |
| H1H18039B | 1674 | 1676 | 1678 | 1680 | 1682 | 1684 | 1686 | 1688 |
| H1H18040B | 1690 | 1692 | 1694 | 1696 | 1698 | 1700 | 1702 | 1704 |
| H1H18041B | 1706 | 1708 | 1710 | 1712 | 1714 | 1716 | 1718 | 1720 |
| H1H18042B | 1722 | 1724 | 1726 | 1728 | 1730 | 1732 | 1734 | 1736 |
| H1H18043B | 1738 | 1740 | 1742 | 1744 | 1746 | 1748 | 1750 | 1752 |
| H1H18044B | 1754 | 1756 | 1758 | 1760 | 1762 | 1764 | 1766 | 1768 |
| H1H18045B | 1770 | 1772 | 1774 | 1776 | 1778 | 1780 | 1782 | 1784 |
| H1H18046B | 1786 | 1788 | 1790 | 1792 | 1794 | 1796 | 1798 | 1800 |
| H1H18047B | 1802 | 1804 | 1806 | 1808 | 1810 | 1812 | 1814 | 1816 |
| H1H18048B | 1818 | 1820 | 1822 | 1824 | 1826 | 1828 | 1830 | 1832 |
| H1H18049B | 1834 | 1836 | 1838 | 1840 | 1842 | 1844 | 1846 | 1848 |
| H1H18051B | 1850 | 1852 | 1854 | 1856 | 1858 | 1860 | 1862 | 1864 |
| H1H18052B | 1866 | 1868 | 1870 | 1872 | 1874 | 1876 | 1878 | 1880 |
| H1H18053B | 1882 | 1884 | 1886 | 1888 | 1890 | 1892 | 1894 | 1896 |
| H1H18054B | 1898 | 1900 | 1902 | 1904 | 1906 | 1908 | 1910 | 1912 |
| H1H18055B | 1914 | 1916 | 1918 | 1920 | 1922 | 1924 | 1926 | 1928 |
| H1H18056B | 1930 | 1932 | 1934 | 1936 | 1938 | 1940 | 1942 | 1944 |
| H1H18057B | 1946 | 1948 | 1950 | 1952 | 1954 | 1956 | 1958 | 1960 |
| H1H18058B | 1962 | 1964 | 1966 | 1968 | 1970 | 1972 | 1974 | 1976 |
| H1H18059B | 1978 | 1980 | 1982 | 1984 | 1986 | 1988 | 1990 | 1992 |
| H1H18060B | 1994 | 1996 | 1998 | 2000 | 2002 | 2004 | 2006 | 2008 |
| H1H18061B | 2010 | 2012 | 2014 | 2016 | 2018 | 2020 | 2022 | 2024 |
| H1H18062B | 2026 | 2028 | 2030 | 2032 | 2034 | 2036 | 2038 | 2040 |
| H1H18063B | 2042 | 2044 | 2046 | 2048 | 2050 | 2052 | 2054 | 2056 |
| H1H18064B | 2058 | 2060 | 2062 | 2064 | 2066 | 2068 | 2070 | 2072 |
| H1H18065B | 2074 | 2076 | 2078 | 2080 | 2082 | 2084 | 2086 | 2088 |
| H1H18066B | 2090 | 2092 | 2094 | 2096 | 2098 | 2100 | 2102 | 2104 |
| H1H18067B | 2106 | 2108 | 2110 | 2112 | 2114 | 2116 | 2118 | 2120 |
| H1H18068B | 2122 | 2124 | 2126 | 2128 | 2130 | 2132 | 2134 | 2136 |
| H1H18069B | 2138 | 2140 | 2142 | 2144 | 2146 | 2148 | 2150 | 2152 |
| H1H18070B | 2154 | 2156 | 2158 | 2160 | 2162 | 2164 | 2166 | 2168 |
| H1H18071B | 2170 | 2172 | 2174 | 2176 | 2178 | 2180 | 2182 | 2184 |
| H1H18072B | 2186 | 2188 | 2190 | 2192 | 2194 | 2196 | 2198 | 2200 |
| H1H18073B | 2202 | 2204 | 2206 | 2208 | 2210 | 2212 | 2214 | 2216 |
| H1H18074B | 2218 | 2220 | 2222 | 2224 | 2226 | 2228 | 2230 | 2232 |
| H1H18075B | 2234 | 2236 | 2238 | 2240 | 2242 | 2244 | 2246 | 2248 |
| H1H18076B | 2250 | 2252 | 2254 | 2256 | 2258 | 2260 | 2262 | 2264 |
| H1H18077B | 2266 | 2268 | 2270 | 2272 | 2274 | 2276 | 2278 | 2280 |
| H1H18078B | 2282 | 2284 | 2286 | 2288 | 2290 | 2292 | 2294 | 2296 |
| H1H18079B | 2298 | 2300 | 2302 | 2304 | 2306 | 2308 | 2310 | 2312 |
| H1H18080B | 2314 | 2316 | 2318 | 2320 | 2322 | 2324 | 2326 | 2328 |
| H1H18081B | 2330 | 2332 | 2334 | 2336 | 2338 | 2340 | 2342 | 2344 |
| H1H18082B | 2346 | 2348 | 2350 | 2352 | 2354 | 2356 | 2358 | 2360 |
| H1H18083B | 2362 | 2364 | 2366 | 2368 | 2370 | 2372 | 2374 | 2376 |
| H1H18084B | 2378 | 2380 | 2382 | 2384 | 2386 | 2388 | 2390 | 2392 |
| H1H18085B | 2394 | 2396 | 2398 | 2400 | 2402 | 2404 | 2406 | 2408 |
| H1H18086B | 2410 | 2412 | 2414 | 2416 | 2418 | 2420 | 2422 | 2424 |
| H1H18087B | 2426 | 2428 | 2430 | 2432 | 2434 | 2436 | 2438 | 2440 |
| H1H18088B | 2442 | 2444 | 2446 | 2448 | 2450 | 2452 | 2454 | 2456 |
| H1H18089B | 2458 | 2460 | 2462 | 2464 | 2466 | 2468 | 2470 | 2472 |
| H1H18090B | 2474 | 2476 | 2478 | 2480 | 2482 | 2484 | 2486 | 2488 |
| H1H18091B | 2490 | 2492 | 2494 | 2496 | 2498 | 2500 | 2502 | 2504 |
| H1H18092B | 2506 | 2508 | 2510 | 2512 | 2514 | 2516 | 2518 | 2520 |
| H1H18093B | 2522 | 2524 | 2526 | 2528 | 2530 | 2532 | 2534 | 2536 |
| H1H18094B | 2538 | 2540 | 2542 | 2544 | 2546 | 2548 | 2550 | 2552 |
| H1H18095B | 2554 | 2556 | 2558 | 2560 | 2562 | 2564 | 2566 | 2568 |
| H1H18096B | 2570 | 2572 | 2574 | 2576 | 2578 | 2580 | 2582 | 2584 |
| H1H18097B | 2586 | 2588 | 2590 | 2592 | 2594 | 2596 | 2598 | 2600 |
| H1H18098B | 2602 | 2604 | 2606 | 2608 | 2610 | 2612 | 2614 | 2616 |
| H1H18099B | 2618 | 2620 | 2622 | 2624 | 2626 | 2628 | 2630 | 2632 |
| H1H18100B | 2634 | 2636 | 2638 | 2640 | 2642 | 2644 | 2646 | 2648 |
| H1H18101B | 2650 | 2652 | 2654 | 2656 | 2658 | 2660 | 2662 | 2664 |
| H1H18102B | 2666 | 2668 | 2670 | 2672 | 2674 | 2676 | 2678 | 2680 |
| H1H18103B | 2682 | 2684 | 2686 | 2688 | 2690 | 2692 | 2694 | 2696 |
| H1H18104B | 2698 | 2700 | 2702 | 2704 | 2706 | 2708 | 2710 | 2712 |
| H1H18105B | 2714 | 2716 | 2718 | 2720 | 2722 | 2724 | 2726 | 2728 |
| H1H18107B | 2730 | 2732 | 2734 | 2736 | 2738 | 2740 | 2742 | 2744 |
| H1H18108B | 2746 | 2748 | 2750 | 2752 | 2754 | 2756 | 2758 | 2760 |
| H1H18109B | 2762 | 2764 | 2766 | 2768 | 2770 | 2772 | 2774 | 2776 |
| H1H18110B | 2778 | 2780 | 2782 | 2784 | 2786 | 2788 | 2790 | 2792 |
| H1H18111B | 2794 | 2796 | 2798 | 2800 | 2802 | 2804 | 2806 | 2808 |
| H1H18112B | 2810 | 2812 | 2814 | 2816 | 2818 | 2820 | 2822 | 2824 |
| H1H18113B | 2826 | 2828 | 2830 | 2832 | 2834 | 2836 | 2838 | 2840 |
| H1H18114B | 2842 | 2844 | 2846 | 2848 | 2850 | 2852 | 2854 | 2856 |
| H1H18115B | 2858 | 2860 | 2862 | 2864 | 2866 | 2868 | 2870 | 2872 |
| H1H18116B | 2874 | 2876 | 2878 | 2880 | 2882 | 2884 | 2886 | 2888 |
| H1H18117B | 2890 | 2892 | 2894 | 2896 | 2898 | 2900 | 2902 | 2904 |
| H1H18118B | 2906 | 2908 | 2910 | 2912 | 2914 | 2916 | 2918 | 2920 |
| H1H18119B | 2922 | 2924 | 2926 | 2928 | 2930 | 2932 | 2934 | 2936 |
| H1H18120B | 2938 | 2940 | 2942 | 2944 | 2946 | 2948 | 2950 | 2952 |
| H1H18121B | 2954 | 2956 | 2958 | 2960 | 2962 | 2964 | 2966 | 2968 |
| H1H18122B | 2970 | 2972 | 2974 | 2976 | 2978 | 2980 | 2982 | 2984 |
| H1H18123B | 2986 | 2988 | 2990 | 2992 | 2994 | 2996 | 2998 | 3000 |
| H1H18124B | 3002 | 3004 | 3006 | 3008 | 3010 | 3012 | 3014 | 3016 |
| H1H18125B | 3018 | 3020 | 3022 | 3024 | 3026 | 3028 | 3030 | 3032 |
| H1H18126B | 3034 | 3036 | 3038 | 3040 | 3042 | 3044 | 3046 | 3048 |
| H1H18127B | 3050 | 3052 | 3054 | 3056 | 3058 | 3060 | 3062 | 3064 |
| H1H18128B | 3066 | 3068 | 3070 | 3072 | 3074 | 3076 | 3078 | 3080 |
| H1H18129B | 3082 | 3084 | 3086 | 3088 | 3090 | 3092 | 3094 | 3096 |
| H1H18130B | 3098 | 3100 | 3102 | 3104 | 3106 | 3108 | 3110 | 3112 |
| H1H18131B | 3114 | 3116 | 3118 | 3120 | 3122 | 3124 | 3126 | 3128 |
| H1H18132B | 3130 | 3132 | 3134 | 3136 | 3138 | 3140 | 3142 | 3144 |
| H1H18133B | 3146 | 3148 | 3150 | 3152 | 3154 | 3156 | 3158 | 3160 |
| H1H18134B | 3162 | 3164 | 3166 | 3168 | 3170 | 3172 | 3174 | 3176 |
| H1H18135B | 3178 | 3180 | 3182 | 3184 | 3186 | 3188 | 3190 | 3192 |
| H1H18136B | 3194 | 3196 | 3198 | 3200 | 3202 | 3204 | 3206 | 3208 |
| H1H18137B | 3210 | 3212 | 3214 | 3216 | 3218 | 3220 | 3222 | 3224 |
| H1H18138B | 3226 | 3228 | 3230 | 3232 | 3234 | 3236 | 3238 | 3240 |
| H1H18139B | 3242 | 3244 | 3246 | 3248 | 3250 | 3252 | 3254 | 3256 |
| H1H18140B | 3258 | 3260 | 3262 | 3264 | 3266 | 3268 | 3270 | 3272 |
| H1H18141B | 3274 | 3276 | 3278 | 3280 | 3282 | 3284 | 3286 | 3288 |
| H1H18142B | 3290 | 3292 | 3294 | 3296 | 3298 | 3300 | 3302 | 3304 |
| H1H18143B | 3306 | 3308 | 3310 | 3312 | 3314 | 3316 | 3318 | 3320 |
| H1H18144B | 3322 | 3324 | 3326 | 3328 | 3330 | 3332 | 3334 | 3336 |
| H1H18145B | 3338 | 3340 | 3342 | 3344 | 3346 | 3348 | 3350 | 3352 |
| H1H18146B | 3354 | 3356 | 3358 | 3360 | 3362 | 3364 | 3366 | 3368 |
| H1H18147B | 3370 | 3372 | 3374 | 3376 | 3378 | 3380 | 3382 | 3384 |
| H1H18148B | 3386 | 3388 | 3390 | 3392 | 3394 | 3396 | 3398 | 3400 |
| H1H18149B | 3402 | 3404 | 3406 | 3408 | 3410 | 3412 | 3414 | 3416 |
| H1H18150B | 3418 | 3420 | 3422 | 3424 | 3426 | 3428 | 3430 | 3432 |
| H1H18151B | 3434 | 3436 | 3438 | 3440 | 3442 | 3444 | 3446 | 3448 |
| H1H18152B | 3450 | 3452 | 3454 | 3456 | 3458 | 3460 | 3462 | 3464 |
| H1H18153B | 3466 | 3468 | 3470 | 3472 | 3474 | 3476 | 3478 | 3480 |
| H1H18154B | 3482 | 3484 | 3486 | 3488 | 3490 | 3492 | 3494 | 3496 |
| H1H18155B | 3498 | 3500 | 3502 | 3504 | 3506 | 3508 | 3510 | 3512 |
| H1H18156B | 3514 | 3516 | 3518 | 3520 | 3522 | 3524 | 3526 | 3528 |
| H1H18157B | 3530 | 3532 | 3534 | 3536 | 3538 | 3540 | 3542 | 3544 |
| H1H18158B | 3546 | 3548 | 3550 | 3552 | 3554 | 3556 | 3558 | 3560 |
| H1H18159B | 3562 | 3564 | 3566 | 3568 | 3570 | 3572 | 3574 | 3576 |
| H1H18160B | 3578 | 3580 | 3582 | 3584 | 3586 | 3588 | 3590 | 3592 |
| H1H18161B | 3594 | 3596 | 3598 | 3600 | 3602 | 3604 | 3606 | 3608 |
| H1H18162B | 3610 | 3612 | 3614 | 3616 | 3618 | 3620 | 3622 | 3624 |
| H1H18163B | 3626 | 3628 | 3630 | 3632 | 3634 | 3636 | 3638 | 3640 |
| H1H18164B | 3642 | 3644 | 3646 | 3648 | 3650 | 3652 | 3654 | 3656 |
| H1H18165B | 3658 | 3660 | 3662 | 3664 | 3666 | 3668 | 3670 | 3672 |
| H1H18166B | 3674 | 3676 | 3678 | 3680 | 3682 | 3684 | 3686 | 3688 |
| H1H18167B | 3690 | 3692 | 3694 | 3696 | 3698 | 3700 | 3702 | 3704 |
| H1H18168B | 3706 | 3708 | 3710 | 3712 | 3714 | 3716 | 3718 | 3720 |
| H1H18169B | 3722 | 3724 | 3726 | 3728 | 3730 | 3732 | 3734 | 3736 |
| H1H18170B | 3738 | 3740 | 3742 | 3744 | 3746 | 3748 | 3750 | 3752 |
| H1H18171B | 3754 | 3756 | 3758 | 3760 | 3762 | 3764 | 3766 | 3768 |
| H1H18172B | 3770 | 3772 | 3774 | 3776 | 3778 | 3780 | 3782 | 3784 |
| H1H18173B | 3786 | 3788 | 3790 | 3792 | 3794 | 3796 | 3798 | 3800 |
| H1H18174B | 3802 | 3804 | 3806 | 3808 | 3810 | 3812 | 3814 | 3816 |
| H1H18175B | 3818 | 3820 | 3822 | 3824 | 3826 | 3828 | 3830 | 3832 |
| H1H18176B | 3834 | 3836 | 3838 | 3840 | 3842 | 3844 | 3846 | 3848 |
| H1H18177B | 3850 | 3852 | 3854 | 3856 | 3858 | 3860 | 3862 | 3864 |
| H1H18178B | 3866 | 3868 | 3870 | 3872 | 3874 | 3876 | 3878 | 3880 |
| H1H18179B | 3882 | 3884 | 3886 | 3888 | 3890 | 3892 | 3894 | 3896 |
| H1H18180B | 3898 | 3900 | 3902 | 3904 | 3906 | 3908 | 3910 | 3912 |
| H1H18181B | 3914 | 3916 | 3918 | 3920 | 3922 | 3924 | 3926 | 3928 |
| H1H18182B | 3930 | 3932 | 3934 | 3936 | 3938 | 3940 | 3942 | 3944 |
| H1H18183B | 3946 | 3948 | 3950 | 3952 | 3954 | 3956 | 3958 | 3960 |
| H1H18184B | 3962 | 3964 | 3966 | 3968 | 3970 | 3972 | 3974 | 3976 |
| H1H18185B | 3978 | 3980 | 3982 | 3984 | 3986 | 3988 | 3990 | 3992 |
| H1H18186B | 3994 | 3996 | 3998 | 4000 | 4002 | 4004 | 4006 | 4008 |
| H1H18187B | 4010 | 4012 | 4014 | 4016 | 4018 | 4020 | 4022 | 4024 |
| H1H18188B | 4026 | 4028 | 4030 | 4032 | 4034 | 4036 | 4038 | 4040 |
| H1H18189B | 4042 | 4044 | 4046 | 4048 | 4050 | 4052 | 4054 | 4056 |
| H1H18190B | 4058 | 4060 | 4062 | 4064 | 4066 | 4068 | 4070 | 4072 |
| H1H18191B | 4074 | 4076 | 4078 | 4080 | 4082 | 4084 | 4086 | 4088 |
| H1H18192B | 4090 | 4092 | 4094 | 4096 | 4098 | 4100 | 4102 | 4104 |
| H1H18193B | 4106 | 4108 | 4110 | 4112 | 4114 | 4116 | 4118 | 4120 |
| H1H18194B | 4122 | 4124 | 4126 | 4128 | 4130 | 4132 | 4134 | 4136 |
| H1H18195B | 4138 | 4140 | 4142 | 4144 | 4146 | 4148 | 4150 | 4152 |
| H1H18196B | 4154 | 4156 | 4158 | 4160 | 4162 | 4164 | 4166 | 4168 |
| H1H18197B | 4170 | 4172 | 4174 | 4176 | 4178 | 4180 | 4182 | 4184 |
| H1H18198B | 4186 | 4188 | 4190 | 4192 | 4194 | 4196 | 4198 | 4200 |
| H1H18199B | 4202 | 4204 | 4206 | 4208 | 4210 | 4212 | 4214 | 4216 |
| H1H18200B | 4218 | 4220 | 4222 | 4224 | 4226 | 4228 | 4230 | 4232 |
| H1H18201B | 4234 | 4236 | 4238 | 4240 | 4242 | 4244 | 4246 | 4248 |
| H1H18202B | 4250 | 4252 | 4254 | 4256 | 4258 | 4260 | 4262 | 4264 |
| H1H18203B | 4266 | 4268 | 4270 | 4272 | 4274 | 4276 | 4278 | 4280 |
| H1H18204B | 4282 | 4284 | 4286 | 4288 | 4290 | 4292 | 4294 | 4296 |
| H1H18205B | 4298 | 4300 | 4302 | 4304 | 4306 | 4308 | 4310 | 4312 |
| H1H18206B | 4314 | 4316 | 4318 | 4320 | 4322 | 4324 | 4326 | 4328 |
| H1H18207B | 4330 | 4332 | 4334 | 4336 | 4338 | 4340 | 4342 | 4344 |
| H1H18208B | 4346 | 4348 | 4350 | 4352 | 4354 | 4356 | 4358 | 4360 |
| H1H18209B | 4362 | 4364 | 4366 | 4368 | 4370 | 4372 | 4374 | 4376 |
| H1H18210B | 4378 | 4380 | 4382 | 4384 | 4386 | 4388 | 4390 | 4392 |
| H1H18211B | 4394 | 4396 | 4398 | 4400 | 4402 | 4404 | 4406 | 4408 |
| H1H18212B | 4410 | 4412 | 4414 | 4416 | 4418 | 4420 | 4422 | 4424 |
| H1H18213B | 4426 | 4428 | 4430 | 4432 | 4434 | 4436 | 4438 | 4440 |
| H1H18214B | 4442 | 4444 | 4446 | 4448 | 4450 | 4452 | 4454 | 4456 |
| H1H18216B | 4458 | 4460 | 4462 | 4464 | 4466 | 4468 | 4470 | 4472 |
| H1H18217B | 4474 | 4476 | 4478 | 4480 | 4482 | 4484 | 4486 | 4488 |
| H1H18218B | 4490 | 4492 | 4494 | 4496 | 4498 | 4500 | 4502 | 4504 |
| H1H18219B | 4506 | 4508 | 4510 | 4512 | 4514 | 4516 | 4518 | 4520 |
| H1H18220B | 4522 | 4524 | 4526 | 4528 | 4530 | 4532 | 4534 | 4536 |
| H1H18221B | 4538 | 4540 | 4542 | 4544 | 4546 | 4548 | 4550 | 4552 |
| H1H18222B | 4554 | 4556 | 4558 | 4560 | 4562 | 4564 | 4566 | 4568 |
| H1H18223B | 4570 | 4572 | 4574 | 4576 | 4578 | 4580 | 4582 | 4584 |
| H1H18224B | 4586 | 4588 | 4590 | 4592 | 4594 | 4596 | 4598 | 4600 |
| H1H18225B | 4602 | 4604 | 4606 | 4608 | 4610 | 4612 | 4614 | 4616 |
| H1H18226B | 4618 | 4620 | 4622 | 4624 | 4626 | 4628 | 4630 | 4632 |
| H1H18227B | 4634 | 4636 | 4638 | 4640 | 4642 | 4644 | 4646 | 4648 |
| H1H18228B | 4650 | 4652 | 4654 | 4656 | 4658 | 4660 | 4662 | 4664 |
| H1H18229B | 4666 | 4668 | 4670 | 4672 | 4674 | 4676 | 4678 | 4680 |
| H1H18230B | 4682 | 4684 | 4686 | 4688 | 4690 | 4692 | 4694 | 4696 |
| H1H18231B | 4698 | 4700 | 4702 | 4704 | 4706 | 4708 | 4710 | 4712 |
| H1H18232B | 4714 | 4716 | 4718 | 4720 | 4722 | 4724 | 4726 | 4728 |
| H1H18233B | 4730 | 4732 | 4734 | 4736 | 4738 | 4740 | 4742 | 4744 |
| H1H18234B | 4746 | 4748 | 4750 | 4752 | 4754 | 4756 | 4758 | 4760 |
| H1H18235B | 4762 | 4764 | 4766 | 4768 | 4770 | 4772 | 4774 | 4776 |
| H1H18236B | 4778 | 4780 | 4782 | 4784 | 4786 | 4788 | 4790 | 4792 |
| H1H18237B | 4794 | 4796 | 4798 | 4800 | 4802 | 4804 | 4806 | 4808 |
| H1H18238B | 4810 | 4812 | 4814 | 4816 | 4818 | 4820 | 4822 | 4824 |
| H1H18239B | 4826 | 4828 | 4830 | 4832 | 4834 | 4836 | 4838 | 4840 |
| H1H18240B | 4842 | 4844 | 4846 | 4848 | 4850 | 4852 | 4854 | 4856 |
| H1H18241B | 4858 | 4860 | 4862 | 4864 | 4866 | 4868 | 4870 | 4872 |
| H1H18242B | 4874 | 4876 | 4878 | 4880 | 4882 | 4884 | 4886 | 4888 |
| H1H18243B | 4890 | 4892 | 4894 | 4896 | 4898 | 4900 | 4902 | 4904 |
| H1H18244B | 4906 | 4908 | 4910 | 4912 | 4914 | 4916 | 4918 | 4920 |
| H1H18245B | 4922 | 4924 | 4926 | 4928 | 4930 | 4932 | 4934 | 4936 |
| H1H18246B | 4938 | 4940 | 4942 | 4944 | 4946 | 4948 | 4950 | 4952 |
| H1H18247B | 4954 | 4956 | 4958 | 4960 | 4962 | 4964 | 4966 | 4968 |
| H1H18248B | 4970 | 4972 | 4974 | 4976 | 4978 | 4980 | 4982 | 4984 |
| H1H18249B | 4986 | 4988 | 4990 | 4992 | 4994 | 4996 | 4998 | 5000 |
| H1H18250B | 5002 | 5004 | 5006 | 5008 | 5010 | 5012 | 5014 | 5016 |
| H1H18251B | 5018 | 5020 | 5022 | 5024 | 5026 | 5028 | 5030 | 5032 |
| H1H18252B | 5034 | 5036 | 5038 | 5040 | 5042 | 5044 | 5046 | 5048 |
| H1H18253B | 5050 | 5052 | 5054 | 5056 | 5058 | 5060 | 5062 | 5064 |
| H1H18254B | 5066 | 5068 | 5070 | 5072 | 5074 | 5076 | 5078 | 5080 |
| H1H18255B | 5082 | 5084 | 5086 | 5088 | 5090 | 5092 | 5094 | 5096 |
| H1H18256B | 5098 | 5100 | 5102 | 5104 | 5106 | 5108 | 5110 | 5112 |
| H1H18257B | 5114 | 5116 | 5118 | 5120 | 5122 | 5124 | 5126 | 5128 |
| H1H18258B | 5130 | 5132 | 5134 | 5136 | 5138 | 5140 | 5142 | 5144 |
| H1H18259B | 5146 | 5148 | 5150 | 5152 | 5154 | 5156 | 5158 | 5160 |
| H1H18261B | 5162 | 5164 | 5166 | 5168 | 5170 | 5172 | 5174 | 5176 |
| H1H18262B | 5178 | 5180 | 5182 | 5184 | 5186 | 5188 | 5190 | 5192 |
| H1H18263B | 5194 | 5196 | 5198 | 5200 | 5202 | 5204 | 5206 | 5208 |
| H1H18264B | 5210 | 5212 | 5214 | 5216 | 5218 | 5220 | 5222 | 5224 |
| H1H18265B | 5226 | 5228 | 5230 | 5232 | 5234 | 5236 | 5238 | 5240 |
| H1H18266B | 5242 | 5244 | 5246 | 5248 | 5250 | 5252 | 5254 | 5256 |
| H1H18267B | 5258 | 5260 | 5262 | 5264 | 5266 | 5268 | 5270 | 5272 |
| H1H18268B | 5274 | 5276 | 5278 | 5280 | 5282 | 5284 | 5286 | 5288 |
| H1H18269B | 5290 | 5292 | 5294 | 5296 | 5298 | 5300 | 5302 | 5304 |
| H1H18270B | 5306 | 5308 | 5310 | 5312 | 5314 | 5316 | 5318 | 5320 |
| H1H18271B | 5322 | 5324 | 5326 | 5328 | 5330 | 5332 | 5334 | 5336 |
| H1H18272B | 5338 | 5340 | 5342 | 5344 | 5346 | 5348 | 5350 | 5352 |
| H1H18274B | 5354 | 5356 | 5358 | 5360 | 5362 | 5364 | 5366 | 5368 |
| H1H18275B | 5370 | 5372 | 5374 | 5376 | 5378 | 5380 | 5382 | 5384 |
| H1H18276B | 5386 | 5388 | 5390 | 5392 | 5394 | 5396 | 5398 | 5400 |
| H1H18277B | 5402 | 5404 | 5406 | 5408 | 5410 | 5412 | 5414 | 5416 |
| H1H18278B | 5418 | 5420 | 5422 | 5424 | 5426 | 5428 | 5430 | 5432 |
| H1H18279B | 5434 | 5436 | 5438 | 5440 | 5442 | 5444 | 5446 | 5448 |
| H1H18280B | 5450 | 5452 | 5454 | 5456 | 5458 | 5460 | 5462 | 5464 |
| H1H18281B | 5466 | 5468 | 5470 | 5472 | 5474 | 5476 | 5478 | 5480 |
| H1H18282B | 5482 | 5484 | 5486 | 5488 | 5490 | 5492 | 5494 | 5496 |
| H1H18283B | 5498 | 5500 | 5502 | 5504 | 5506 | 5508 | 5510 | 5512 |
| H1H18284B | 5514 | 5516 | 5518 | 5520 | 5522 | 5524 | 5526 | 5528 |
| H1H18285B | 5530 | 5532 | 5534 | 5536 | 5538 | 5540 | 5542 | 5544 |
| H1H18286B | 5546 | 5548 | 5550 | 5552 | 5554 | 5556 | 5558 | 5560 |
| H1H18287B | 5562 | 5564 | 5566 | 5568 | 5570 | 5572 | 5574 | 5576 |
| H1H18288B | 5578 | 5580 | 5582 | 5584 | 5586 | 5588 | 5590 | 5592 |
| H1H18289B | 5594 | 5596 | 5598 | 5600 | 5602 | 5604 | 5606 | 5608 |
| H1H18290B | 5610 | 5612 | 5614 | 5616 | 5618 | 5620 | 5622 | 5624 |
| H1H18291B | 5626 | 5628 | 5630 | 5632 | 5634 | 5636 | 5638 | 5640 |
| H1H18292B | 5642 | 5644 | 5646 | 5648 | 5650 | 5652 | 5654 | 5656 |
| H1H18293B | 5658 | 5660 | 5662 | 5664 | 5666 | 5668 | 5670 | 5672 |
| H1H18294B | 5674 | 5676 | 5678 | 5680 | 5682 | 5684 | 5686 | 5688 |
| H1H18295B | 5690 | 5692 | 5694 | 5696 | 5698 | 5700 | 5702 | 5704 |
| H1H18297B | 5706 | 5708 | 5710 | 5712 | 5714 | 5716 | 5718 | 5720 |
| H1H18298B | 5722 | 5724 | 5726 | 5728 | 5730 | 5732 | 5734 | 5736 |
| H1H18299B | 5738 | 5740 | 5742 | 5744 | 5746 | 5748 | 5750 | 5752 |
| H1H18300B | 5754 | 5756 | 5758 | 5760 | 5762 | 5764 | 5766 | 5768 |
| H1H18301B | 5770 | 5772 | 5774 | 5776 | 5778 | 5780 | 5782 | 5784 |
| H1H18302B | 5786 | 5788 | 5790 | 5792 | 5794 | 5796 | 5798 | 5800 |
| H1H18303B | 5802 | 5804 | 5806 | 5808 | 5810 | 5812 | 5814 | 5816 |
| H1H18304B | 5818 | 5820 | 5822 | 5824 | 5826 | 5828 | 5830 | 5832 |
| H1H18305B | 5834 | 5836 | 5838 | 5840 | 5842 | 5844 | 5846 | 5848 |
| H1H18306B | 5850 | 5852 | 5854 | 5856 | 5858 | 5860 | 5862 | 5864 |
| H1H18307B | 5866 | 5868 | 5870 | 5872 | 5874 | 5876 | 5878 | 5880 |
| H1H18308B | 5882 | 5884 | 5886 | 5888 | 5890 | 5892 | 5894 | 5896 |
| H1H18309B | 5898 | 5900 | 5902 | 5904 | 5906 | 5908 | 5910 | 5912 |
| H1H18310B | 5914 | 5916 | 5918 | 5920 | 5922 | 5924 | 5926 | 5928 |
| H1H18311B | 5930 | 5932 | 5934 | 5936 | 5938 | 5940 | 5942 | 5944 |
| H1H18312B | 5946 | 5948 | 5950 | 5952 | 5954 | 5956 | 5958 | 5960 |
| H1H18313B | 5962 | 5964 | 5966 | 5968 | 5970 | 5972 | 5974 | 5976 |
| H1H18314B | 5978 | 5980 | 5982 | 5984 | 5986 | 5988 | 5990 | 5992 |
| H1H18315B | 5994 | 5996 | 5998 | 6000 | 6002 | 6004 | 6006 | 6008 |
| H1H18316B | 6010 | 6012 | 6014 | 6016 | 6018 | 6020 | 6022 | 6024 |
| H1H18317B | 6026 | 6028 | 6030 | 6032 | 6034 | 6036 | 6038 | 6040 |
| H1H18318B | 6042 | 6044 | 6046 | 6048 | 6050 | 6052 | 6054 | 6056 |
| H1H18319B | 6058 | 6060 | 6062 | 6064 | 6066 | 6068 | 6070 | 6072 |
| H1H18320B | 6074 | 6076 | 6078 | 6080 | 6082 | 6084 | 6086 | 6088 |
| H1H18321B | 6090 | 6092 | 6094 | 6096 | 6098 | 6100 | 6102 | 6104 |
| H1H18322B | 6106 | 6108 | 6110 | 6112 | 6114 | 6116 | 6118 | 6120 |
| H1H18323B | 6122 | 6124 | 6126 | 6128 | 6130 | 6132 | 6134 | 6136 |
| H1H18324B | 6138 | 6140 | 6142 | 6144 | 6146 | 6148 | 6150 | 6152 |
| H1H18325B | 6154 | 6156 | 6158 | 6160 | 6162 | 6164 | 6166 | 6168 |
| H1H18326B | 6170 | 6172 | 6174 | 6176 | 6178 | 6180 | 6182 | 6184 |
| H1H18327B | 6186 | 6188 | 6190 | 6192 | 6194 | 6196 | 6198 | 6200 |
| H1H18328B | 6202 | 6204 | 6206 | 6208 | 6210 | 6212 | 6214 | 6216 |
| H1H18329B | 6218 | 6220 | 6222 | 6224 | 6226 | 6228 | 6230 | 6232 |
| H1H18330B | 6234 | 6236 | 6238 | 6240 | 6242 | 6244 | 6246 | 6248 |
| H1H18331B | 6250 | 6252 | 6254 | 6256 | 6258 | 6260 | 6262 | 6264 |
| H1H18332B | 6266 | 6268 | 6270 | 6272 | 6274 | 6276 | 6278 | 6280 |
| H1H18333B | 6282 | 6284 | 6286 | 6288 | 6290 | 6292 | 6294 | 6296 |
| H1H18334B | 6298 | 6300 | 6302 | 6304 | 6306 | 6308 | 6310 | 6312 |
| H1H18335B | 6314 | 6316 | 6318 | 6320 | 6322 | 6324 | 6326 | 6328 |
| 핵산 서열 번호 | ||||||||
| 항체 명칭 | HCVR | HCDR1 | HCDR2 | HCDR3 | LCVR | LCDR1 | LCDR2 | LCDR3 |
| H1H17952B | 297 | 299 | 301 | 303 | 305 | 307 | 309 | 311 |
| H1H17953B | 313 | 315 | 317 | 319 | 321 | 323 | 325 | 327 |
| H1H17954B | 329 | 331 | 333 | 335 | 337 | 339 | 341 | 343 |
| H1H17955B | 345 | 347 | 349 | 351 | 353 | 355 | 357 | 359 |
| H1H17956B | 361 | 363 | 365 | 367 | 369 | 371 | 373 | 375 |
| H1H17957B | 377 | 379 | 381 | 383 | 385 | 387 | 389 | 391 |
| H1H17958B | 393 | 395 | 397 | 399 | 401 | 403 | 405 | 407 |
| H1H17959B | 409 | 411 | 413 | 415 | 417 | 419 | 421 | 423 |
| H1H17960B | 425 | 427 | 429 | 431 | 433 | 435 | 437 | 439 |
| H1H17961B | 441 | 443 | 445 | 447 | 449 | 451 | 453 | 455 |
| H1H17962B | 457 | 459 | 461 | 463 | 465 | 467 | 469 | 471 |
| H1H17963B | 473 | 475 | 477 | 479 | 481 | 483 | 485 | 487 |
| H1H17964B | 489 | 491 | 493 | 495 | 497 | 499 | 501 | 503 |
| H1H17965B | 505 | 507 | 509 | 511 | 513 | 515 | 517 | 519 |
| H1H17966B | 521 | 523 | 525 | 527 | 529 | 531 | 533 | 535 |
| H1H17967B | 537 | 539 | 541 | 543 | 545 | 547 | 549 | 551 |
| H1H17968B | 553 | 555 | 557 | 559 | 561 | 563 | 565 | 567 |
| H1H17969B | 569 | 571 | 573 | 575 | 577 | 579 | 581 | 583 |
| H1H17970B | 585 | 587 | 589 | 591 | 593 | 595 | 597 | 599 |
| H1H17971B | 601 | 603 | 605 | 607 | 609 | 611 | 613 | 615 |
| H1H17972B | 617 | 619 | 621 | 623 | 625 | 627 | 629 | 631 |
| H1H17973B | 633 | 635 | 637 | 639 | 641 | 643 | 645 | 647 |
| H1H17974B | 649 | 651 | 653 | 655 | 657 | 659 | 661 | 663 |
| H1H17975B | 665 | 667 | 669 | 671 | 673 | 675 | 677 | 679 |
| H1H17976B | 681 | 683 | 685 | 687 | 689 | 691 | 693 | 695 |
| H1H17977B | 697 | 699 | 701 | 703 | 705 | 707 | 709 | 711 |
| H1H17978B | 713 | 715 | 717 | 719 | 721 | 723 | 725 | 727 |
| H1H17979B | 729 | 731 | 733 | 735 | 737 | 739 | 741 | 743 |
| H1H17980B | 745 | 747 | 749 | 751 | 753 | 755 | 757 | 759 |
| H1H17981B | 761 | 763 | 765 | 767 | 769 | 771 | 773 | 775 |
| H1H17982B | 777 | 779 | 781 | 783 | 785 | 787 | 789 | 791 |
| H1H17983B | 793 | 795 | 797 | 799 | 801 | 803 | 805 | 807 |
| H1H17984B | 809 | 811 | 813 | 815 | 817 | 819 | 821 | 823 |
| H1H17985B | 825 | 827 | 829 | 831 | 833 | 835 | 837 | 839 |
| H1H17986B | 841 | 843 | 845 | 847 | 849 | 851 | 853 | 855 |
| H1H17987B | 857 | 859 | 861 | 863 | 865 | 867 | 869 | 871 |
| H1H17988B | 873 | 875 | 877 | 879 | 881 | 883 | 885 | 887 |
| H1H17989B | 889 | 891 | 893 | 895 | 897 | 899 | 901 | 903 |
| H1H17990B | 905 | 907 | 909 | 911 | 913 | 915 | 917 | 919 |
| H1H17991B | 921 | 923 | 925 | 927 | 929 | 931 | 933 | 935 |
| H1H17992B | 937 | 939 | 941 | 943 | 945 | 947 | 949 | 951 |
| H1H17993B | 953 | 955 | 957 | 959 | 961 | 963 | 965 | 967 |
| H1H17994B | 969 | 971 | 973 | 975 | 977 | 979 | 981 | 983 |
| H1H17995B | 985 | 987 | 989 | 991 | 993 | 995 | 997 | 999 |
| H1H17996B | 1001 | 1003 | 1005 | 1007 | 1009 | 1011 | 1013 | 1015 |
| H1H17997B | 1017 | 1019 | 1021 | 1023 | 1025 | 1027 | 1029 | 1031 |
| H1H17998B | 1033 | 1035 | 1037 | 1039 | 1041 | 1043 | 1045 | 1047 |
| H1H17999B | 1049 | 1051 | 1053 | 1055 | 1057 | 1059 | 1061 | 1063 |
| H1H18000B | 1065 | 1067 | 1069 | 1071 | 1073 | 1075 | 1077 | 1079 |
| H1H18001B | 1081 | 1083 | 1085 | 1087 | 1089 | 1091 | 1093 | 1095 |
| H1H18002B | 1097 | 1099 | 1101 | 1103 | 1105 | 1107 | 1109 | 1111 |
| H1H18003B | 1113 | 1115 | 1117 | 1119 | 1121 | 1123 | 1125 | 1127 |
| H1H18004B | 1129 | 1131 | 1133 | 1135 | 1137 | 1139 | 1141 | 1143 |
| H1H18005B | 1145 | 1147 | 1149 | 1151 | 1153 | 1155 | 1157 | 1159 |
| H1H18006B | 1161 | 1163 | 1165 | 1167 | 1169 | 1171 | 1173 | 1175 |
| H1H18007B | 1177 | 1179 | 1181 | 1183 | 1185 | 1187 | 1189 | 1191 |
| H1H18008B | 1193 | 1195 | 1197 | 1199 | 1201 | 1203 | 1205 | 1207 |
| H1H18009B | 1209 | 1211 | 1213 | 1215 | 1217 | 1219 | 1221 | 1223 |
| H1H18010B | 1225 | 1227 | 1229 | 1231 | 1233 | 1235 | 1237 | 1239 |
| H1H18011B | 1241 | 1243 | 1245 | 1247 | 1249 | 1251 | 1253 | 1255 |
| H1H18012B | 1257 | 1259 | 1261 | 1263 | 1265 | 1267 | 1269 | 1271 |
| H1H18013B | 1273 | 1275 | 1277 | 1279 | 1281 | 1283 | 1285 | 1287 |
| H1H18014B | 1289 | 1291 | 1293 | 1295 | 1297 | 1299 | 1301 | 1303 |
| H1H18015B | 1305 | 1307 | 1309 | 1311 | 1313 | 1315 | 1317 | 1319 |
| H1H18016B | 1321 | 1323 | 1325 | 1327 | 1329 | 1331 | 1333 | 1335 |
| H1H18017B | 1337 | 1339 | 1341 | 1343 | 1345 | 1347 | 1349 | 1351 |
| H1H18018B | 1353 | 1355 | 1357 | 1359 | 1361 | 1363 | 1365 | 1367 |
| H1H18019B | 1369 | 1371 | 1373 | 1375 | 1377 | 1379 | 1381 | 1383 |
| H1H18020B | 1385 | 1387 | 1389 | 1391 | 1393 | 1395 | 1397 | 1399 |
| H1H18021B | 1401 | 1403 | 1405 | 1407 | 1409 | 1411 | 1413 | 1415 |
| H1H18022B | 1417 | 1419 | 1421 | 1423 | 1425 | 1427 | 1429 | 1431 |
| H1H18023B | 1433 | 1435 | 1437 | 1439 | 1441 | 1443 | 1445 | 1447 |
| H1H18024B | 1449 | 1451 | 1453 | 1455 | 1457 | 1459 | 1461 | 1463 |
| H1H18025B | 1465 | 1467 | 1469 | 1471 | 1473 | 1475 | 1477 | 1479 |
| H1H18026B | 1481 | 1483 | 1485 | 1487 | 1489 | 1491 | 1493 | 1495 |
| H1H18027B | 1497 | 1499 | 1501 | 1503 | 1505 | 1507 | 1509 | 1511 |
| H1H18028B | 1513 | 1515 | 1517 | 1519 | 1521 | 1523 | 1525 | 1527 |
| H1H18029B | 1529 | 1531 | 1533 | 1535 | 1537 | 1539 | 1541 | 1543 |
| H1H18030B | 1545 | 1547 | 1549 | 1551 | 1553 | 1555 | 1557 | 1559 |
| H1H18031B | 1561 | 1563 | 1565 | 1567 | 1569 | 1571 | 1573 | 1575 |
| H1H18032B | 1577 | 1579 | 1581 | 1583 | 1585 | 1587 | 1589 | 1591 |
| H1H18033B | 1593 | 1595 | 1597 | 1599 | 1601 | 1603 | 1605 | 1607 |
| H1H18034B | 1609 | 1611 | 1613 | 1615 | 1617 | 1619 | 1621 | 1623 |
| H1H18035B | 1625 | 1627 | 1629 | 1631 | 1633 | 1635 | 1637 | 1639 |
| H1H18037B | 1641 | 1643 | 1645 | 1647 | 1649 | 1651 | 1653 | 1655 |
| H1H18038B | 1657 | 1659 | 1661 | 1663 | 1665 | 1667 | 1669 | 1671 |
| H1H18039B | 1673 | 1675 | 1677 | 1679 | 1681 | 1683 | 1685 | 1687 |
| H1H18040B | 1689 | 1691 | 1693 | 1695 | 1697 | 1699 | 1701 | 1703 |
| H1H18041B | 1705 | 1707 | 1709 | 1711 | 1713 | 1715 | 1717 | 1719 |
| H1H18042B | 1721 | 1723 | 1725 | 1727 | 1729 | 1731 | 1733 | 1735 |
| H1H18043B | 1737 | 1739 | 1741 | 1743 | 1745 | 1747 | 1749 | 1751 |
| H1H18044B | 1753 | 1755 | 1757 | 1759 | 1761 | 1763 | 1765 | 1767 |
| H1H18045B | 1769 | 1771 | 1773 | 1775 | 1777 | 1779 | 1781 | 1783 |
| H1H18046B | 1785 | 1787 | 1789 | 1791 | 1793 | 1795 | 1797 | 1799 |
| H1H18047B | 1801 | 1803 | 1805 | 1807 | 1809 | 1811 | 1813 | 1815 |
| H1H18048B | 1817 | 1819 | 1821 | 1823 | 1825 | 1827 | 1829 | 1831 |
| H1H18049B | 1833 | 1835 | 1837 | 1839 | 1841 | 1843 | 1845 | 1847 |
| H1H18051B | 1849 | 1851 | 1853 | 1855 | 1857 | 1859 | 1861 | 1863 |
| H1H18052B | 1865 | 1867 | 1869 | 1871 | 1873 | 1875 | 1877 | 1879 |
| H1H18053B | 1881 | 1883 | 1885 | 1887 | 1889 | 1891 | 1893 | 1895 |
| H1H18054B | 1897 | 1899 | 1901 | 1903 | 1905 | 1907 | 1909 | 1911 |
| H1H18055B | 1913 | 1915 | 1917 | 1919 | 1921 | 1923 | 1925 | 1927 |
| H1H18056B | 1929 | 1931 | 1933 | 1935 | 1937 | 1939 | 1941 | 1943 |
| H1H18057B | 1945 | 1947 | 1949 | 1951 | 1953 | 1955 | 1957 | 1959 |
| H1H18058B | 1961 | 1963 | 1965 | 1967 | 1969 | 1971 | 1973 | 1975 |
| H1H18059B | 1977 | 1979 | 1981 | 1983 | 1985 | 1987 | 1989 | 1991 |
| H1H18060B | 1993 | 1995 | 1997 | 1999 | 2001 | 2003 | 2005 | 2007 |
| H1H18061B | 2009 | 2011 | 2013 | 2015 | 2017 | 2019 | 2021 | 2023 |
| H1H18062B | 2025 | 2027 | 2029 | 2031 | 2033 | 2035 | 2037 | 2039 |
| H1H18063B | 2041 | 2043 | 2045 | 2047 | 2049 | 2051 | 2053 | 2055 |
| H1H18064B | 2057 | 2059 | 2061 | 2063 | 2065 | 2067 | 2069 | 2071 |
| H1H18065B | 2073 | 2075 | 2077 | 2079 | 2081 | 2083 | 2085 | 2087 |
| H1H18066B | 2089 | 2091 | 2093 | 2095 | 2097 | 2099 | 2101 | 2103 |
| H1H18067B | 2105 | 2107 | 2109 | 2111 | 2113 | 2115 | 2117 | 2119 |
| H1H18068B | 2121 | 2123 | 2125 | 2127 | 2129 | 2131 | 2133 | 2135 |
| H1H18069B | 2137 | 2139 | 2141 | 2143 | 2145 | 2147 | 2149 | 2151 |
| H1H18070B | 2153 | 2155 | 2157 | 2159 | 2161 | 2163 | 2165 | 2167 |
| H1H18071B | 2169 | 2171 | 2173 | 2175 | 2177 | 2179 | 2181 | 2183 |
| H1H18072B | 2185 | 2187 | 2189 | 2191 | 2193 | 2195 | 2197 | 2199 |
| H1H18073B | 2201 | 2203 | 2205 | 2207 | 2209 | 2211 | 2213 | 2215 |
| H1H18074B | 2217 | 2219 | 2221 | 2223 | 2225 | 2227 | 2229 | 2231 |
| H1H18075B | 2233 | 2235 | 2237 | 2239 | 2241 | 2243 | 2245 | 2247 |
| H1H18076B | 2249 | 2251 | 2253 | 2255 | 2257 | 2259 | 2261 | 2263 |
| H1H18077B | 2265 | 2267 | 2269 | 2271 | 2273 | 2275 | 2277 | 2279 |
| H1H18078B | 2281 | 2283 | 2285 | 2287 | 2289 | 2291 | 2293 | 2295 |
| H1H18079B | 2297 | 2299 | 2301 | 2303 | 2305 | 2307 | 2309 | 2311 |
| H1H18080B | 2313 | 2315 | 2317 | 2319 | 2321 | 2323 | 2325 | 2327 |
| H1H18081B | 2329 | 2331 | 2333 | 2335 | 2337 | 2339 | 2341 | 2343 |
| H1H18082B | 2345 | 2347 | 2349 | 2351 | 2353 | 2355 | 2357 | 2359 |
| H1H18083B | 2361 | 2363 | 2365 | 2367 | 2369 | 2371 | 2373 | 2375 |
| H1H18084B | 2377 | 2379 | 2381 | 2383 | 2385 | 2387 | 2389 | 2391 |
| H1H18085B | 2393 | 2395 | 2397 | 2399 | 2401 | 2403 | 2405 | 2407 |
| H1H18086B | 2409 | 2411 | 2413 | 2415 | 2417 | 2419 | 2421 | 2423 |
| H1H18087B | 2425 | 2427 | 2429 | 2431 | 2433 | 2435 | 2437 | 2439 |
| H1H18088B | 2441 | 2443 | 2445 | 2447 | 2449 | 2451 | 2453 | 2455 |
| H1H18089B | 2457 | 2459 | 2461 | 2463 | 2465 | 2467 | 2469 | 2471 |
| H1H18090B | 2473 | 2475 | 2477 | 2479 | 2481 | 2483 | 2485 | 2487 |
| H1H18091B | 2489 | 2491 | 2493 | 2495 | 2497 | 2499 | 2501 | 2503 |
| H1H18092B | 2505 | 2507 | 2509 | 2511 | 2513 | 2515 | 2517 | 2519 |
| H1H18093B | 2521 | 2523 | 2525 | 2527 | 2529 | 2531 | 2533 | 2535 |
| H1H18094B | 2537 | 2539 | 2541 | 2543 | 2545 | 2547 | 2549 | 2551 |
| H1H18095B | 2553 | 2555 | 2557 | 2559 | 2561 | 2563 | 2565 | 2567 |
| H1H18096B | 2569 | 2571 | 2573 | 2575 | 2577 | 2579 | 2581 | 2583 |
| H1H18097B | 2585 | 2587 | 2589 | 2591 | 2593 | 2595 | 2597 | 2599 |
| H1H18098B | 2601 | 2603 | 2605 | 2607 | 2609 | 2611 | 2613 | 2615 |
| H1H18099B | 2617 | 2619 | 2621 | 2623 | 2625 | 2627 | 2629 | 2631 |
| H1H18100B | 2633 | 2635 | 2637 | 2639 | 2641 | 2643 | 2645 | 2647 |
| H1H18101B | 2649 | 2651 | 2653 | 2655 | 2657 | 2659 | 2661 | 2663 |
| H1H18102B | 2665 | 2667 | 2669 | 2671 | 2673 | 2675 | 2677 | 2679 |
| H1H18103B | 2681 | 2683 | 2685 | 2687 | 2689 | 2691 | 2693 | 2695 |
| H1H18104B | 2697 | 2699 | 2701 | 2703 | 2705 | 2707 | 2709 | 2711 |
| H1H18105B | 2713 | 2715 | 2717 | 2719 | 2721 | 2723 | 2725 | 2727 |
| H1H18107B | 2729 | 2731 | 2733 | 2735 | 2737 | 2739 | 2741 | 2743 |
| H1H18108B | 2745 | 2747 | 2749 | 2751 | 2753 | 2755 | 2757 | 2759 |
| H1H18109B | 2761 | 2763 | 2765 | 2767 | 2769 | 2771 | 2773 | 2775 |
| H1H18110B | 2777 | 2779 | 2781 | 2783 | 2785 | 2787 | 2789 | 2791 |
| H1H18111B | 2793 | 2795 | 2797 | 2799 | 2801 | 2803 | 2805 | 2807 |
| H1H18112B | 2809 | 2811 | 2813 | 2815 | 2817 | 2819 | 2821 | 2823 |
| H1H18113B | 2825 | 2827 | 2829 | 2831 | 2833 | 2835 | 2837 | 2839 |
| H1H18114B | 2841 | 2843 | 2845 | 2847 | 2849 | 2851 | 2853 | 2855 |
| H1H18115B | 2857 | 2859 | 2861 | 2863 | 2865 | 2867 | 2869 | 2871 |
| H1H18116B | 2873 | 2875 | 2877 | 2879 | 2881 | 2883 | 2885 | 2887 |
| H1H18117B | 2889 | 2891 | 2893 | 2895 | 2897 | 2899 | 2901 | 2903 |
| H1H18118B | 2905 | 2907 | 2909 | 2911 | 2913 | 2915 | 2917 | 2919 |
| H1H18119B | 2921 | 2923 | 2925 | 2927 | 2929 | 2931 | 2933 | 2935 |
| H1H18120B | 2937 | 2939 | 2941 | 2943 | 2945 | 2947 | 2949 | 2951 |
| H1H18121B | 2953 | 2955 | 2957 | 2959 | 2961 | 2963 | 2965 | 2967 |
| H1H18122B | 2969 | 2971 | 2973 | 2975 | 2977 | 2979 | 2981 | 2983 |
| H1H18123B | 2985 | 2987 | 2989 | 2991 | 2993 | 2995 | 2997 | 2999 |
| H1H18124B | 3001 | 3003 | 3005 | 3007 | 3009 | 3011 | 3013 | 3015 |
| H1H18125B | 3017 | 3019 | 3021 | 3023 | 3025 | 3027 | 3029 | 3031 |
| H1H18126B | 3033 | 3035 | 3037 | 3039 | 3041 | 3043 | 3045 | 3047 |
| H1H18127B | 3049 | 3051 | 3053 | 3055 | 3057 | 3059 | 3061 | 3063 |
| H1H18128B | 3065 | 3067 | 3069 | 3071 | 3073 | 3075 | 3077 | 3079 |
| H1H18129B | 3081 | 3083 | 3085 | 3087 | 3089 | 3091 | 3093 | 3095 |
| H1H18130B | 3097 | 3099 | 3101 | 3103 | 3105 | 3107 | 3109 | 3111 |
| H1H18131B | 3113 | 3115 | 3117 | 3119 | 3121 | 3123 | 3125 | 3127 |
| H1H18132B | 3129 | 3131 | 3133 | 3135 | 3137 | 3139 | 3141 | 3143 |
| H1H18133B | 3145 | 3147 | 3149 | 3151 | 3153 | 3155 | 3157 | 3159 |
| H1H18134B | 3161 | 3163 | 3165 | 3167 | 3169 | 3171 | 3173 | 3175 |
| H1H18135B | 3177 | 3179 | 3181 | 3183 | 3185 | 3187 | 3189 | 3191 |
| H1H18136B | 3193 | 3195 | 3197 | 3199 | 3201 | 3203 | 3205 | 3207 |
| H1H18137B | 3209 | 3211 | 3213 | 3215 | 3217 | 3219 | 3221 | 3223 |
| H1H18138B | 3225 | 3227 | 3229 | 3231 | 3233 | 3235 | 3237 | 3239 |
| H1H18139B | 3241 | 3243 | 3245 | 3247 | 3249 | 3251 | 3253 | 3255 |
| H1H18140B | 3257 | 3259 | 3261 | 3263 | 3265 | 3267 | 3269 | 3271 |
| H1H18141B | 3273 | 3275 | 3277 | 3279 | 3281 | 3283 | 3285 | 3287 |
| H1H18142B | 3289 | 3291 | 3293 | 3295 | 3297 | 3299 | 3301 | 3303 |
| H1H18143B | 3305 | 3307 | 3309 | 3311 | 3313 | 3315 | 3317 | 3319 |
| H1H18144B | 3321 | 3323 | 3325 | 3327 | 3329 | 3331 | 3333 | 3335 |
| H1H18145B | 3337 | 3339 | 3341 | 3343 | 3345 | 3347 | 3349 | 3351 |
| H1H18146B | 3353 | 3355 | 3357 | 3359 | 3361 | 3363 | 3365 | 3367 |
| H1H18147B | 3369 | 3371 | 3373 | 3375 | 3377 | 3379 | 3381 | 3383 |
| H1H18148B | 3385 | 3387 | 3389 | 3391 | 3393 | 3395 | 3397 | 3399 |
| H1H18149B | 3401 | 3403 | 3405 | 3407 | 3409 | 3411 | 3413 | 3415 |
| H1H18150B | 3417 | 3419 | 3421 | 3423 | 3425 | 3427 | 3429 | 3431 |
| H1H18151B | 3433 | 3435 | 3437 | 3439 | 3441 | 3443 | 3445 | 3447 |
| H1H18152B | 3449 | 3451 | 3453 | 3455 | 3457 | 3459 | 3461 | 3463 |
| H1H18153B | 3465 | 3467 | 3469 | 3471 | 3473 | 3475 | 3477 | 3479 |
| H1H18154B | 3481 | 3483 | 3485 | 3487 | 3489 | 3491 | 3493 | 3495 |
| H1H18155B | 3497 | 3499 | 3501 | 3503 | 3505 | 3507 | 3509 | 3511 |
| H1H18156B | 3513 | 3515 | 3517 | 3519 | 3521 | 3523 | 3525 | 3527 |
| H1H18157B | 3529 | 3531 | 3533 | 3535 | 3537 | 3539 | 3541 | 3543 |
| H1H18158B | 3545 | 3547 | 3549 | 3551 | 3553 | 3555 | 3557 | 3559 |
| H1H18159B | 3561 | 3563 | 3565 | 3567 | 3569 | 3571 | 3573 | 3575 |
| H1H18160B | 3577 | 3579 | 3581 | 3583 | 3585 | 3587 | 3589 | 3591 |
| H1H18161B | 3593 | 3595 | 3597 | 3599 | 3601 | 3603 | 3605 | 3607 |
| H1H18162B | 3609 | 3611 | 3613 | 3615 | 3617 | 3619 | 3621 | 3623 |
| H1H18163B | 3625 | 3627 | 3629 | 3631 | 3633 | 3635 | 3637 | 3639 |
| H1H18164B | 3641 | 3643 | 3645 | 3647 | 3649 | 3651 | 3653 | 3655 |
| H1H18165B | 3657 | 3659 | 3661 | 3663 | 3665 | 3667 | 3669 | 3671 |
| H1H18166B | 3673 | 3675 | 3677 | 3679 | 3681 | 3683 | 3685 | 3687 |
| H1H18167B | 3689 | 3691 | 3693 | 3695 | 3697 | 3699 | 3701 | 3703 |
| H1H18168B | 3705 | 3707 | 3709 | 3711 | 3713 | 3715 | 3717 | 3719 |
| H1H18169B | 3721 | 3723 | 3725 | 3727 | 3729 | 3731 | 3733 | 3735 |
| H1H18170B | 3737 | 3739 | 3741 | 3743 | 3745 | 3747 | 3749 | 3751 |
| H1H18171B | 3753 | 3755 | 3757 | 3759 | 3761 | 3763 | 3765 | 3767 |
| H1H18172B | 3769 | 3771 | 3773 | 3775 | 3777 | 3779 | 3781 | 3783 |
| H1H18173B | 3785 | 3787 | 3789 | 3791 | 3793 | 3795 | 3797 | 3799 |
| H1H18174B | 3801 | 3803 | 3805 | 3807 | 3809 | 3811 | 3813 | 3815 |
| H1H18175B | 3817 | 3819 | 3821 | 3823 | 3825 | 3827 | 3829 | 3831 |
| H1H18176B | 3833 | 3835 | 3837 | 3839 | 3841 | 3843 | 3845 | 3847 |
| H1H18177B | 3849 | 3851 | 3853 | 3855 | 3857 | 3859 | 3861 | 3863 |
| H1H18178B | 3865 | 3867 | 3869 | 3871 | 3873 | 3875 | 3877 | 3879 |
| H1H18179B | 3881 | 3883 | 3885 | 3887 | 3889 | 3891 | 3893 | 3895 |
| H1H18180B | 3897 | 3899 | 3901 | 3903 | 3905 | 3907 | 3909 | 3911 |
| H1H18181B | 3913 | 3915 | 3917 | 3919 | 3921 | 3923 | 3925 | 3927 |
| H1H18182B | 3929 | 3931 | 3933 | 3935 | 3937 | 3939 | 3941 | 3943 |
| H1H18183B | 3945 | 3947 | 3949 | 3951 | 3953 | 3955 | 3957 | 3959 |
| H1H18184B | 3961 | 3963 | 3965 | 3967 | 3969 | 3971 | 3973 | 3975 |
| H1H18185B | 3977 | 3979 | 3981 | 3983 | 3985 | 3987 | 3989 | 3991 |
| H1H18186B | 3993 | 3995 | 3997 | 3999 | 4001 | 4003 | 4005 | 4007 |
| H1H18187B | 4009 | 4011 | 4013 | 4015 | 4017 | 4019 | 4021 | 4023 |
| H1H18188B | 4025 | 4027 | 4029 | 4031 | 4033 | 4035 | 4037 | 4039 |
| H1H18189B | 4041 | 4043 | 4045 | 4047 | 4049 | 4051 | 4053 | 4055 |
| H1H18190B | 4057 | 4059 | 4061 | 4063 | 4065 | 4067 | 4069 | 4071 |
| H1H18191B | 4073 | 4075 | 4077 | 4079 | 4081 | 4083 | 4085 | 4087 |
| H1H18192B | 4089 | 4091 | 4093 | 4095 | 4097 | 4099 | 4101 | 4103 |
| H1H18193B | 4105 | 4107 | 4109 | 4111 | 4113 | 4115 | 4117 | 4119 |
| H1H18194B | 4121 | 4123 | 4125 | 4127 | 4129 | 4131 | 4133 | 4135 |
| H1H18195B | 4137 | 4139 | 4141 | 4143 | 4145 | 4147 | 4149 | 4151 |
| H1H18196B | 4153 | 4155 | 4157 | 4159 | 4161 | 4163 | 4165 | 4167 |
| H1H18197B | 4169 | 4171 | 4173 | 4175 | 4177 | 4179 | 4181 | 4183 |
| H1H18198B | 4185 | 4187 | 4189 | 4191 | 4193 | 4195 | 4197 | 4199 |
| H1H18199B | 4201 | 4203 | 4205 | 4207 | 4209 | 4211 | 4213 | 4215 |
| H1H18200B | 4217 | 4219 | 4221 | 4223 | 4225 | 4227 | 4229 | 4231 |
| H1H18201B | 4233 | 4235 | 4237 | 4239 | 4241 | 4243 | 4245 | 4247 |
| H1H18202B | 4249 | 4251 | 4253 | 4255 | 4257 | 4259 | 4261 | 4263 |
| H1H18203B | 4265 | 4267 | 4269 | 4271 | 4273 | 4275 | 4277 | 4279 |
| H1H18204B | 4281 | 4283 | 4285 | 4287 | 4289 | 4291 | 4293 | 4295 |
| H1H18205B | 4297 | 4299 | 4301 | 4303 | 4305 | 4307 | 4309 | 4311 |
| H1H18206B | 4313 | 4315 | 4317 | 4319 | 4321 | 4323 | 4325 | 4327 |
| H1H18207B | 4329 | 4331 | 4333 | 4335 | 4337 | 4339 | 4341 | 4343 |
| H1H18208B | 4345 | 4347 | 4349 | 4351 | 4353 | 4355 | 4357 | 4359 |
| H1H18209B | 4361 | 4363 | 4365 | 4367 | 4369 | 4371 | 4373 | 4375 |
| H1H18210B | 4377 | 4379 | 4381 | 4383 | 4385 | 4387 | 4389 | 4391 |
| H1H18211B | 4393 | 4395 | 4397 | 4399 | 4401 | 4403 | 4405 | 4407 |
| H1H18212B | 4409 | 4411 | 4413 | 4415 | 4417 | 4419 | 4421 | 4423 |
| H1H18213B | 4425 | 4427 | 4429 | 4431 | 4433 | 4435 | 4437 | 4439 |
| H1H18214B | 4441 | 4443 | 4445 | 4447 | 4449 | 4451 | 4453 | 4455 |
| H1H18216B | 4457 | 4459 | 4461 | 4463 | 4465 | 4467 | 4469 | 4471 |
| H1H18217B | 4473 | 4475 | 4477 | 4479 | 4481 | 4483 | 4485 | 4487 |
| H1H18218B | 4489 | 4491 | 4493 | 4495 | 4497 | 4499 | 4501 | 4503 |
| H1H18219B | 4505 | 4507 | 4509 | 4511 | 4513 | 4515 | 4517 | 4519 |
| H1H18220B | 4521 | 4523 | 4525 | 4527 | 4529 | 4531 | 4533 | 4535 |
| H1H18221B | 4537 | 4539 | 4541 | 4543 | 4545 | 4547 | 4549 | 4551 |
| H1H18222B | 4553 | 4555 | 4557 | 4559 | 4561 | 4563 | 4565 | 4567 |
| H1H18223B | 4569 | 4571 | 4573 | 4575 | 4577 | 4579 | 4581 | 4583 |
| H1H18224B | 4585 | 4587 | 4589 | 4591 | 4593 | 4595 | 4597 | 4599 |
| H1H18225B | 4601 | 4603 | 4605 | 4607 | 4609 | 4611 | 4613 | 4615 |
| H1H18226B | 4617 | 4619 | 4621 | 4623 | 4625 | 4627 | 4629 | 4631 |
| H1H18227B | 4633 | 4635 | 4637 | 4639 | 4641 | 4643 | 4645 | 4647 |
| H1H18228B | 4649 | 4651 | 4653 | 4655 | 4657 | 4659 | 4661 | 4663 |
| H1H18229B | 4665 | 4667 | 4669 | 4671 | 4673 | 4675 | 4677 | 4679 |
| H1H18230B | 4681 | 4683 | 4685 | 4687 | 4689 | 4691 | 4693 | 4695 |
| H1H18231B | 4697 | 4699 | 4701 | 4703 | 4705 | 4707 | 4709 | 4711 |
| H1H18232B | 4713 | 4715 | 4717 | 4719 | 4721 | 4723 | 4725 | 4727 |
| H1H18233B | 4729 | 4731 | 4733 | 4735 | 4737 | 4739 | 4741 | 4743 |
| H1H18234B | 4745 | 4747 | 4749 | 4751 | 4753 | 4755 | 4757 | 4759 |
| H1H18235B | 4761 | 4763 | 4765 | 4767 | 4769 | 4771 | 4773 | 4775 |
| H1H18236B | 4777 | 4779 | 4781 | 4783 | 4785 | 4787 | 4789 | 4791 |
| H1H18237B | 4793 | 4795 | 4797 | 4799 | 4801 | 4803 | 4805 | 4807 |
| H1H18238B | 4809 | 4811 | 4813 | 4815 | 4817 | 4819 | 4821 | 4823 |
| H1H18239B | 4825 | 4827 | 4829 | 4831 | 4833 | 4835 | 4837 | 4839 |
| H1H18240B | 4841 | 4843 | 4845 | 4847 | 4849 | 4851 | 4853 | 4855 |
| H1H18241B | 4857 | 4859 | 4861 | 4863 | 4865 | 4867 | 4869 | 4871 |
| H1H18242B | 4873 | 4875 | 4877 | 4879 | 4881 | 4883 | 4885 | 4887 |
| H1H18243B | 4889 | 4891 | 4893 | 4895 | 4897 | 4899 | 4901 | 4903 |
| H1H18244B | 4905 | 4907 | 4909 | 4911 | 4913 | 4915 | 4917 | 4919 |
| H1H18245B | 4921 | 4923 | 4925 | 4927 | 4929 | 4931 | 4933 | 4935 |
| H1H18246B | 4937 | 4939 | 4941 | 4943 | 4945 | 4947 | 4949 | 4951 |
| H1H18247B | 4953 | 4955 | 4957 | 4959 | 4961 | 4963 | 4965 | 4967 |
| H1H18248B | 4969 | 4971 | 4973 | 4975 | 4977 | 4979 | 4981 | 4983 |
| H1H18249B | 4985 | 4987 | 4989 | 4991 | 4993 | 4995 | 4997 | 4999 |
| H1H18250B | 5001 | 5003 | 5005 | 5007 | 5009 | 5011 | 5013 | 5015 |
| H1H18251B | 5017 | 5019 | 5021 | 5023 | 5025 | 5027 | 5029 | 5031 |
| H1H18252B | 5033 | 5035 | 5037 | 5039 | 5041 | 5043 | 5045 | 5047 |
| H1H18253B | 5049 | 5051 | 5053 | 5055 | 5057 | 5059 | 5061 | 5063 |
| H1H18254B | 5065 | 5067 | 5069 | 5071 | 5073 | 5075 | 5077 | 5079 |
| H1H18255B | 5081 | 5083 | 5085 | 5087 | 5089 | 5091 | 5093 | 5095 |
| H1H18256B | 5097 | 5099 | 5101 | 5103 | 5105 | 5107 | 5109 | 5111 |
| H1H18257B | 5113 | 5115 | 5117 | 5119 | 5121 | 5123 | 5125 | 5127 |
| H1H18258B | 5129 | 5131 | 5133 | 5135 | 5137 | 5139 | 5141 | 5143 |
| H1H18259B | 5145 | 5147 | 5149 | 5151 | 5153 | 5155 | 5157 | 5159 |
| H1H18261B | 5161 | 5163 | 5165 | 5167 | 5169 | 5171 | 5173 | 5175 |
| H1H18262B | 5177 | 5179 | 5181 | 5183 | 5185 | 5187 | 5189 | 5191 |
| H1H18263B | 5193 | 5195 | 5197 | 5199 | 5201 | 5203 | 5205 | 5207 |
| H1H18264B | 5209 | 5211 | 5213 | 5215 | 5217 | 5219 | 5221 | 5223 |
| H1H18265B | 5225 | 5227 | 5229 | 5231 | 5233 | 5235 | 5237 | 5239 |
| H1H18266B | 5241 | 5243 | 5245 | 5247 | 5249 | 5251 | 5253 | 5255 |
| H1H18267B | 5257 | 5259 | 5261 | 5263 | 5265 | 5267 | 5269 | 5271 |
| H1H18268B | 5273 | 5275 | 5277 | 5279 | 5281 | 5283 | 5285 | 5287 |
| H1H18269B | 5289 | 5291 | 5293 | 5295 | 5297 | 5299 | 5301 | 5303 |
| H1H18270B | 5305 | 5307 | 5309 | 5311 | 5313 | 5315 | 5317 | 5319 |
| H1H18271B | 5321 | 5323 | 5325 | 5327 | 5329 | 5331 | 5333 | 5335 |
| H1H18272B | 5337 | 5339 | 5341 | 5343 | 5345 | 5347 | 5349 | 5351 |
| H1H18274B | 5353 | 5355 | 5357 | 5359 | 5361 | 5363 | 5365 | 5367 |
| H1H18275B | 5369 | 5371 | 5373 | 5375 | 5377 | 5379 | 5381 | 5383 |
| H1H18276B | 5385 | 5387 | 5389 | 5391 | 5393 | 5395 | 5397 | 5399 |
| H1H18277B | 5401 | 5403 | 5405 | 5407 | 5409 | 5411 | 5413 | 5415 |
| H1H18278B | 5417 | 5419 | 5421 | 5423 | 5425 | 5427 | 5429 | 5431 |
| H1H18279B | 5433 | 5435 | 5437 | 5439 | 5441 | 5443 | 5445 | 5447 |
| H1H18280B | 5449 | 5451 | 5453 | 5455 | 5457 | 5459 | 5461 | 5463 |
| H1H18281B | 5465 | 5467 | 5469 | 5471 | 5473 | 5475 | 5477 | 5479 |
| H1H18282B | 5481 | 5483 | 5485 | 5487 | 5489 | 5491 | 5493 | 5495 |
| H1H18283B | 5497 | 5499 | 5501 | 5503 | 5505 | 5507 | 5509 | 5511 |
| H1H18284B | 5513 | 5515 | 5517 | 5519 | 5521 | 5523 | 5525 | 5527 |
| H1H18285B | 5529 | 5531 | 5533 | 5535 | 5537 | 5539 | 5541 | 5543 |
| H1H18286B | 5545 | 5547 | 5549 | 5551 | 5553 | 5555 | 5557 | 5559 |
| H1H18287B | 5561 | 5563 | 5565 | 5567 | 5569 | 5571 | 5573 | 5575 |
| H1H18288B | 5577 | 5579 | 5581 | 5583 | 5585 | 5587 | 5589 | 5591 |
| H1H18289B | 5593 | 5595 | 5597 | 5599 | 5601 | 5603 | 5605 | 5607 |
| H1H18290B | 5609 | 5611 | 5613 | 5615 | 5617 | 5619 | 5621 | 5623 |
| H1H18291B | 5625 | 5627 | 5629 | 5631 | 5633 | 5635 | 5637 | 5639 |
| H1H18292B | 5641 | 5643 | 5645 | 5647 | 5649 | 5651 | 5653 | 5655 |
| H1H18293B | 5657 | 5659 | 5661 | 5663 | 5665 | 5667 | 5669 | 5671 |
| H1H18294B | 5673 | 5675 | 5677 | 5679 | 5681 | 5683 | 5685 | 5687 |
| H1H18295B | 5689 | 5691 | 5693 | 5695 | 5697 | 5699 | 5701 | 5703 |
| H1H18297B | 5705 | 5707 | 5709 | 5711 | 5713 | 5715 | 5717 | 5719 |
| H1H18298B | 5721 | 5723 | 5725 | 5727 | 5729 | 5731 | 5733 | 5735 |
| H1H18299B | 5737 | 5739 | 5741 | 5743 | 5745 | 5747 | 5749 | 5751 |
| H1H18300B | 5753 | 5755 | 5757 | 5759 | 5761 | 5763 | 5765 | 5767 |
| H1H18301B | 5769 | 5771 | 5773 | 5775 | 5777 | 5779 | 5781 | 5783 |
| H1H18302B | 5785 | 5787 | 5789 | 5791 | 5793 | 5795 | 5797 | 5799 |
| H1H18303B | 5801 | 5803 | 5805 | 5807 | 5809 | 5811 | 5813 | 5815 |
| H1H18304B | 5817 | 5819 | 5821 | 5823 | 5825 | 5827 | 5829 | 5831 |
| H1H18305B | 5833 | 5835 | 5837 | 5839 | 5841 | 5843 | 5845 | 5847 |
| H1H18306B | 5849 | 5851 | 5853 | 5855 | 5857 | 5859 | 5861 | 5863 |
| H1H18307B | 5865 | 5867 | 5869 | 5871 | 5873 | 5875 | 5877 | 5879 |
| H1H18308B | 5881 | 5883 | 5885 | 5887 | 5889 | 5891 | 5893 | 5895 |
| H1H18309B | 5897 | 5899 | 5901 | 5903 | 5905 | 5907 | 5909 | 5911 |
| H1H18310B | 5913 | 5915 | 5917 | 5919 | 5921 | 5923 | 5925 | 5927 |
| H1H18311B | 5929 | 5931 | 5933 | 5935 | 5937 | 5939 | 5941 | 5943 |
| H1H18312B | 5945 | 5947 | 5949 | 5951 | 5953 | 5955 | 5957 | 5959 |
| H1H18313B | 5961 | 5963 | 5965 | 5967 | 5969 | 5971 | 5973 | 5975 |
| H1H18314B | 5977 | 5979 | 5981 | 5983 | 5985 | 5987 | 5989 | 5991 |
| H1H18315B | 5993 | 5995 | 5997 | 5999 | 6001 | 6003 | 6005 | 6007 |
| H1H18316B | 6009 | 6011 | 6013 | 6015 | 6017 | 6019 | 6021 | 6023 |
| H1H18317B | 6025 | 6027 | 6029 | 6031 | 6033 | 6035 | 6037 | 6039 |
| H1H18318B | 6041 | 6043 | 6045 | 6047 | 6049 | 6051 | 6053 | 6055 |
| H1H18319B | 6057 | 6059 | 6061 | 6063 | 6065 | 6067 | 6069 | 6071 |
| H1H18320B | 6073 | 6075 | 6077 | 6079 | 6081 | 6083 | 6085 | 6087 |
| H1H18321B | 6089 | 6091 | 6093 | 6095 | 6097 | 6099 | 6101 | 6103 |
| H1H18322B | 6105 | 6107 | 6109 | 6111 | 6113 | 6115 | 6117 | 6119 |
| H1H18323B | 6121 | 6123 | 6125 | 6127 | 6129 | 6131 | 6133 | 6135 |
| H1H18324B | 6137 | 6139 | 6141 | 6143 | 6145 | 6147 | 6149 | 6151 |
| H1H18325B | 6153 | 6155 | 6157 | 6159 | 6161 | 6163 | 6165 | 6167 |
| H1H18326B | 6169 | 6171 | 6173 | 6175 | 6177 | 6179 | 6181 | 6183 |
| H1H18327B | 6185 | 6187 | 6189 | 6191 | 6193 | 6195 | 6197 | 6199 |
| H1H18328B | 6201 | 6203 | 6205 | 6207 | 6209 | 6211 | 6213 | 6215 |
| H1H18329B | 6217 | 6219 | 6221 | 6223 | 6225 | 6227 | 6229 | 6231 |
| H1H18330B | 6233 | 6235 | 6237 | 6239 | 6241 | 6243 | 6245 | 6247 |
| H1H18331B | 6249 | 6251 | 6253 | 6255 | 6257 | 6259 | 6261 | 6263 |
| H1H18332B | 6265 | 6267 | 6269 | 6271 | 6273 | 6275 | 6277 | 6279 |
| H1H18333B | 6281 | 6283 | 6285 | 6287 | 6289 | 6291 | 6293 | 6295 |
| H1H18334B | 6297 | 6299 | 6301 | 6303 | 6305 | 6307 | 6309 | 6311 |
| H1H18335B | 6313 | 6315 | 6317 | 6319 | 6321 | 6323 | 6325 | 6327 |
| 약물 | T1/2 (d) | Cmax (μ/mL) | AUC(d* μ /mL) |
| H1H11729P | 11.1 ± 0.8 | 12.0 ± 0.9 | 147 ± 3.4 |
| Control I mAb | 5.67 ± 0.6 | 10.4 ± 0.6 | 93.8 ± 4.8 |
| 약물 | T1/2 (d) | Cmax (μg/mL) | AUC(d* μg /mL) |
| H1H11729P | 13.4 ± 1.46 | 41.3 ± 7.84 | 863 ± 145 |
| Control I mAb | 8.05 ± 2.17 | 24.9 ± 1.87 | 320 ± 70.1 |
| PID | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) |
| 경구 위관 영양법 대조군 (미감염) | 5 | 100 (5/5) |
| H1H11729P | 5 | 100 (5/5) |
| 오셀타미비르 (25 mg/kg BID x 5d) | 5 | 40 (2/5) |
| 오셀타미비르 (5 mg/kg BID x 5d) | 5 | 0 (0/5) |
| hIgG1 음성 아이소타입 대조군 | 5 | 0 (0/5) |
| 경구 위관 영양법 대조군 (감염) | 5 | 0 (0/5) |
| PID | 군 당 마우스의 수 | 퍼센트 생존률 (각 군에서 생존한 마우스의 수/마우스의 총 수) |
| H1H11729P (15 mg/kg) | 15 | 60 (9/15) |
| H1H11729P (7 mg/kg) | 15 | 35.7 (5/15) |
| H1H11729P (15 mg/kg) + 오셀타미비르 (25 mg/kg BID x 5d) | 15 | 86.7 (13/15) |
| H1H11729P (7 mg/kg) + 오셀타미비르 (25 mg/kg BID x 5d) | 15 | 60 (9/15) |
| 오셀타미비르 (25 mg/kg BID x 5 d) | 15 | 20 (3/15) |
| hIgG1 음성 아이소타입 대조군 | 15 | 0 (0/15) |
| 경구 위관 영양법 대조군 (감염) | 15 | 0 (0/15) |
Claims (36)
- 인플루엔자 A 헤마글루티닌 (HA)에 특이적으로 결합하는 분리된 재조합 항체 또는 이것의 항원-결합 단편으로서, 항체 또는 이것의 항원-결합 단편은
i) (a) 서열번호: 20의 HCDR1, (b) 서열번호: 22의 HCDR2; (c) 서열번호: 24의 HCDR3; (d) 서열번호: 28의 LCDR1; (e) 서열번호: 30의 LCDR2 및 (f) 서열번호: 32의 LCDR3, 또는
ii) (a) 서열번호: 52의 HCDR1, (b) 서열번호: 54의 HCDR2; (c) 서열번호: 56의 HCDR3; (d) 서열번호: 68의 LCDR1; (e) 서열번호: 70의 LCDR2 및 (f) 서열번호: 72의 LCDR3
을 포함하는, 분리된 재조합 항체 또는 이것의 항원-결합 단편. - 제1 항에 있어서, 항체 또는 이것의 항원 결합 단편은
(a) 완전한 인간 단클론성 항체이다;
(b) 실시간 생체막 간섭계 기반 바이오센서로 측정된 것으로서 10-9M 미만의 해리 상수 (KD)로 인플루엔자 HA에 결합한다;
(c) 370분 초과의 해리 반감기 (t½)를 나타낸다;
(d) H1N1, H5N1, H9N2, H13N6 및 H16N3으로부터 선택된 1군 인플루엔자 A 바이러스의 중화를 나타내며, IC50은 130nM 미만이다;
(e) 인플루엔자 바이러스 감염된 세포의 보체 매개 용해를 나타내며 EC50은 66nM 미만이다; 및
(f) 인플루엔자 바이러스 감염의 동물 모델에서 바이러스 공격접종 이전 또는 이후 투여될 때 상기 항체 또는 이것의 항원 결합 단편이 투여되지 않았을 때와 비교하여 증가된 생존률을 나타낸다
는 특징들 중 둘 이상을 가지는, 분리된 재조합 항체 또는 이것의 항원-결합 단편. - 제1 항에 있어서, 항체는 원숭이에서 Control I mAb보다 1.5배 더 큰 해리 반감기 및 마우스에서 Control I mAb보다 2배 더 큰 해리 반감기를 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 감염 후 48시간에 투여될 때, 오셀타미비르와 비교하여 인플루엔자 바이러스 감염된 포유동물에서 증가된 생존률을 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 5 mg/kg 내지 25 mg/kg의 용량으로 5일 동안 1일 2회 투여된 오셀타미비르의 경구 투여와 비교하여 15 mg/kg의 1회 정맥 내 용량으로서 인플루엔자 바이러스 감염된 포유동물에 투여될 때 증가된 생존률을 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 감염 후 48시간에 15 mg/kg의 1회 용량으로 투여될 때, 인플루엔자 바이러스 감염된 포유동물에서 100%의 생존률을 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 25 mg/kg의 용량으로 5일 동안 1일 2회 경구 투여될 때 오셀타미비르로 관찰된 40% 생존률과 비교하여 15 mg/kg의 1회 용량으로 투여될 때 인플루엔자 바이러스로 감염된 포유동물에서 100%의 생존률을 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 감염 후 72시간에 오셀타미비르와 함께 투여될 때 인플루엔자 바이러스로 감염된 포유동물에서 오셀타미비르가 단독으로 투여될 때와 비교하여 증가된 생존률을 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 오셀타미비르와 조합하여 사용될 때, 항체가 7 mg/kg 내지 15 mg/kg의 범위의 1회 정맥 내 용량으로 투여되고 오셀타미비르가 25 mg/kg의 용량으로 5일 동안 1일 2회 경구 투여되는 경우 오셀타미비르가 단독으로 투여될 때와 비교하여 증가된 생존률을 나타내는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 서열 번호: 18 또는 50으로 구성된 중쇄 가변 영역(HCVR)을 포함하는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 서열 번호: 26 또는 66으로 구성된 경쇄 가변 영역(LCVR)을 포함하는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 서열 번호: 18/26으로 구성된 HCVR/LCVR 아미노산 서열 쌍을 포함하는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 서열 번호: 50/66으로 구성된 HCVR/LCVR 아미노산 서열 쌍을 포함하는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항에 있어서, 항체는 숙주 세포로의 인플루엔자 바이러스의 부착 및/또는 진입을 방지하는 것을 특징으로 하는 분리된 재조합 항체 또는 이것의 항원-결합 단편.
- 제1 항 내지 제14 항 중 어느 한 항에 제시된 항체의 HCVR을 암호화하는 폴리뉴클레오타이드 서열을 포함하는 제1 핵산 분자, 및 LCVR을 암호화하는 폴리뉴클레오타이드 서열을 포함하는 제2 핵산 분자를 포함하는, 조성물.
- 제1 항 내지 제14 항 중 어느 한 항에 제시된 항체의 HCVR을 암호화하는 폴리뉴클레오타이드 서열을 포함하는 제1 핵산 분자, 및 LCVR을 암호화하는 폴리뉴클레오타이드 서열을 포함하는 제2 핵산 분자를 포함하는, 숙주 세포.
- 제16 항에 있어서, HCVR을 암호화하는 폴리뉴클레오타이드 서열을 포함하는 제1 핵산 분자가 발현 벡터 내에 있는 것을 특징으로 하는 숙주 세포.
- 제16 항에 있어서, LCVR을 암호화하는 폴리뉴클레오타이드 서열을 포함하는 제2 핵산 분자가 발현 벡터 내에 있는 것을 특징으로 하는 숙주 세포.
- 인플루엔자 바이러스 감염을 예방, 치료 또는 경감하기 위한 약학적 조성물로서, 제1 항 내지 제14 항 중 어느 한 항의 분리된 재조합 항체 또는 이것의 항원-결합 단편 및 약학적으로 허용 가능한 담체 또는 희석제를 포함하는, 약학적 조성물.
- 제19 항에 있어서, 약학적 조성물은 열, 기침, 근육통, 비루, 숨가쁨, 폐렴 또는 기관지염으로 구성된 군으로부터 선택되는 인플루엔자 바이러스 감염으로 인한 하나 이상의 증상을 예방, 치료 또는 경감하는 것을 특징으로 하는 약학적 조성물.
- 제19 항에 있어서, 약학적 조성물은 대상체에게 예방적으로 또는 치료적으로 투여되는 것을 특징으로 하는 약학적 조성물.
- 제21 항에 있어서, 약학적 조성물은 면역 손상된 개체, 65세를 초과한 고령의 성인, 의료계 종사자 및 기저 질환의 병력을 가진 사람으로 구성된 군으로부터 선택된 대상체에게 예방적으로 투여되는 것을 특징으로 하는 약학적 조성물.
- 제22 항에 있어서, 기저 질환은 심장병 또는 당뇨병인 것을 특징으로 하는 약학적 조성물.
- 제19 항에 있어서, 약학적 조성물은 항바이러스제, 항염증제, 인플루엔자 HA에 대한 다른 항체, 인플루엔자에 대한 백신, 식이보충제 및 인플루엔자 감염을 치료하기 위한 임의의 다른 완화 요법으로 구성된 군으로부터 선택되는 제2 치료제와 조합하여 투여되는 것을 특징으로 하는 약학적 조성물.
- 제24 항에 있어서, 항염증제는 코르티코스테로이드 또는 비-스테로이드성 항염증제인 것을 특징으로 하는 약학적 조성물.
- 제24 항에 있어서, 식이보충제는 항산화제인 것을 특징으로 하는 약학적 조성물.
- 제24 항에 있어서, 제2 치료제는 항체와 같은 투여 경로를 통해 또는 항체와 다른 투여 경로를 통해 투여되는 것을 특징으로 하는 약학적 조성물.
- 제27 항에 있어서, 제2 치료제는 경구로 투여되는 것을 특징으로 하는 약학적 조성물.
- 제24 항에 있어서, 항바이러스제는 오셀타미비르인 것을 특징으로 하는 약학적 조성물.
- 제29 항에 있어서, 오셀타미비르는 항체의 투여 이전에, 투여와 동시에, 또는 투여 이후에 투여되는 것을 특징으로 하는 약학적 조성물.
- 제19 항에 있어서, 약학적 조성물은 피하로, 정맥 내로, 피부 내로, 근육 내로, 비강 내로, 또는 경구로 투여되는 것을 특징으로 하는 약학적 조성물.
- 항인플루엔자 A 헤마글루티닌(HA) 항체 또는 이것의 항원-결합 단편을 생산하는 방법으로서, 항체 또는 이것의 항원-결합 단편의 생산을 허용하는 조건 하에서 제16 항의 숙주 세포를 배양하는 단계를 포함하고, 선택적으로 생산된 항체 또는 이것의 항원-결합 단편을 회수하는 단계를 포함하는, 방법.
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462094752P | 2014-12-19 | 2014-12-19 | |
| US62/094,752 | 2014-12-19 | ||
| US201562152122P | 2015-04-24 | 2015-04-24 | |
| US62/152,122 | 2015-04-24 | ||
| PCT/US2015/066654 WO2016100807A2 (en) | 2014-12-19 | 2015-12-18 | Human antibodies to influenza hemagglutinin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20170098888A KR20170098888A (ko) | 2017-08-30 |
| KR102729973B1 true KR102729973B1 (ko) | 2024-11-14 |
Family
ID=55073153
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020177020050A Active KR102729973B1 (ko) | 2014-12-19 | 2015-12-18 | 인플루엔자 헤마글루티닌에 대한 인간 항체 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10392432B2 (ko) |
| EP (1) | EP3233908A2 (ko) |
| JP (2) | JP6711828B2 (ko) |
| KR (1) | KR102729973B1 (ko) |
| CN (1) | CN108064240B (ko) |
| AU (1) | AU2015364415B2 (ko) |
| BR (1) | BR112017012944A2 (ko) |
| CA (1) | CA2969749A1 (ko) |
| CL (2) | CL2017001610A1 (ko) |
| CO (1) | CO2017006580A2 (ko) |
| EA (1) | EA036953B1 (ko) |
| IL (1) | IL252659B (ko) |
| MX (2) | MX386403B (ko) |
| MY (1) | MY185320A (ko) |
| PH (1) | PH12017500949A1 (ko) |
| SG (2) | SG11201704212SA (ko) |
| TW (2) | TWI702229B (ko) |
| UY (1) | UY36458A (ko) |
| WO (1) | WO2016100807A2 (ko) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| JP7104629B2 (ja) | 2016-02-24 | 2022-07-21 | ビステラ, インコーポレイテッド | インフルエンザウイルスに対する抗体分子の製剤 |
| UA127450C2 (uk) * | 2016-09-21 | 2023-08-30 | Аптево Рісьорч Енд Дівелопмент Елелсі | Рекомбінантний поліпептид, що зв'язується з cd123 |
| WO2018075621A1 (en) * | 2016-10-19 | 2018-04-26 | Vanderbilt University | Human orthopoxvirus antibodies and methods of use therefor |
| TWI781130B (zh) * | 2017-01-03 | 2022-10-21 | 美商再生元醫藥公司 | 抗金黃色葡萄球菌溶血素a毒素之人類抗體 |
| US11434303B2 (en) | 2017-06-28 | 2022-09-06 | Bluefin Biomedicine, Inc. | Anti-LY6H antibodies and antibody drug conjugates |
| SG11202001368SA (en) * | 2017-08-18 | 2020-03-30 | Gritstone Oncology Inc | Antigen-binding proteins tatrgeting shared antigens |
| MX2020007772A (es) | 2018-01-26 | 2020-09-18 | Regeneron Pharma | Anticuerpos humanos contra hemaglutinina de influenza. |
| US10941213B2 (en) | 2018-01-26 | 2021-03-09 | Regeneron Pharmaceuticals, Inc. | Anti-TMPRSS2 antibodies and antigen-binding fragments |
| WO2019169231A1 (en) * | 2018-03-02 | 2019-09-06 | The University Of Chicago | Methods and composition for neutralization of influenza |
| KR20200060969A (ko) * | 2018-11-23 | 2020-06-02 | (주)셀트리온 | 인플루엔자 바이러스 질환을 치료하기 위한 투여 요법 |
| KR20210126641A (ko) | 2019-02-12 | 2021-10-20 | 리제너론 파아마슈티컬스, 인크. | 보체 및 표적 항원에 결합하기 위해 이중 특이적 항체를 사용하는 조성물 및 방법 |
| CA3132521A1 (en) * | 2019-03-25 | 2020-10-01 | Visterra, Inc. | Compositions and methods for treating and preventing influenza |
| MX2021011956A (es) | 2019-04-03 | 2021-12-15 | Regeneron Pharma | Metodos y composiciones para la insercion de secuencias codificantes de anticuerpos en un locus de puerto seguro. |
| WO2020251834A1 (en) * | 2019-06-11 | 2020-12-17 | The Rockefeller University | Antibodies and methods for treatment of viral infections |
| WO2021026064A2 (en) * | 2019-08-06 | 2021-02-11 | Regents Of The University Of Minnesota | Compositions and methods for treating serpin b13 disorders |
| US11773156B2 (en) * | 2019-10-28 | 2023-10-03 | Regeneron Pharmaceuticals, Inc. | Anti-hemagglutinin antibodies and methods of use thereof |
| KR20210095781A (ko) | 2020-01-24 | 2021-08-03 | 주식회사 에이프릴바이오 | 항원결합 단편 및 생리활성 이펙터 모이어티로 구성된 융합 컨스트럭트를 포함하는 다중결합항체 및 이를 포함하는 약학조성물 |
| IL294989A (en) | 2020-01-24 | 2022-09-01 | Regeneron Pharma | Protein-antiviral compound conjugates |
| CN115427457A (zh) | 2020-02-10 | 2022-12-02 | 瑞泽恩制药公司 | 抗tmprss2抗体和抗原结合片段 |
| SI4045533T1 (sl) | 2020-03-26 | 2024-03-29 | Vanderbilt University | Človeška monoklonska protitelesa proti koronavirusu s hudim akutnim respiratornim sindromom 2 (SARS-COV-2) |
| US20230122364A1 (en) * | 2020-03-27 | 2023-04-20 | Vanderbilt University | HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2) |
| CN113527483B (zh) * | 2020-04-17 | 2023-09-22 | 珠海泰诺麦博制药股份有限公司 | 抗人神经生长因子的抗体 |
| BR112022021780A2 (pt) | 2020-04-27 | 2023-03-07 | Twist Bioscience Corp | Bibliotecas de ácido nucléico variantes para coronavírus |
| US20230391856A1 (en) * | 2020-10-23 | 2023-12-07 | Icahn School Of Medicine At Mount Sinai | Sars-cov-2 antibodies and uses thereof |
| KR102604669B1 (ko) * | 2021-03-30 | 2023-11-21 | 충남대학교산학협력단 | 조류인플루엔자 바이러스의 ha 단백질에 특이적인 단클론항체, 및 이의 용도 |
| IL307947A (en) | 2021-07-28 | 2023-12-01 | Regeneron Pharma | An antiviral compound of proteins |
| WO2023034564A2 (en) * | 2021-09-02 | 2023-03-09 | Memorial Sloan-Kettering Cancer Center | Anti-cd33 antibodies and uses thereof |
| US20250059260A1 (en) * | 2021-12-22 | 2025-02-20 | The University Of Chicago | Methods for detecting or treating influenza infections |
| KR20240135631A (ko) | 2022-01-14 | 2024-09-11 | 리제너론 파마슈티칼스 인코포레이티드 | 베루카린 a 유도체 및 이의 항체 약물 접합체 |
| CN120659785A (zh) | 2022-11-30 | 2025-09-16 | 里珍纳龙药品有限公司 | Tlr7激动剂及其抗体-药物缀合物 |
| CN115993452B (zh) * | 2023-03-23 | 2023-06-16 | 深圳市卫光生物制品股份有限公司 | 一种流感病毒疫苗血凝素含量测定方法及试剂盒 |
| WO2025077869A1 (en) * | 2023-10-13 | 2025-04-17 | Biocytogen Pharmaceuticals (Beijing) Co., Ltd. | Anti-ny-eso-1 antibodies and uses thereof |
| WO2025117727A1 (en) | 2023-11-29 | 2025-06-05 | Regeneron Pharmaceuticals, Inc. | Analogs of quinoxaline/quinoline cytotoxins, linker- payloads, protein-drug conjugates, and uses thereof |
| WO2025160340A2 (en) | 2024-01-26 | 2025-07-31 | Regeneron Pharmaceuticals, Inc. | Combination immunosuppression for inhibiting an immune response and enabling immunogen administration and re-administration |
| WO2025160324A2 (en) | 2024-01-26 | 2025-07-31 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for using plasma cell depleting agents and/or b cell depleting agents to suppress host anti-aav antibody response and enable aav transduction and re-dosing |
| WO2025166216A1 (en) * | 2024-02-02 | 2025-08-07 | The Board Of Regents Of The University Of Texas System | Trop2-targeting antibodies and uses thereof |
| WO2025184137A1 (en) * | 2024-02-27 | 2025-09-04 | Adimab, Llc | Influenza antibodies and methods of use thereof |
| WO2025184567A1 (en) | 2024-03-01 | 2025-09-04 | Regeneron Pharmaceuticals, Inc. | Methods and compositions for re-dosing aav using anti-cd40 antagonistic antibody to suppress host anti-aav antibody response |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013011347A1 (en) * | 2011-07-18 | 2013-01-24 | Institute For Research In Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
Family Cites Families (54)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5589174A (en) | 1992-09-17 | 1996-12-31 | Takara Shuzo Co., Ltd. | Anti-human influenza virus antibody |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| WO2005103081A2 (en) | 2004-04-20 | 2005-11-03 | Genmab A/S | Human monoclonal antibodies against cd20 |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| AU2007254831B2 (en) | 2006-06-02 | 2012-03-22 | Regeneron Pharmaceuticals, Inc. | High affinity antibodies to human IL-6 receptor |
| EA017203B1 (ru) * | 2006-09-07 | 2012-10-30 | Круселл Холланд Б.В. | Связывающие молекулы человека, способные нейтрализовать вирус гриппа h5n1, и их применение |
| US8124092B2 (en) | 2007-03-13 | 2012-02-28 | Institute For Research In Biomedicine | Antibodies against H5N1 strains of influenza A virus |
| WO2008140415A1 (en) | 2007-05-11 | 2008-11-20 | Temasek Life Sciences Laboratory Limited | H5 subtype-specific binding proteins useful for h5 avian influenza diagnosis and surveillance |
| EP2174957B1 (en) | 2007-06-15 | 2016-03-16 | Xiamen University | Monoclonal antibodies binding to avian influenza virus subtype h5 haemagglutinin and uses thereof |
| WO2009035412A1 (en) | 2007-09-13 | 2009-03-19 | Temasek Life Sciences Laboratory Limited | Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof |
| SG183032A1 (en) | 2007-09-13 | 2012-08-30 | Temasek Life Sciences Lab Ltd | Monoclonal antibodies specific to hemagglutininand neuraminidase from influenza virus h5-subtypeor n1-subtype and uses thereof |
| FR2921928B1 (fr) | 2007-10-08 | 2011-03-04 | Sanofi Pasteur | Anticorps monoclonaux specifiques de l'hemagglutinine du virus grippal |
| US20110038935A1 (en) | 2007-12-06 | 2011-02-17 | Marasco Wayne A | Antibodies against influenza virus and methods of use thereof |
| US8574830B2 (en) | 2008-02-05 | 2013-11-05 | Temasek Life Sciences Laboratory Limited | Binding protein and epitope-blocking ELISA for the universal detection of H5-subtype influenza viruses |
| WO2009111865A1 (en) | 2008-03-12 | 2009-09-17 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Health | Reagents and methods for detecting influenza virus proteins |
| ITTO20080204A1 (it) | 2008-03-17 | 2009-09-18 | Pomona Biotechnologies Llc | Anticorpi monoclonali atti a reagire con una pluralita di sottotipi del virus influenzale a |
| CN101990575B (zh) | 2008-03-28 | 2015-06-17 | 国立大学法人北海道大学 | 抗h5亚型a型流感病毒血凝素单克隆抗体 |
| US20100040635A1 (en) | 2008-03-28 | 2010-02-18 | Sea Lane Biotechnologies | Neutralizing antibodies to influenza viruses |
| ITTO20080398A1 (it) | 2008-05-27 | 2009-11-28 | Pomona Biotechnologies Llc | Anticorpi monoclonali aventi proprieta' di cross-neutralizzazione omosubtipica per virus influenzali di tipo a sottotipo h1 |
| ES2662519T3 (es) | 2008-07-25 | 2018-04-06 | Institute For Research In Biomedicine | Anticuerpos neutralizantes contra el virus de la gripe A y usos de estos |
| US8871207B2 (en) | 2008-07-25 | 2014-10-28 | Humabs, LLC | Neutralizing anti-influenza A virus antibodies and uses thereof |
| EP2328928A2 (en) | 2008-08-25 | 2011-06-08 | Dana-Farber Cancer Institute, Inc. | Conserved influenza hemagglutinin epitope and antibodies thereto |
| CN102292350A (zh) | 2008-12-24 | 2011-12-21 | 淡马锡生命科学研究院有限公司 | 对来自甲型流感病毒血凝素的融合肽特异的单克隆抗体及其用途 |
| JP5780762B2 (ja) | 2008-12-25 | 2015-09-16 | 国立大学法人大阪大学 | 抗ヒトインフルエンザウイルス・ヒト型抗体 |
| WO2010127252A2 (en) | 2009-04-30 | 2010-11-04 | Vanderbilt University | Monoclonal antibodies to influenza h1n1 virus and uses thereof |
| MY183517A (en) | 2009-05-11 | 2021-02-24 | Janssen Vaccines & Prevention Bv | Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof |
| AU2010249046A1 (en) | 2009-05-13 | 2011-12-01 | Sea Lane Biotechnologies, Llc | Neutralizing molecules to influenza viruses |
| AU2010254136B2 (en) | 2009-05-26 | 2016-09-29 | Mount Sinai School Of Medicine | Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof |
| TWI507525B (zh) | 2009-06-26 | 2015-11-11 | Regeneron Pharma | 具天然免疫球蛋白形式之易分離的雙專一性抗體 |
| JP2013501807A (ja) | 2009-08-14 | 2013-01-17 | セラクローン サイエンシーズ, インコーポレイテッド | インフルエンザの治療および診断のための組成物および方法 |
| WO2011041391A1 (en) | 2009-09-29 | 2011-04-07 | Fraunhofer Usa, Inc. | Influenza hemagglutinin antibodies, compositions, and related methods |
| KR102283195B1 (ko) | 2010-02-08 | 2021-07-29 | 리제너론 파마슈티칼스 인코포레이티드 | 일반적인 경쇄 마우스 |
| EP2545074A4 (en) | 2010-03-08 | 2014-01-08 | Celltrion Inc | HUMAN MONOCLONAL ANTIBODIES MADE FROM HUMAN B-CELLS WITH NEUTRALIZING EFFECT AGAINST INFLUENZA A-VIRUS |
| US20130022608A1 (en) | 2010-03-26 | 2013-01-24 | Pomona Ricerca S.R.L. | FULL-LENGTH IgG IMMUNOGLOBULINS CAPABLE OF RECOGNIZING A HETEROSUBTYPE NEUTRALIZING EPITOPE ON THE HEMAGGLUTININ STEM REGION AND USES THEREOF |
| CN106397584A (zh) * | 2010-06-17 | 2017-02-15 | 特瑞利斯生物科学有限责任公司 | 可用于被动流感免疫的抗体 |
| AU2011289275A1 (en) | 2010-08-12 | 2013-02-21 | Theraclone Sciences, Inc. | Anti-hemagglutinin antibody compositions and methods of use thereof |
| SG187769A1 (en) | 2010-08-23 | 2013-03-28 | Temasek Life Sciences Lab Ltd | Monoclonal antibody specific to major neutralizing epitope of influenza h5 hemagglutinin |
| US9534042B2 (en) | 2010-09-03 | 2017-01-03 | Fujita Health University | Influenza virus-neutralizing antibody and screening method therefor |
| WO2012045001A2 (en) | 2010-09-30 | 2012-04-05 | Vanderbilt University | Influenza virus antibodies and immunogens and uses therefor |
| US8900585B2 (en) | 2010-10-20 | 2014-12-02 | New York Blood Center, Inc. | Influenza hemagglutinin-specific monoclonal antibodies for preventing and treating influenza virus infection |
| US8916160B2 (en) | 2011-02-14 | 2014-12-23 | Theraclone Sciences, Inc. | Compositions and methods for the therapy and diagnosis of influenza |
| IN2014CN00953A (ko) | 2011-07-14 | 2015-04-10 | Crucell Holland Bv | |
| AU2012346669B2 (en) | 2011-12-02 | 2017-08-31 | Kling Biotherapeutics B.V. | Influenza A virus specific antibodies |
| ES2664625T3 (es) | 2012-03-08 | 2018-04-20 | Janssen Vaccines & Prevention B.V. | Moléculas de unión humanas que pueden unirse a los virus de la influenza b y neutralizarlos, y sus usos |
| US9969794B2 (en) | 2012-05-10 | 2018-05-15 | Visterra, Inc. | HA binding agents |
| BR112014027991A2 (pt) | 2012-05-10 | 2017-07-18 | Massachusetts Inst Technology | agentes para neutralização de influenza |
| US20140086927A1 (en) | 2012-09-25 | 2014-03-27 | Fujita Health University | Novel epitope and mechanism of antigen-antibody interaction in an influenza virus |
| CA2890669A1 (en) | 2012-11-13 | 2014-05-22 | Genetech, Inc. | Anti-hemagglutinin antibodies and methods of use |
| KR20140118682A (ko) | 2013-03-29 | 2014-10-08 | (주)셀트리온 | 2 이상의 인플루엔자 a 바이러스 중화 결합 분자를 포함하는 조성물 |
| SG10202103140XA (en) | 2013-10-02 | 2021-05-28 | Medimmune Llc | Neutralizing anti-influenza a antibodies and uses thereof |
| TWI702229B (zh) | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| US10941213B2 (en) * | 2018-01-26 | 2021-03-09 | Regeneron Pharmaceuticals, Inc. | Anti-TMPRSS2 antibodies and antigen-binding fragments |
-
2015
- 2015-12-17 TW TW108142869A patent/TWI702229B/zh not_active IP Right Cessation
- 2015-12-17 TW TW104142578A patent/TWI701258B/zh not_active IP Right Cessation
- 2015-12-18 CN CN201580076671.9A patent/CN108064240B/zh active Active
- 2015-12-18 JP JP2017528166A patent/JP6711828B2/ja active Active
- 2015-12-18 WO PCT/US2015/066654 patent/WO2016100807A2/en active Application Filing
- 2015-12-18 EP EP15820981.7A patent/EP3233908A2/en active Pending
- 2015-12-18 KR KR1020177020050A patent/KR102729973B1/ko active Active
- 2015-12-18 US US14/974,361 patent/US10392432B2/en active Active
- 2015-12-18 SG SG11201704212SA patent/SG11201704212SA/en unknown
- 2015-12-18 BR BR112017012944-2A patent/BR112017012944A2/pt not_active IP Right Cessation
- 2015-12-18 SG SG10202010170SA patent/SG10202010170SA/en unknown
- 2015-12-18 MY MYPI2017701896A patent/MY185320A/en unknown
- 2015-12-18 AU AU2015364415A patent/AU2015364415B2/en active Active
- 2015-12-18 UY UY0001036458A patent/UY36458A/es not_active Application Discontinuation
- 2015-12-18 MX MX2017008186A patent/MX386403B/es unknown
- 2015-12-18 EA EA201791086A patent/EA036953B1/ru unknown
- 2015-12-18 CA CA2969749A patent/CA2969749A1/en active Pending
-
2017
- 2017-05-24 PH PH12017500949A patent/PH12017500949A1/en unknown
- 2017-06-04 IL IL252659A patent/IL252659B/en active IP Right Grant
- 2017-06-19 MX MX2021007679A patent/MX2021007679A/es unknown
- 2017-06-19 CL CL2017001610A patent/CL2017001610A1/es unknown
- 2017-06-29 CO CONC2017/0006580A patent/CO2017006580A2/es unknown
-
2018
- 2018-12-13 JP JP2018233091A patent/JP2019055996A/ja not_active Withdrawn
-
2019
- 2019-07-25 US US16/522,603 patent/US10689436B2/en active Active
- 2019-08-05 CL CL2019002196A patent/CL2019002196A1/es unknown
-
2020
- 2020-05-08 US US16/870,669 patent/US11453714B2/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013011347A1 (en) * | 2011-07-18 | 2013-01-24 | Institute For Research In Biomedicine | Neutralizing anti-influenza a virus antibodies and uses thereof |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102729973B1 (ko) | 인플루엔자 헤마글루티닌에 대한 인간 항체 | |
| JP7500812B2 (ja) | 中東呼吸器症候群-コロナウイルススパイクタンパク質に対するヒト抗体 | |
| CN113354732B (zh) | 针对埃博拉病毒糖蛋白的人抗体 | |
| KR102820941B1 (ko) | 인플루엔자 헤마글루티닌에 대한 인간 항체 | |
| JP7611908B2 (ja) | 抗血球凝集素抗体およびその使用方法 | |
| EA046393B1 (ru) | Антитела к гемагглютинину и их применение | |
| EA044791B1 (ru) | Человеческие антитела к гемагглютинину вируса гриппа |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
Patent event date: 20170718 Patent event code: PA01051R01D Comment text: International Patent Application |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20201124 Comment text: Request for Examination of Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20230424 Patent event code: PE09021S01D |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20231120 Patent event code: PE09021S01D |
|
| E90F | Notification of reason for final refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Final Notice of Reason for Refusal Patent event date: 20240527 Patent event code: PE09021S02D |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20240906 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20241111 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 20241112 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration |